id	sid	tid	token	lemma	pos
aji-130	1	1	_	_	PUNCT
aji-130	2	1	_	_	PUNCT
aji-130	3	1	_	_	PUNCT
aji-130	4	1	_	_	PUNCT
aji-130	5	1	_	_	PUNCT
aji-130	6	1	_	_	PUNCT
aji-130	7	1	_	_	PUNCT
aji-130	8	1	_	_	PUNCT
aji-130	9	1	_	_	PUNCT
aji-130	10	1	_	_	PUNCT
aji-130	11	1	_	_	PUNCT
aji-130	12	1	_	_	PUNCT
aji-130	13	1	_	_	PUNCT
aji-130	14	1	_	_	PUNCT
aji-130	15	1	_	_	PUNCT
aji-130	16	1	_	_	PUNCT
aji-130	17	1	_	_	PUNCT
aji-130	18	1	_	_	PUNCT
aji-130	19	1	_	_	PUNCT
aji-130	20	1	_	_	PUNCT
aji-130	21	1	_	_	PUNCT
aji-130	22	1	_	_	PUNCT
aji-130	23	1	_	_	PUNCT
aji-130	24	1	_	_	PUNCT
aji-130	25	1	_	_	PUNCT
aji-130	26	1	_	_	PUNCT
aji-130	27	1	_	_	PUNCT
aji-130	28	1	_	_	PUNCT
aji-130	29	1	_	_	PUNCT
aji-130	30	1	_	_	PUNCT
aji-130	31	1	_	_	PUNCT
aji-130	32	1	_	_	PUNCT
aji-130	33	1	_	_	PUNCT
aji-130	34	1	_	_	PUNCT
aji-130	35	1	_	_	PUNCT
aji-130	36	1	_	_	PUNCT
aji-130	37	1	_	_	PUNCT
aji-130	38	1	_	_	PUNCT
aji-130	39	1	_	_	PUNCT
aji-130	40	1	_	_	PUNCT
aji-130	41	1	_	_	PUNCT
aji-130	42	1	_	_	PUNCT
aji-130	43	1	_	_	PUNCT
aji-130	44	1	_	_	PUNCT
aji-130	45	1	_	_	PUNCT
aji-130	46	1	_	_	PUNCT
aji-130	47	1	_	_	PUNCT
aji-130	48	1	_	_	PUNCT
aji-130	49	1	_	_	PUNCT
aji-130	50	1	_	_	PUNCT
aji-130	51	1	_	_	PUNCT
aji-130	52	1	_	_	PUNCT
aji-130	53	1	_	_	PUNCT
aji-130	54	1	_	_	PUNCT
aji-130	55	1	_	_	PUNCT
aji-130	56	1	_	_	PUNCT
aji-130	57	1	_	_	PUNCT
aji-130	58	1	_	_	PUNCT
aji-130	59	1	_	_	PUNCT
aji-130	60	1	_	_	PUNCT
aji-130	61	1	_	_	PUNCT
aji-130	62	1	_	_	PUNCT
aji-130	63	1	_	_	PUNCT
aji-130	64	1	_	_	PUNCT
aji-130	65	1	_	_	PUNCT
aji-130	66	1	_	_	PUNCT
aji-130	67	1	_	_	PUNCT
aji-130	68	1	_	_	PUNCT
aji-130	69	1	_	_	PUNCT
aji-130	70	1	_	_	PUNCT
aji-130	71	1	_	_	PUNCT
aji-130	72	1	_	_	PUNCT
aji-130	73	1	_	_	PUNCT
aji-130	74	1	_	_	PUNCT
aji-130	75	1	_	_	PUNCT
aji-130	76	1	_	_	PUNCT
aji-130	77	1	_	_	PUNCT
aji-130	78	1	_	_	PUNCT
aji-130	79	1	_	_	PUNCT
aji-130	80	1	_	_	PUNCT
aji-130	81	1	_	_	PUNCT
aji-130	82	1	_	_	PUNCT
aji-130	83	1	_	_	PUNCT
aji-130	84	1	_	_	PUNCT
aji-130	85	1	_	_	PUNCT
aji-130	86	1	_	_	PUNCT
aji-130	87	1	_	_	PUNCT
aji-130	88	1	_	_	PUNCT
aji-130	89	1	_	_	PUNCT
aji-130	90	1	_	_	PUNCT
aji-130	91	1	_	_	PUNCT
aji-130	92	1	_	_	PUNCT
aji-130	93	1	_	_	PUNCT
aji-130	94	1	_	_	PUNCT
aji-130	95	1	_	_	PUNCT
aji-130	96	1	_	_	PUNCT
aji-130	97	1	_	_	PUNCT
aji-130	98	1	_	_	PUNCT
aji-130	99	1	_	_	PUNCT
aji-130	100	1	_	_	PUNCT
aji-130	101	1	_	_	PUNCT
aji-130	102	1	*	*	PUNCT
aji-130	102	2	corresponding	correspond	VERB
aji-130	102	3	author	author	NOUN
aji-130	102	4	:	:	PUNCT
aji-130	102	5	e	e	NOUN
aji-130	102	6	-	-	NOUN
aji-130	102	7	mail	mail	NOUN
aji-130	102	8	:	:	PUNCT
aji-130	102	9	celso@alergoimuno.med.br	celso@alergoimuno.med.br	ADJ
aji-130	102	10	;	;	PUNCT
aji-130	102	11	asian	asian	ADJ
aji-130	102	12	j.	j.	PROPN
aji-130	102	13	immunol	immunol	PROPN
aji-130	102	14	.	.	PROPN
aji-130	102	15	,	,	PUNCT
aji-130	102	16	vol	vol	NOUN
aji-130	102	17	.	.	PROPN
aji-130	102	18	7	7	NUM
aji-130	102	19	,	,	PUNCT
aji-130	102	20	no	no	INTJ
aji-130	102	21	.	.	NOUN
aji-130	102	22	1	1	NUM
aji-130	102	23	,	,	PUNCT
aji-130	102	24	pp	pp	ADJ
aji-130	102	25	.	.	PUNCT
aji-130	103	1	63	63	NUM
aji-130	103	2	-	-	SYM
aji-130	103	3	70	70	NUM
aji-130	103	4	,	,	PUNCT
aji-130	103	5	2024	2024	NUM
aji-130	103	6	asian	asian	ADJ
aji-130	103	7	journal	journal	NOUN
aji-130	103	8	of	of	ADP
aji-130	103	9	immunology	immunology	NOUN
aji-130	103	10	volume	volume	NOUN
aji-130	103	11	7	7	NUM
aji-130	103	12	,	,	PUNCT
aji-130	103	13	issue	issue	NOUN
aji-130	103	14	1	1	NUM
aji-130	103	15	,	,	PUNCT
aji-130	103	16	page	page	NOUN
aji-130	103	17	63	63	NUM
aji-130	103	18	-	-	SYM
aji-130	103	19	70	70	NUM
aji-130	103	20	,	,	PUNCT
aji-130	103	21	2024	2024	NUM
aji-130	103	22	;	;	PUNCT
aji-130	103	23	article	article	NOUN
aji-130	103	24	no.aji.115657	no.aji.115657	ADP
aji-130	103	25	exploring	explore	VERB
aji-130	103	26	the	the	DET
aji-130	103	27	role	role	NOUN
aji-130	103	28	of	of	ADP
aji-130	103	29	leukocyte	leukocyte	NOUN
aji-130	103	30	adherence	adherence	NOUN
aji-130	103	31	inhibition	inhibition	NOUN
aji-130	103	32	test	test	NOUN
aji-130	103	33	in	in	ADP
aji-130	103	34	assessing	assess	VERB
aji-130	103	35	non	non	ADJ
aji-130	103	36	-	-	ADJ
aji-130	103	37	ige	ige	ADJ
aji-130	103	38	mediated	mediate	VERB
aji-130	103	39	immunoreactivity	immunoreactivity	NOUN
aji-130	103	40	to	to	ADP
aji-130	103	41	benzoic	benzoic	NOUN
aji-130	103	42	acid	acid	NOUN
aji-130	103	43	in	in	ADP
aji-130	103	44	allergic	allergic	ADJ
aji-130	103	45	patients	patient	NOUN
aji-130	103	46	celso	celso	PROPN
aji-130	103	47	eduardo	eduardo	PROPN
aji-130	103	48	olivier	olivier	PROPN
aji-130	103	49	a	a	PROPN
aji-130	103	50	*	*	PROPN
aji-130	103	51	,	,	PUNCT
aji-130	103	52	daiana	daiana	PROPN
aji-130	103	53	guedes	guede	VERB
aji-130	103	54	pinto	pinto	NOUN
aji-130	103	55	a	a	PRON
aji-130	103	56	,	,	PUNCT
aji-130	103	57	ana	ana	PROPN
aji-130	103	58	paula	paula	PROPN
aji-130	103	59	monezzi	monezzi	PROPN
aji-130	103	60	teixeira	teixeira	PROPN
aji-130	103	61	a	a	PROPN
aji-130	103	62	,	,	PUNCT
aji-130	103	63	jhéssica	jhéssica	PROPN
aji-130	103	64	letícia	letícia	PROPN
aji-130	103	65	santos	santo	VERB
aji-130	103	66	santana	santana	PROPN
aji-130	103	67	a	a	PROPN
aji-130	103	68	,	,	PUNCT
aji-130	103	69	raquel	raquel	NOUN
aji-130	103	70	acácia	acácia	PROPN
aji-130	103	71	pereira	pereira	PROPN
aji-130	103	72	gonçalves	gonçalves	PROPN
aji-130	103	73	santos	santos	PROPN
aji-130	103	74	a	a	PRON
aji-130	103	75	,	,	PUNCT
aji-130	103	76	and	and	CCONJ
aji-130	103	77	regiane	regiane	VERB
aji-130	103	78	patussi	patussi	PROPN
aji-130	103	79	santos	santos	PROPN
aji-130	103	80	lima	lima	PROPN
aji-130	103	81	b	b	PROPN
aji-130	103	82	a	a	DET
aji-130	103	83	instituto	instituto	PROPN
aji-130	103	84	alergoimuno	alergoimuno	PROPN
aji-130	103	85	de	de	X
aji-130	103	86	americana	americana	PROPN
aji-130	103	87	,	,	PUNCT
aji-130	103	88	brazil	brazil	PROPN
aji-130	103	89	.	.	PUNCT
aji-130	104	1	b	b	PROPN
aji-130	104	2	lavoisier	lavoisier	NOUN
aji-130	104	3	’s	’s	PART
aji-130	104	4	laboratories	laboratory	NOUN
aji-130	104	5	,	,	PUNCT
aji-130	104	6	são	são	PROPN
aji-130	104	7	paulo	paulo	PROPN
aji-130	104	8	,	,	PUNCT
aji-130	104	9	brazil	brazil	PROPN
aji-130	104	10	.	.	PUNCT
aji-130	105	1	authors	author	NOUN
aji-130	105	2	’	’	PART
aji-130	105	3	contributions	contribution	NOUN
aji-130	105	4	this	this	DET
aji-130	105	5	work	work	NOUN
aji-130	105	6	was	be	AUX
aji-130	105	7	carried	carry	VERB
aji-130	105	8	out	out	ADP
aji-130	105	9	in	in	ADP
aji-130	105	10	collaboration	collaboration	NOUN
aji-130	105	11	among	among	ADP
aji-130	105	12	all	all	DET
aji-130	105	13	authors	author	NOUN
aji-130	105	14	.	.	PUNCT
aji-130	106	1	all	all	DET
aji-130	106	2	authors	author	NOUN
aji-130	106	3	read	read	VERB
aji-130	106	4	and	and	CCONJ
aji-130	106	5	approved	approve	VERB
aji-130	106	6	the	the	DET
aji-130	106	7	final	final	ADJ
aji-130	106	8	manuscript	manuscript	NOUN
aji-130	106	9	.	.	PUNCT
aji-130	107	1	article	article	NOUN
aji-130	107	2	information	information	PROPN
aji-130	107	3	doi	doi	PROPN
aji-130	107	4	:	:	PUNCT
aji-130	107	5	https://doi.org/10.9734/aji/2024/v7i1130	https://doi.org/10.9734/aji/2024/v7i1130	PROPN
aji-130	107	6	open	open	ADJ
aji-130	107	7	peer	peer	NOUN
aji-130	107	8	review	review	NOUN
aji-130	107	9	history	history	NOUN
aji-130	107	10	:	:	PUNCT
aji-130	107	11	this	this	DET
aji-130	107	12	journal	journal	NOUN
aji-130	107	13	follows	follow	VERB
aji-130	107	14	the	the	DET
aji-130	107	15	advanced	advance	VERB
aji-130	107	16	open	open	ADJ
aji-130	107	17	peer	peer	NOUN
aji-130	107	18	review	review	NOUN
aji-130	107	19	policy	policy	NOUN
aji-130	107	20	.	.	PUNCT
aji-130	108	1	identity	identity	NOUN
aji-130	108	2	of	of	ADP
aji-130	108	3	the	the	DET
aji-130	108	4	reviewers	reviewer	NOUN
aji-130	108	5	,	,	PUNCT
aji-130	108	6	editor(s	editor(s	NOUN
aji-130	108	7	)	)	PUNCT
aji-130	108	8	and	and	CCONJ
aji-130	108	9	additional	additional	ADJ
aji-130	108	10	reviewers	reviewer	NOUN
aji-130	108	11	,	,	PUNCT
aji-130	108	12	peer	peer	NOUN
aji-130	108	13	review	review	NOUN
aji-130	108	14	comments	comment	NOUN
aji-130	108	15	,	,	PUNCT
aji-130	108	16	different	different	ADJ
aji-130	108	17	versions	version	NOUN
aji-130	108	18	of	of	ADP
aji-130	108	19	the	the	DET
aji-130	108	20	manuscript	manuscript	NOUN
aji-130	108	21	,	,	PUNCT
aji-130	108	22	comments	comment	NOUN
aji-130	108	23	of	of	ADP
aji-130	108	24	the	the	DET
aji-130	108	25	editors	editor	NOUN
aji-130	108	26	,	,	PUNCT
aji-130	108	27	etc	etc	X
aji-130	108	28	are	be	AUX
aji-130	108	29	available	available	ADJ
aji-130	108	30	here	here	ADV
aji-130	108	31	:	:	PUNCT
aji-130	108	32	https://www.sdiarticle5.com/review-history/115657	https://www.sdiarticle5.com/review-history/115657	PROPN
aji-130	108	33	received	receive	VERB
aji-130	108	34	:	:	PUNCT
aji-130	108	35	02/04/2024	02/04/2024	NUM
aji-130	108	36	accepted	accept	VERB
aji-130	108	37	:	:	PUNCT
aji-130	108	38	13/04/2024	13/04/2024	NUM
aji-130	108	39	published	publish	VERB
aji-130	108	40	:	:	PUNCT
aji-130	108	41	17/04/2024	17/04/2024	NUM
aji-130	108	42	abstract	abstract	ADJ
aji-130	108	43	background	background	NOUN
aji-130	108	44	:	:	PUNCT
aji-130	108	45	several	several	ADJ
aji-130	108	46	publications	publication	NOUN
aji-130	108	47	report	report	VERB
aji-130	108	48	benzoic	benzoic	NOUN
aji-130	108	49	acid	acid	NOUN
aji-130	108	50	as	as	ADP
aji-130	108	51	responsible	responsible	ADJ
aji-130	108	52	for	for	ADP
aji-130	108	53	non	non	ADJ
aji-130	108	54	–	–	PUNCT
aji-130	108	55	ige	ige	ADJ
aji-130	108	56	-	-	PUNCT
aji-130	108	57	mediated	mediate	VERB
aji-130	108	58	allergic	allergic	ADJ
aji-130	108	59	reactions	reaction	NOUN
aji-130	108	60	.	.	PUNCT
aji-130	109	1	no	no	DET
aji-130	109	2	standardized	standardized	ADJ
aji-130	109	3	lab	lab	NOUN
aji-130	109	4	exam	exam	NOUN
aji-130	109	5	identifies	identify	VERB
aji-130	109	6	these	these	DET
aji-130	109	7	reactions	reaction	NOUN
aji-130	109	8	besides	besides	ADV
aji-130	109	9	in	in	ADP
aji-130	109	10	vivo	vivo	ADJ
aji-130	109	11	provocation	provocation	NOUN
aji-130	109	12	tests	test	NOUN
aji-130	109	13	.	.	PUNCT
aji-130	110	1	aim	aim	VERB
aji-130	110	2	:	:	PUNCT
aji-130	110	3	to	to	PART
aji-130	110	4	evaluate	evaluate	VERB
aji-130	110	5	the	the	DET
aji-130	110	6	potential	potential	NOUN
aji-130	110	7	of	of	ADP
aji-130	110	8	the	the	DET
aji-130	110	9	leukocyte	leukocyte	NOUN
aji-130	110	10	adherence	adherence	NOUN
aji-130	110	11	inhibition	inhibition	NOUN
aji-130	110	12	test	test	NOUN
aji-130	110	13	(	(	PUNCT
aji-130	110	14	lait	lait	NOUN
aji-130	110	15	)	)	PUNCT
aji-130	110	16	to	to	PART
aji-130	110	17	discriminate	discriminate	VERB
aji-130	110	18	non	non	ADJ
aji-130	110	19	–	–	PUNCT
aji-130	110	20	ige	ige	ADJ
aji-130	110	21	-	-	PUNCT
aji-130	110	22	mediated	mediate	VERB
aji-130	110	23	immunoreactivity	immunoreactivity	NOUN
aji-130	110	24	against	against	ADP
aji-130	110	25	benzoic	benzoic	ADJ
aji-130	110	26	acid	acid	NOUN
aji-130	110	27	in	in	ADP
aji-130	110	28	patients	patient	NOUN
aji-130	110	29	with	with	ADP
aji-130	110	30	non	non	ADJ
aji-130	110	31	–	–	PUNCT
aji-130	110	32	ige	ige	ADJ
aji-130	110	33	-	-	PUNCT
aji-130	110	34	mediated	mediate	VERB
aji-130	110	35	allergic	allergic	ADJ
aji-130	110	36	phenotypes	phenotype	NOUN
aji-130	110	37	.	.	PUNCT
aji-130	111	1	original	original	ADJ
aji-130	111	2	research	research	NOUN
aji-130	111	3	article	article	NOUN
aji-130	111	4	https://doi.org/10.9734/aji/2024/v7i1130	https://doi.org/10.9734/aji/2024/v7i1130	PROPN
aji-130	111	5	olivier	olivier	NOUN
aji-130	111	6	et	et	PROPN
aji-130	111	7	al	al	PROPN
aji-130	111	8	.	.	PROPN
aji-130	111	9	;	;	PUNCT
aji-130	111	10	asian	asian	PROPN
aji-130	111	11	j.	j.	PROPN
aji-130	111	12	immunol	immunol	PROPN
aji-130	111	13	.	.	PROPN
aji-130	111	14	,	,	PUNCT
aji-130	111	15	vol	vol	NOUN
aji-130	111	16	.	.	PROPN
aji-130	111	17	7	7	NUM
aji-130	111	18	,	,	PUNCT
aji-130	111	19	no	no	INTJ
aji-130	111	20	.	.	NOUN
aji-130	111	21	1	1	NUM
aji-130	111	22	,	,	PUNCT
aji-130	111	23	pp	pp	ADJ
aji-130	111	24	.	.	PUNCT
aji-130	112	1	63	63	NUM
aji-130	112	2	-	-	SYM
aji-130	112	3	70	70	NUM
aji-130	112	4	,	,	PUNCT
aji-130	112	5	2024	2024	NUM
aji-130	112	6	;	;	PUNCT
aji-130	112	7	article	article	NOUN
aji-130	112	8	no.aji.115657	no.aji.115657	ADP
aji-130	112	9	64	64	NUM
aji-130	112	10	study	study	NOUN
aji-130	112	11	design	design	NOUN
aji-130	112	12	:	:	PUNCT
aji-130	112	13	we	we	PRON
aji-130	112	14	retrospectively	retrospectively	ADV
aji-130	112	15	examined	examine	VERB
aji-130	112	16	the	the	DET
aji-130	112	17	medical	medical	ADJ
aji-130	112	18	charts	chart	NOUN
aji-130	112	19	of	of	ADP
aji-130	112	20	100	100	NUM
aji-130	112	21	patients	patient	NOUN
aji-130	112	22	diagnosed	diagnose	VERB
aji-130	112	23	with	with	ADP
aji-130	112	24	allergic	allergic	ADJ
aji-130	112	25	rhinitis	rhinitis	NOUN
aji-130	112	26	,	,	PUNCT
aji-130	112	27	allergic	allergic	ADJ
aji-130	112	28	bronchitis	bronchitis	NOUN
aji-130	112	29	,	,	PUNCT
aji-130	112	30	asthma	asthma	NOUN
aji-130	112	31	,	,	PUNCT
aji-130	112	32	sinus	sinus	NOUN
aji-130	112	33	headache	headache	NOUN
aji-130	112	34	,	,	PUNCT
aji-130	112	35	atopic	atopic	NOUN
aji-130	112	36	dermatitis	dermatitis	NOUN
aji-130	112	37	,	,	PUNCT
aji-130	112	38	and/or	and/or	CCONJ
aji-130	112	39	urticaria	urticaria	NOUN
aji-130	112	40	with	with	ADP
aji-130	112	41	clinical	clinical	ADJ
aji-130	112	42	suspicion	suspicion	NOUN
aji-130	112	43	of	of	ADP
aji-130	112	44	non	non	ADJ
aji-130	112	45	–	–	PUNCT
aji-130	112	46	ige	ige	ADJ
aji-130	112	47	-	-	PUNCT
aji-130	112	48	mediated	mediate	VERB
aji-130	112	49	benzoic	benzoic	ADJ
aji-130	112	50	acid	acid	NOUN
aji-130	112	51	hypersensitivity	hypersensitivity	NOUN
aji-130	112	52	who	who	PRON
aji-130	112	53	were	be	AUX
aji-130	112	54	investigated	investigate	VERB
aji-130	112	55	with	with	ADP
aji-130	112	56	ex	ex	X
aji-130	112	57	vivo	vivo	NOUN
aji-130	112	58	challenge	challenge	NOUN
aji-130	112	59	test	test	NOUN
aji-130	112	60	monitored	monitor	VERB
aji-130	112	61	by	by	ADP
aji-130	112	62	lait	lait	NOUN
aji-130	112	63	against	against	ADP
aji-130	112	64	benzoic	benzoic	ADJ
aji-130	112	65	acid	acid	NOUN
aji-130	112	66	.	.	PUNCT
aji-130	113	1	the	the	DET
aji-130	113	2	cohort	cohort	NOUN
aji-130	113	3	counted	count	VERB
aji-130	113	4	30	30	NUM
aji-130	113	5	males	male	NOUN
aji-130	113	6	;	;	PUNCT
aji-130	113	7	the	the	DET
aji-130	113	8	mean	mean	ADJ
aji-130	113	9	age	age	NOUN
aji-130	113	10	was	be	AUX
aji-130	113	11	41.9	41.9	NUM
aji-130	113	12	years	year	NOUN
aji-130	113	13	,	,	PUNCT
aji-130	113	14	the	the	DET
aji-130	113	15	sd	sd	NOUN
aji-130	113	16	was	be	AUX
aji-130	113	17	20.4	20.4	NUM
aji-130	113	18	years	year	NOUN
aji-130	113	19	,	,	PUNCT
aji-130	113	20	and	and	CCONJ
aji-130	113	21	the	the	DET
aji-130	113	22	range	range	NOUN
aji-130	113	23	was	be	AUX
aji-130	113	24	2	2	NUM
aji-130	113	25	to	to	PART
aji-130	113	26	90	90	NUM
aji-130	113	27	years	year	NOUN
aji-130	113	28	.	.	PUNCT
aji-130	114	1	place	place	NOUN
aji-130	114	2	and	and	CCONJ
aji-130	114	3	duration	duration	NOUN
aji-130	114	4	of	of	ADP
aji-130	114	5	study	study	NOUN
aji-130	114	6	:	:	PUNCT
aji-130	114	7	instituto	instituto	PROPN
aji-130	114	8	alergoimuno	alergoimuno	PROPN
aji-130	114	9	de	de	X
aji-130	114	10	americana	americana	PROPN
aji-130	114	11	–	–	PUNCT
aji-130	114	12	são	são	PROPN
aji-130	114	13	paulo	paulo	PROPN
aji-130	114	14	–	–	PUNCT
aji-130	114	15	brazil	brazil	PROPN
aji-130	114	16	–	–	PUNCT
aji-130	114	17	between	between	ADP
aji-130	114	18	january	january	PROPN
aji-130	114	19	2018	2018	NUM
aji-130	114	20	and	and	CCONJ
aji-130	114	21	march	march	PROPN
aji-130	114	22	2024	2024	NUM
aji-130	114	23	.	.	PUNCT
aji-130	115	1	methodology	methodology	NOUN
aji-130	115	2	:	:	PUNCT
aji-130	115	3	the	the	DET
aji-130	115	4	percentage	percentage	NOUN
aji-130	115	5	of	of	ADP
aji-130	115	6	leukocyte	leukocyte	NOUN
aji-130	115	7	adherence	adherence	NOUN
aji-130	115	8	inhibition	inhibition	NOUN
aji-130	115	9	(	(	PUNCT
aji-130	115	10	lai	lai	PROPN
aji-130	115	11	)	)	PUNCT
aji-130	115	12	promoted	promote	VERB
aji-130	115	13	by	by	ADP
aji-130	115	14	the	the	DET
aji-130	115	15	ex	ex	ADJ
aji-130	115	16	vivo	vivo	ADJ
aji-130	115	17	challenges	challenge	NOUN
aji-130	115	18	against	against	ADP
aji-130	115	19	1	1	NUM
aji-130	115	20	mg	mg	NUM
aji-130	115	21	/	/	SYM
aji-130	115	22	ml	ml	NOUN
aji-130	115	23	benzoic	benzoic	ADJ
aji-130	115	24	acid	acid	NOUN
aji-130	115	25	was	be	AUX
aji-130	115	26	distributed	distribute	VERB
aji-130	115	27	in	in	ADP
aji-130	115	28	ranges	range	NOUN
aji-130	115	29	through	through	ADP
aji-130	115	30	a	a	DET
aji-130	115	31	cascade	cascade	NOUN
aji-130	115	32	distribution	distribution	NOUN
aji-130	115	33	chart	chart	NOUN
aji-130	115	34	to	to	PART
aji-130	115	35	outline	outline	VERB
aji-130	115	36	the	the	DET
aji-130	115	37	variability	variability	NOUN
aji-130	115	38	of	of	ADP
aji-130	115	39	the	the	DET
aji-130	115	40	results	result	NOUN
aji-130	115	41	.	.	PUNCT
aji-130	116	1	results	result	NOUN
aji-130	116	2	:	:	PUNCT
aji-130	116	3	the	the	DET
aji-130	116	4	lai	lai	PROPN
aji-130	116	5	ranged	range	VERB
aji-130	116	6	from	from	ADP
aji-130	116	7	0	0	NUM
aji-130	116	8	%	%	NOUN
aji-130	116	9	to	to	PART
aji-130	116	10	97	97	NUM
aji-130	116	11	%	%	NOUN
aji-130	116	12	;	;	PUNCT
aji-130	116	13	the	the	DET
aji-130	116	14	mean	mean	NOUN
aji-130	116	15	was	be	AUX
aji-130	116	16	41.1	41.1	NUM
aji-130	116	17	%	%	NOUN
aji-130	116	18	;	;	PUNCT
aji-130	116	19	the	the	DET
aji-130	116	20	median	median	NOUN
aji-130	116	21	was	be	AUX
aji-130	116	22	40.5	40.5	NUM
aji-130	116	23	%	%	NOUN
aji-130	116	24	;	;	PUNCT
aji-130	116	25	the	the	DET
aji-130	116	26	standard	standard	ADJ
aji-130	116	27	deviation	deviation	NOUN
aji-130	116	28	was	be	AUX
aji-130	116	29	24.2	24.2	NUM
aji-130	116	30	%	%	NOUN
aji-130	116	31	;	;	PUNCT
aji-130	116	32	the	the	DET
aji-130	116	33	mode	mode	NOUN
aji-130	116	34	was	be	AUX
aji-130	116	35	0	0	NUM
aji-130	116	36	and	and	CCONJ
aji-130	116	37	59	59	NUM
aji-130	116	38	(	(	PUNCT
aji-130	116	39	each	each	PRON
aji-130	116	40	appeared	appear	VERB
aji-130	116	41	four	four	NUM
aji-130	116	42	times	time	NOUN
aji-130	116	43	)	)	PUNCT
aji-130	116	44	.	.	PUNCT
aji-130	117	1	the	the	DET
aji-130	117	2	cascade	cascade	NOUN
aji-130	117	3	distribution	distribution	NOUN
aji-130	117	4	demonstrates	demonstrate	VERB
aji-130	117	5	a	a	DET
aji-130	117	6	wide	wide	ADJ
aji-130	117	7	distribution	distribution	NOUN
aji-130	117	8	of	of	ADP
aji-130	117	9	lai	lai	PROPN
aji-130	117	10	results	result	NOUN
aji-130	117	11	.	.	PUNCT
aji-130	118	1	this	this	DET
aji-130	118	2	extensive	extensive	ADJ
aji-130	118	3	distribution	distribution	NOUN
aji-130	118	4	of	of	ADP
aji-130	118	5	lai	lai	PROPN
aji-130	118	6	results	result	NOUN
aji-130	118	7	suggests	suggest	VERB
aji-130	118	8	that	that	SCONJ
aji-130	118	9	some	some	DET
aji-130	118	10	patients	patient	NOUN
aji-130	118	11	had	have	VERB
aji-130	118	12	mild	mild	ADJ
aji-130	118	13	,	,	PUNCT
aji-130	118	14	moderate	moderate	ADJ
aji-130	118	15	,	,	PUNCT
aji-130	118	16	or	or	CCONJ
aji-130	118	17	severe	severe	ADJ
aji-130	118	18	non	non	ADJ
aji-130	118	19	–	–	PUNCT
aji-130	118	20	ige	ige	ADJ
aji-130	118	21	-	-	PUNCT
aji-130	118	22	mediated	mediate	VERB
aji-130	118	23	immunoreactivity	immunoreactivity	NOUN
aji-130	118	24	against	against	ADP
aji-130	118	25	benzoic	benzoic	ADJ
aji-130	118	26	acid	acid	NOUN
aji-130	118	27	,	,	PUNCT
aji-130	118	28	while	while	SCONJ
aji-130	118	29	others	other	NOUN
aji-130	118	30	did	do	AUX
aji-130	118	31	not	not	PART
aji-130	118	32	present	present	VERB
aji-130	118	33	any	any	DET
aji-130	118	34	immunoreactivity	immunoreactivity	NOUN
aji-130	118	35	against	against	ADP
aji-130	118	36	it	it	PRON
aji-130	118	37	.	.	PUNCT
aji-130	119	1	conclusion	conclusion	NOUN
aji-130	119	2	:	:	PUNCT
aji-130	119	3	our	our	PRON
aji-130	119	4	preliminary	preliminary	ADJ
aji-130	119	5	results	result	NOUN
aji-130	119	6	support	support	VERB
aji-130	119	7	that	that	SCONJ
aji-130	119	8	the	the	DET
aji-130	119	9	lait	lait	NOUN
aji-130	119	10	performed	perform	VERB
aji-130	119	11	with	with	ADP
aji-130	119	12	benzoic	benzoic	ADJ
aji-130	119	13	acid	acid	NOUN
aji-130	119	14	may	may	AUX
aji-130	119	15	discriminate	discriminate	VERB
aji-130	119	16	diverse	diverse	ADJ
aji-130	119	17	degrees	degree	NOUN
aji-130	119	18	of	of	ADP
aji-130	119	19	ex	ex	X
aji-130	119	20	vivo	vivo	NOUN
aji-130	119	21	immunoreactivity	immunoreactivity	NOUN
aji-130	119	22	in	in	ADP
aji-130	119	23	patients	patient	NOUN
aji-130	119	24	suffering	suffer	VERB
aji-130	119	25	from	from	ADP
aji-130	119	26	diversified	diversified	ADJ
aji-130	119	27	allergic	allergic	ADJ
aji-130	119	28	phenotypes	phenotype	NOUN
aji-130	119	29	.	.	PUNCT
aji-130	120	1	it	it	PRON
aji-130	120	2	is	be	AUX
aji-130	120	3	worth	worth	ADJ
aji-130	120	4	carrying	carry	VERB
aji-130	120	5	out	out	ADP
aji-130	120	6	more	more	ADV
aji-130	120	7	in	in	ADP
aji-130	120	8	-	-	PUNCT
aji-130	120	9	depth	depth	NOUN
aji-130	120	10	studies	study	NOUN
aji-130	120	11	to	to	PART
aji-130	120	12	evaluate	evaluate	VERB
aji-130	120	13	the	the	DET
aji-130	120	14	usefulness	usefulness	NOUN
aji-130	120	15	of	of	ADP
aji-130	120	16	lait	lait	NOUN
aji-130	120	17	in	in	ADP
aji-130	120	18	diagnosing	diagnose	VERB
aji-130	120	19	non	non	ADJ
aji-130	120	20	–	–	PUNCT
aji-130	120	21	ige	ige	ADJ
aji-130	120	22	-	-	PUNCT
aji-130	120	23	mediated	mediate	VERB
aji-130	120	24	benzoic	benzoic	ADJ
aji-130	120	25	acid	acid	NOUN
aji-130	120	26	allergies	allergy	NOUN
aji-130	120	27	.	.	PUNCT
aji-130	121	1	keywords	keyword	NOUN
aji-130	121	2	:	:	PUNCT
aji-130	121	3	allergy	allergy	NOUN
aji-130	121	4	;	;	PUNCT
aji-130	121	5	asthma	asthma	NOUN
aji-130	121	6	;	;	PUNCT
aji-130	121	7	atopic	atopic	NOUN
aji-130	121	8	dermatitis	dermatitis	NOUN
aji-130	121	9	;	;	PUNCT
aji-130	121	10	bronchitis	bronchitis	NOUN
aji-130	121	11	;	;	PUNCT
aji-130	121	12	diagnosis	diagnosis	NOUN
aji-130	121	13	;	;	PUNCT
aji-130	121	14	exposome	exposome	NOUN
aji-130	121	15	-	-	PUNCT
aji-130	121	16	wide	wide	ADJ
aji-130	121	17	association	association	NOUN
aji-130	121	18	study	study	NOUN
aji-130	121	19	;	;	PUNCT
aji-130	121	20	hypersensitivity	hypersensitivity	NOUN
aji-130	121	21	;	;	PUNCT
aji-130	121	22	leukocyte	leukocyte	ADJ
aji-130	121	23	adherence	adherence	NOUN
aji-130	121	24	inhibition	inhibition	NOUN
aji-130	121	25	test	test	NOUN
aji-130	121	26	;	;	PUNCT
aji-130	121	27	non	non	ADJ
aji-130	121	28	–	–	PUNCT
aji-130	121	29	ige	ige	ADJ
aji-130	121	30	-	-	PUNCT
aji-130	121	31	mediated	mediate	VERB
aji-130	121	32	immunoreactivity	immunoreactivity	NOUN
aji-130	121	33	;	;	PUNCT
aji-130	121	34	precision	precision	NOUN
aji-130	121	35	medicine	medicine	NOUN
aji-130	121	36	;	;	PUNCT
aji-130	121	37	rhinitis	rhinitis	NOUN
aji-130	121	38	;	;	PUNCT
aji-130	121	39	sinus	sinus	NOUN
aji-130	121	40	headache	headache	NOUN
aji-130	121	41	;	;	PUNCT
aji-130	121	42	urticaria	urticaria	NOUN
aji-130	121	43	.	.	PUNCT
aji-130	122	1	abbreviations	abbreviation	NOUN
aji-130	122	2	lai	lai	NOUN
aji-130	122	3	:	:	PUNCT
aji-130	122	4	leukocyte	leukocyte	NOUN
aji-130	122	5	adherence	adherence	NOUN
aji-130	122	6	inhibition	inhibition	NOUN
aji-130	122	7	lait	lait	NOUN
aji-130	122	8	:	:	PUNCT
aji-130	122	9	leukocyte	leukocyte	ADJ
aji-130	122	10	adherence	adherence	NOUN
aji-130	122	11	inhibition	inhibition	NOUN
aji-130	122	12	test	test	NOUN
aji-130	122	13	1	1	NUM
aji-130	122	14	.	.	PUNCT
aji-130	123	1	introduction	introduction	NOUN
aji-130	123	2	benzoic	benzoic	PROPN
aji-130	123	3	acid	acid	NOUN
aji-130	123	4	is	be	AUX
aji-130	123	5	an	an	DET
aji-130	123	6	organic	organic	ADJ
aji-130	123	7	compound	compound	NOUN
aji-130	123	8	formed	form	VERB
aji-130	123	9	by	by	ADP
aji-130	123	10	an	an	DET
aji-130	123	11	aromatic	aromatic	ADJ
aji-130	123	12	ring	ring	NOUN
aji-130	123	13	and	and	CCONJ
aji-130	123	14	a	a	DET
aji-130	123	15	carboxyl	carboxyl	NOUN
aji-130	123	16	group	group	NOUN
aji-130	123	17	[	[	X
aji-130	123	18	1	1	NUM
aji-130	123	19	]	]	PUNCT
aji-130	123	20	.	.	PUNCT
aji-130	124	1	benzoic	benzoic	PROPN
aji-130	124	2	acid	acid	NOUN
aji-130	124	3	is	be	AUX
aji-130	124	4	a	a	DET
aji-130	124	5	parent	parent	NOUN
aji-130	124	6	and	and	CCONJ
aji-130	124	7	a	a	DET
aji-130	124	8	metabolic	metabolic	ADJ
aji-130	124	9	common	common	ADJ
aji-130	124	10	pathway	pathway	NOUN
aji-130	124	11	of	of	ADP
aji-130	124	12	a	a	DET
aji-130	124	13	large	large	ADJ
aji-130	124	14	group	group	NOUN
aji-130	124	15	of	of	ADP
aji-130	124	16	structurally	structurally	ADV
aji-130	124	17	related	related	ADJ
aji-130	124	18	substances	substance	NOUN
aji-130	124	19	(	(	PUNCT
aji-130	124	20	aromatic	aromatic	ADJ
aji-130	124	21	salts	salt	NOUN
aji-130	124	22	,	,	PUNCT
aji-130	124	23	alcohols	alcohol	NOUN
aji-130	124	24	,	,	PUNCT
aji-130	124	25	aldehydes	aldehyde	NOUN
aji-130	124	26	,	,	PUNCT
aji-130	124	27	esters	ester	NOUN
aji-130	124	28	,	,	PUNCT
aji-130	124	29	and	and	CCONJ
aji-130	124	30	acetals	acetal	NOUN
aji-130	124	31	)	)	PUNCT
aji-130	124	32	legally	legally	ADV
aji-130	124	33	regulated	regulate	VERB
aji-130	124	34	to	to	PART
aji-130	124	35	be	be	AUX
aji-130	124	36	used	use	VERB
aji-130	124	37	as	as	ADP
aji-130	124	38	additives	additive	NOUN
aji-130	124	39	to	to	ADP
aji-130	124	40	industrialized	industrialize	VERB
aji-130	124	41	foods	food	NOUN
aji-130	124	42	,	,	PUNCT
aji-130	124	43	cosmetics	cosmetic	NOUN
aji-130	124	44	,	,	PUNCT
aji-130	124	45	and	and	CCONJ
aji-130	124	46	medicaments	medicament	NOUN
aji-130	124	47	[	[	X
aji-130	124	48	2	2	NUM
aji-130	124	49	]	]	PUNCT
aji-130	124	50	.	.	PUNCT
aji-130	125	1	used	use	VERB
aji-130	125	2	as	as	ADP
aji-130	125	3	an	an	DET
aji-130	125	4	antimicrobial	antimicrobial	ADJ
aji-130	125	5	,	,	PUNCT
aji-130	125	6	the	the	DET
aji-130	125	7	legally	legally	ADV
aji-130	125	8	acceptable	acceptable	ADJ
aji-130	125	9	daily	daily	ADJ
aji-130	125	10	intake	intake	NOUN
aji-130	125	11	uppermost	uppermost	ADJ
aji-130	125	12	limit	limit	NOUN
aji-130	125	13	for	for	ADP
aji-130	125	14	benzoic	benzoic	ADJ
aji-130	125	15	acid	acid	NOUN
aji-130	125	16	(	(	PUNCT
aji-130	125	17	or	or	CCONJ
aji-130	125	18	the	the	DET
aji-130	125	19	benzyl	benzyl	NOUN
aji-130	125	20	/	/	SYM
aji-130	125	21	benzoic	benzoic	NOUN
aji-130	125	22	moiety	moiety	NOUN
aji-130	125	23	)	)	PUNCT
aji-130	125	24	is	be	AUX
aji-130	125	25	5.0	5.0	NUM
aji-130	125	26	mg	mg	NUM
aji-130	125	27	/	/	SYM
aji-130	125	28	kg	kg	PROPN
aji-130	125	29	body	body	NOUN
aji-130	125	30	weight	weight	NOUN
aji-130	126	1	[	[	X
aji-130	126	2	3	3	NUM
aji-130	126	3	]	]	PUNCT
aji-130	126	4	.	.	PUNCT
aji-130	127	1	“	"	PUNCT
aji-130	127	2	there	there	PRON
aji-130	127	3	is	be	VERB
aji-130	127	4	evidence	evidence	NOUN
aji-130	127	5	that	that	SCONJ
aji-130	127	6	benzyl	benzyl	NOUN
aji-130	127	7	benzoate	benzoate	NOUN
aji-130	127	8	is	be	AUX
aji-130	127	9	hydrolyzed	hydrolyze	VERB
aji-130	127	10	to	to	PART
aji-130	127	11	benzyl	benzyl	VERB
aji-130	127	12	alcohol	alcohol	NOUN
aji-130	127	13	and	and	CCONJ
aji-130	127	14	benzoic	benzoic	ADJ
aji-130	127	15	acid	acid	NOUN
aji-130	127	16	;	;	PUNCT
aji-130	127	17	as	as	ADV
aji-130	127	18	well	well	ADV
aji-130	127	19	,	,	PUNCT
aji-130	127	20	benzyl	benzyl	NOUN
aji-130	127	21	alcohol	alcohol	NOUN
aji-130	127	22	and	and	CCONJ
aji-130	127	23	benzaldehyde	benzaldehyde	NOUN
aji-130	127	24	suffer	suffer	VERB
aji-130	127	25	in	in	ADP
aji-130	127	26	vivo	vivo	ADJ
aji-130	127	27	oxidation	oxidation	NOUN
aji-130	127	28	to	to	ADP
aji-130	127	29	benzoic	benzoic	ADJ
aji-130	127	30	acid	acid	NOUN
aji-130	127	31	”	"	PUNCT
aji-130	128	1	[	[	X
aji-130	128	2	4	4	NUM
aji-130	128	3	]	]	PUNCT
aji-130	128	4	.	.	PUNCT
aji-130	129	1	“	"	PUNCT
aji-130	129	2	in	in	ADP
aji-130	129	3	plants	plant	NOUN
aji-130	129	4	and	and	CCONJ
aji-130	129	5	animals	animal	NOUN
aji-130	129	6	,	,	PUNCT
aji-130	129	7	benzoic	benzoic	ADJ
aji-130	129	8	acid	acid	NOUN
aji-130	129	9	is	be	AUX
aji-130	129	10	produced	produce	VERB
aji-130	129	11	endogenously	endogenously	ADV
aji-130	129	12	through	through	ADP
aji-130	129	13	the	the	DET
aji-130	129	14	phenylalanine	phenylalanine	NOUN
aji-130	129	15	–	–	PUNCT
aji-130	129	16	tyrosine	tyrosine	NOUN
aji-130	129	17	pathway	pathway	NOUN
aji-130	129	18	”	"	PUNCT
aji-130	130	1	[	[	X
aji-130	130	2	5	5	NUM
aji-130	130	3	]	]	PUNCT
aji-130	130	4	.	.	PUNCT
aji-130	131	1	“	"	PUNCT
aji-130	131	2	several	several	ADJ
aji-130	131	3	of	of	ADP
aji-130	131	4	its	its	PRON
aji-130	131	5	derivatives	derivative	NOUN
aji-130	131	6	occur	occur	VERB
aji-130	131	7	naturally	naturally	ADV
aji-130	131	8	in	in	ADP
aji-130	131	9	foods	food	NOUN
aji-130	131	10	,	,	PUNCT
aji-130	131	11	such	such	ADJ
aji-130	131	12	as	as	ADP
aji-130	131	13	fruits	fruit	NOUN
aji-130	131	14	(	(	PUNCT
aji-130	131	15	apple	apple	NOUN
aji-130	131	16	,	,	PUNCT
aji-130	131	17	avocado	avocado	NOUN
aji-130	131	18	,	,	PUNCT
aji-130	131	19	blackberry	blackberry	NOUN
aji-130	131	20	,	,	PUNCT
aji-130	131	21	blueberry	blueberry	NOUN
aji-130	131	22	,	,	PUNCT
aji-130	131	23	cherry	cherry	NOUN
aji-130	131	24	,	,	PUNCT
aji-130	131	25	cranberry	cranberry	NOUN
aji-130	131	26	,	,	PUNCT
aji-130	131	27	melon	melon	NOUN
aji-130	131	28	,	,	PUNCT
aji-130	131	29	papaya	papaya	NOUN
aji-130	131	30	,	,	PUNCT
aji-130	131	31	plum	plum	NOUN
aji-130	131	32	,	,	PUNCT
aji-130	131	33	raspberry	raspberry	NOUN
aji-130	131	34	,	,	PUNCT
aji-130	131	35	strawberry	strawberry	NOUN
aji-130	131	36	,	,	PUNCT
aji-130	131	37	tomato	tomato	NOUN
aji-130	131	38	)	)	PUNCT
aji-130	131	39	,	,	PUNCT
aji-130	131	40	vegetables	vegetable	NOUN
aji-130	131	41	(	(	PUNCT
aji-130	131	42	artichokes	artichoke	NOUN
aji-130	131	43	,	,	PUNCT
aji-130	131	44	asparagus	asparagus	NOUN
aji-130	131	45	,	,	PUNCT
aji-130	131	46	beans	bean	NOUN
aji-130	131	47	,	,	PUNCT
aji-130	131	48	cabbage	cabbage	NOUN
aji-130	131	49	,	,	PUNCT
aji-130	131	50	corn	corn	NOUN
aji-130	131	51	,	,	PUNCT
aji-130	131	52	leek	leek	NOUN
aji-130	131	53	,	,	PUNCT
aji-130	131	54	mushroom	mushroom	NOUN
aji-130	131	55	,	,	PUNCT
aji-130	131	56	potatoes	potato	NOUN
aji-130	131	57	)	)	PUNCT
aji-130	131	58	,	,	PUNCT
aji-130	131	59	meats	meat	NOUN
aji-130	131	60	(	(	PUNCT
aji-130	131	61	beef	beef	NOUN
aji-130	131	62	,	,	PUNCT
aji-130	131	63	chicken	chicken	NOUN
aji-130	131	64	,	,	PUNCT
aji-130	131	65	pork	pork	NOUN
aji-130	131	66	,	,	PUNCT
aji-130	131	67	shellfish	shellfish	NOUN
aji-130	131	68	)	)	PUNCT
aji-130	131	69	,	,	PUNCT
aji-130	131	70	cheeses	cheese	NOUN
aji-130	131	71	,	,	PUNCT
aji-130	131	72	teas	tea	NOUN
aji-130	131	73	and	and	CCONJ
aji-130	131	74	wines	wine	NOUN
aji-130	131	75	”	"	PUNCT
aji-130	132	1	[	[	X
aji-130	132	2	6	6	NUM
aji-130	132	3	]	]	PUNCT
aji-130	132	4	.	.	PUNCT
aji-130	133	1	food	food	NOUN
aji-130	133	2	additives	additive	NOUN
aji-130	133	3	(	(	PUNCT
aji-130	133	4	among	among	ADP
aji-130	133	5	them	they	PRON
aji-130	133	6	benzoic	benzoic	ADJ
aji-130	133	7	acid	acid	NOUN
aji-130	133	8	)	)	PUNCT
aji-130	133	9	have	have	AUX
aji-130	133	10	long	long	ADV
aji-130	133	11	been	be	AUX
aji-130	133	12	described	describe	VERB
aji-130	133	13	as	as	ADP
aji-130	133	14	sensitizer	sensitizer	NOUN
aji-130	133	15	agents	agent	NOUN
aji-130	133	16	responsible	responsible	ADJ
aji-130	133	17	for	for	ADP
aji-130	133	18	human	human	ADJ
aji-130	133	19	allergic	allergic	ADJ
aji-130	133	20	reactions	reaction	NOUN
aji-130	133	21	[	[	X
aji-130	133	22	7	7	NUM
aji-130	133	23	]	]	PUNCT
aji-130	133	24	.	.	PUNCT
aji-130	134	1	a	a	DET
aji-130	134	2	double	double	ADJ
aji-130	134	3	-	-	PUNCT
aji-130	134	4	blinded	blind	VERB
aji-130	134	5	provocation	provocation	NOUN
aji-130	134	6	study	study	NOUN
aji-130	134	7	done	do	VERB
aji-130	134	8	with	with	ADP
aji-130	134	9	benzoic	benzoic	ADJ
aji-130	134	10	acid	acid	NOUN
aji-130	134	11	produced	produce	VERB
aji-130	134	12	objective	objective	ADJ
aji-130	134	13	reactions	reaction	NOUN
aji-130	134	14	in	in	ADP
aji-130	134	15	7	7	NUM
aji-130	134	16	%	%	NOUN
aji-130	134	17	of	of	ADP
aji-130	134	18	patients	patient	NOUN
aji-130	134	19	with	with	ADP
aji-130	134	20	urticaria	urticaria	NOUN
aji-130	134	21	[	[	X
aji-130	134	22	8	8	NUM
aji-130	134	23	]	]	PUNCT
aji-130	134	24	.	.	PUNCT
aji-130	135	1	there	there	PRON
aji-130	135	2	is	be	VERB
aji-130	135	3	a	a	DET
aji-130	135	4	report	report	NOUN
aji-130	135	5	of	of	ADP
aji-130	135	6	a	a	DET
aji-130	135	7	child	child	NOUN
aji-130	135	8	who	who	PRON
aji-130	135	9	developed	develop	VERB
aji-130	135	10	chronic	chronic	ADJ
aji-130	135	11	cheilitis	cheilitis	NOUN
aji-130	135	12	when	when	SCONJ
aji-130	135	13	ingesting	ingest	VERB
aji-130	135	14	daily	daily	ADJ
aji-130	135	15	benzoates	benzoate	NOUN
aji-130	135	16	-	-	PUNCT
aji-130	135	17	preserved	preserve	VERB
aji-130	135	18	industrialized	industrialize	VERB
aji-130	135	19	foods	food	NOUN
aji-130	135	20	[	[	X
aji-130	135	21	9	9	NUM
aji-130	135	22	]	]	PUNCT
aji-130	135	23	.	.	PUNCT
aji-130	136	1	there	there	PRON
aji-130	136	2	are	be	VERB
aji-130	136	3	reports	report	NOUN
aji-130	136	4	of	of	ADP
aji-130	136	5	asthmatic	asthmatic	ADJ
aji-130	136	6	patients	patient	NOUN
aji-130	136	7	who	who	PRON
aji-130	136	8	had	have	VERB
aji-130	136	9	a	a	DET
aji-130	136	10	crisis	crisis	NOUN
aji-130	136	11	of	of	ADP
aji-130	136	12	bronchospasm	bronchospasm	NOUN
aji-130	136	13	after	after	ADP
aji-130	136	14	the	the	DET
aji-130	136	15	intake	intake	NOUN
aji-130	136	16	of	of	ADP
aji-130	136	17	benzoatecontaining	benzoatecontaine	VERB
aji-130	136	18	antiasthmatic	antiasthmatic	ADJ
aji-130	136	19	medicines	medicine	NOUN
aji-130	136	20	[	[	X
aji-130	136	21	10	10	NUM
aji-130	136	22	]	]	PUNCT
aji-130	136	23	.	.	PUNCT
aji-130	137	1	reports	report	NOUN
aji-130	137	2	of	of	ADP
aji-130	137	3	cross	cross	NOUN
aji-130	137	4	-	-	NOUN
aji-130	137	5	reactivity	reactivity	NOUN
aji-130	137	6	among	among	ADP
aji-130	137	7	benzoates	benzoate	NOUN
aji-130	137	8	,	,	PUNCT
aji-130	137	9	azo	azo	NOUN
aji-130	137	10	dyes	dye	NOUN
aji-130	137	11	,	,	PUNCT
aji-130	137	12	and	and	CCONJ
aji-130	137	13	aspirin	aspirin	NOUN
aji-130	137	14	in	in	ADP
aji-130	137	15	patients	patient	NOUN
aji-130	137	16	with	with	ADP
aji-130	137	17	urticaria	urticaria	NOUN
aji-130	137	18	are	be	AUX
aji-130	137	19	also	also	ADV
aji-130	137	20	common	common	ADJ
aji-130	137	21	[	[	X
aji-130	137	22	11	11	NUM
aji-130	137	23	]	]	PUNCT
aji-130	137	24	.	.	PUNCT
aji-130	138	1	most	most	ADJ
aji-130	138	2	provocation	provocation	NOUN
aji-130	138	3	tests	test	NOUN
aji-130	138	4	performed	perform	VERB
aji-130	138	5	with	with	ADP
aji-130	138	6	benzoic	benzoic	ADJ
aji-130	138	7	acid	acid	NOUN
aji-130	138	8	do	do	AUX
aji-130	138	9	not	not	PART
aji-130	138	10	elicit	elicit	VERB
aji-130	138	11	immediate	immediate	ADJ
aji-130	138	12	reactions	reaction	NOUN
aji-130	138	13	;	;	PUNCT
aji-130	138	14	instead	instead	ADV
aji-130	138	15	,	,	PUNCT
aji-130	138	16	the	the	DET
aji-130	138	17	reactions	reaction	NOUN
aji-130	138	18	appear	appear	VERB
aji-130	138	19	within	within	ADP
aji-130	138	20	14	14	NUM
aji-130	138	21	hours	hour	NOUN
aji-130	138	22	after	after	ADP
aji-130	138	23	the	the	DET
aji-130	138	24	challenge	challenge	NOUN
aji-130	138	25	[	[	X
aji-130	138	26	12	12	NUM
aji-130	138	27	]	]	PUNCT
aji-130	138	28	.	.	PUNCT
aji-130	139	1	the	the	DET
aji-130	139	2	immunoreactivity	immunoreactivity	NOUN
aji-130	139	3	elicited	elicit	VERB
aji-130	139	4	against	against	ADP
aji-130	139	5	benzoic	benzoic	NOUN
aji-130	139	6	acid	acid	NOUN
aji-130	139	7	is	be	AUX
aji-130	139	8	non	non	ADJ
aji-130	139	9	–	–	PUNCT
aji-130	139	10	ige	ige	NOUN
aji-130	139	11	-	-	PUNCT
aji-130	139	12	mediated	mediate	VERB
aji-130	139	13	and	and	CCONJ
aji-130	139	14	is	be	AUX
aji-130	139	15	not	not	PART
aji-130	139	16	yet	yet	ADV
aji-130	139	17	acknowledged	acknowledge	VERB
aji-130	139	18	explicitly	explicitly	ADV
aji-130	139	19	among	among	ADP
aji-130	139	20	the	the	DET
aji-130	139	21	recently	recently	ADV
aji-130	139	22	classified	classify	VERB
aji-130	139	23	hypersensitivity	hypersensitivity	NOUN
aji-130	139	24	mechanisms	mechanism	NOUN
aji-130	139	25	[	[	X
aji-130	139	26	13	13	NUM
aji-130	139	27	]	]	PUNCT
aji-130	139	28	.	.	PUNCT
aji-130	140	1	the	the	DET
aji-130	140	2	main	main	ADJ
aji-130	140	3	knowledge	knowledge	NOUN
aji-130	140	4	about	about	ADP
aji-130	140	5	the	the	DET
aji-130	140	6	mechanism	mechanism	NOUN
aji-130	140	7	of	of	ADP
aji-130	140	8	hypersensitivity	hypersensitivity	NOUN
aji-130	140	9	against	against	ADP
aji-130	140	10	benzoate	benzoate	NOUN
aji-130	140	11	(	(	PUNCT
aji-130	140	12	and	and	CCONJ
aji-130	140	13	similar	similar	ADJ
aji-130	140	14	food	food	NOUN
aji-130	140	15	additives	additive	NOUN
aji-130	140	16	)	)	PUNCT
aji-130	140	17	was	be	AUX
aji-130	140	18	brought	bring	VERB
aji-130	140	19	by	by	ADP
aji-130	140	20	an	an	DET
aji-130	140	21	ex	ex	X
aji-130	140	22	vivo	vivo	ADJ
aji-130	140	23	leukocyte	leukocyte	NOUN
aji-130	140	24	challenge	challenge	NOUN
aji-130	140	25	test	test	NOUN
aji-130	140	26	determining	determine	VERB
aji-130	140	27	the	the	DET
aji-130	140	28	olivier	olivier	NOUN
aji-130	140	29	et	et	PROPN
aji-130	140	30	al	al	PROPN
aji-130	140	31	.	.	PROPN
aji-130	140	32	;	;	PUNCT
aji-130	140	33	asian	asian	PROPN
aji-130	140	34	j.	j.	PROPN
aji-130	140	35	immunol	immunol	PROPN
aji-130	140	36	.	.	PROPN
aji-130	140	37	,	,	PUNCT
aji-130	140	38	vol	vol	NOUN
aji-130	140	39	.	.	PROPN
aji-130	141	1	7	7	NUM
aji-130	141	2	,	,	PUNCT
aji-130	141	3	no	no	INTJ
aji-130	141	4	.	.	NOUN
aji-130	141	5	1	1	NUM
aji-130	141	6	,	,	PUNCT
aji-130	141	7	pp	pp	ADJ
aji-130	141	8	.	.	PUNCT
aji-130	142	1	63	63	NUM
aji-130	142	2	-	-	SYM
aji-130	142	3	70	70	NUM
aji-130	142	4	,	,	PUNCT
aji-130	142	5	2024	2024	NUM
aji-130	142	6	;	;	PUNCT
aji-130	142	7	article	article	NOUN
aji-130	142	8	no.aji.115657	no.aji.115657	NOUN
aji-130	142	9	65	65	NUM
aji-130	142	10	increasing	increase	VERB
aji-130	142	11	sulfidoleukotriene	sulfidoleukotriene	NOUN
aji-130	142	12	production	production	NOUN
aji-130	142	13	[	[	X
aji-130	142	14	14	14	NUM
aji-130	142	15	]	]	PUNCT
aji-130	142	16	.	.	PUNCT
aji-130	143	1	since	since	SCONJ
aji-130	143	2	leukotrienes	leukotriene	NOUN
aji-130	143	3	are	be	AUX
aji-130	143	4	known	know	VERB
aji-130	143	5	mediators	mediator	NOUN
aji-130	143	6	of	of	ADP
aji-130	143	7	the	the	DET
aji-130	143	8	leukocyte	leukocyte	NOUN
aji-130	143	9	adherence	adherence	NOUN
aji-130	143	10	inhibition	inhibition	NOUN
aji-130	143	11	phenomenon	phenomenon	NOUN
aji-130	143	12	,	,	PUNCT
aji-130	143	13	we	we	PRON
aji-130	143	14	hypothesize	hypothesize	VERB
aji-130	143	15	that	that	SCONJ
aji-130	143	16	the	the	DET
aji-130	143	17	employ	employ	NOUN
aji-130	143	18	of	of	ADP
aji-130	143	19	the	the	DET
aji-130	143	20	leukocyte	leukocyte	NOUN
aji-130	143	21	adherence	adherence	NOUN
aji-130	143	22	inhibition	inhibition	NOUN
aji-130	143	23	test	test	NOUN
aji-130	143	24	(	(	PUNCT
aji-130	143	25	lait	lait	NOUN
aji-130	143	26	)	)	PUNCT
aji-130	143	27	could	could	AUX
aji-130	143	28	help	help	AUX
aji-130	143	29	identify	identify	VERB
aji-130	143	30	the	the	DET
aji-130	143	31	endotype	endotype	NOUN
aji-130	143	32	responsible	responsible	ADJ
aji-130	143	33	for	for	ADP
aji-130	143	34	benzoic	benzoic	ADJ
aji-130	143	35	acid	acid	NOUN
aji-130	143	36	hypersensitivity	hypersensitivity	NOUN
aji-130	143	37	[	[	X
aji-130	143	38	15	15	NUM
aji-130	143	39	-	-	SYM
aji-130	143	40	17	17	NUM
aji-130	143	41	]	]	PUNCT
aji-130	143	42	.	.	PUNCT
aji-130	144	1	“	"	PUNCT
aji-130	144	2	we	we	PRON
aji-130	144	3	routinely	routinely	ADV
aji-130	144	4	employ	employ	VERB
aji-130	144	5	the	the	DET
aji-130	144	6	lait	lait	NOUN
aji-130	144	7	in	in	ADP
aji-130	144	8	our	our	PRON
aji-130	144	9	facilities	facility	NOUN
aji-130	144	10	to	to	PART
aji-130	144	11	evaluate	evaluate	VERB
aji-130	144	12	non	non	ADJ
aji-130	144	13	–	–	PUNCT
aji-130	144	14	ige	ige	ADJ
aji-130	144	15	-	-	PUNCT
aji-130	144	16	mediated	mediate	VERB
aji-130	144	17	immunoreactivity	immunoreactivity	NOUN
aji-130	144	18	against	against	ADP
aji-130	144	19	suspected	suspect	VERB
aji-130	144	20	allergens	allergen	NOUN
aji-130	144	21	,	,	PUNCT
aji-130	144	22	previously	previously	ADV
aji-130	144	23	engaging	engage	VERB
aji-130	144	24	in	in	ADP
aji-130	144	25	exhaustive	exhaustive	ADJ
aji-130	144	26	provocation	provocation	NOUN
aji-130	144	27	tests	test	NOUN
aji-130	144	28	”	"	PUNCT
aji-130	145	1	[	[	X
aji-130	145	2	18	18	NUM
aji-130	145	3	-	-	SYM
aji-130	145	4	24	24	NUM
aji-130	145	5	]	]	PUNCT
aji-130	145	6	.	.	PUNCT
aji-130	146	1	to	to	PART
aji-130	146	2	evaluate	evaluate	VERB
aji-130	146	3	the	the	DET
aji-130	146	4	potential	potential	NOUN
aji-130	146	5	of	of	ADP
aji-130	146	6	the	the	DET
aji-130	146	7	lait	lait	NOUN
aji-130	146	8	to	to	PART
aji-130	146	9	discriminate	discriminate	VERB
aji-130	146	10	non	non	ADJ
aji-130	146	11	–	–	PUNCT
aji-130	146	12	ige	ige	ADJ
aji-130	146	13	-	-	PUNCT
aji-130	146	14	mediated	mediate	VERB
aji-130	146	15	immunoreactivity	immunoreactivity	NOUN
aji-130	146	16	against	against	ADP
aji-130	146	17	benzoic	benzoic	ADJ
aji-130	146	18	acid	acid	NOUN
aji-130	146	19	,	,	PUNCT
aji-130	146	20	we	we	PRON
aji-130	146	21	retrospectively	retrospectively	ADV
aji-130	146	22	compiled	compile	VERB
aji-130	146	23	the	the	DET
aji-130	146	24	electronic	electronic	ADJ
aji-130	146	25	medical	medical	ADJ
aji-130	146	26	charts	chart	NOUN
aji-130	146	27	of	of	ADP
aji-130	146	28	patients	patient	NOUN
aji-130	146	29	with	with	ADP
aji-130	146	30	non	non	ADJ
aji-130	146	31	–	–	PUNCT
aji-130	146	32	ige	ige	ADJ
aji-130	146	33	-	-	PUNCT
aji-130	146	34	mediated	mediate	VERB
aji-130	146	35	allergic	allergic	ADJ
aji-130	146	36	rhinitis	rhinitis	NOUN
aji-130	146	37	,	,	PUNCT
aji-130	146	38	allergic	allergic	ADJ
aji-130	146	39	bronchitis	bronchitis	NOUN
aji-130	146	40	,	,	PUNCT
aji-130	146	41	asthma	asthma	NOUN
aji-130	146	42	,	,	PUNCT
aji-130	146	43	sinus	sinus	NOUN
aji-130	146	44	headache	headache	NOUN
aji-130	146	45	,	,	PUNCT
aji-130	146	46	atopic	atopic	NOUN
aji-130	146	47	dermatitis	dermatitis	NOUN
aji-130	146	48	,	,	PUNCT
aji-130	146	49	and/or	and/or	CCONJ
aji-130	146	50	urticaria	urticaria	NOUN
aji-130	146	51	who	who	PRON
aji-130	146	52	were	be	AUX
aji-130	146	53	investigated	investigate	VERB
aji-130	146	54	with	with	ADP
aji-130	146	55	this	this	DET
aji-130	146	56	procedure	procedure	NOUN
aji-130	146	57	.	.	PUNCT
aji-130	147	1	the	the	DET
aji-130	147	2	present	present	ADJ
aji-130	147	3	study	study	NOUN
aji-130	147	4	hypothesizes	hypothesize	VERB
aji-130	147	5	that	that	SCONJ
aji-130	147	6	the	the	DET
aji-130	147	7	lait	lait	NOUN
aji-130	147	8	may	may	AUX
aji-130	147	9	differentiate	differentiate	VERB
aji-130	147	10	diverse	diverse	ADJ
aji-130	147	11	degrees	degree	NOUN
aji-130	147	12	of	of	ADP
aji-130	147	13	immunoreactivity	immunoreactivity	NOUN
aji-130	147	14	against	against	ADP
aji-130	147	15	benzoic	benzoic	ADJ
aji-130	147	16	acid	acid	NOUN
aji-130	147	17	among	among	ADP
aji-130	147	18	patients	patient	NOUN
aji-130	147	19	suffering	suffer	VERB
aji-130	147	20	from	from	ADP
aji-130	147	21	allergic	allergic	ADJ
aji-130	147	22	phenotypes	phenotype	NOUN
aji-130	147	23	.	.	PUNCT
aji-130	148	1	2	2	X
aji-130	148	2	.	.	X
aji-130	148	3	materials	material	NOUN
aji-130	148	4	and	and	CCONJ
aji-130	148	5	methods	method	NOUN
aji-130	148	6	2.1	2.1	NUM
aji-130	148	7	subjects	subject	NOUN
aji-130	148	8	after	after	ADP
aji-130	148	9	receiving	receive	VERB
aji-130	148	10	institutional	institutional	ADJ
aji-130	148	11	review	review	NOUN
aji-130	148	12	board	board	NOUN
aji-130	148	13	approval	approval	NOUN
aji-130	148	14	from	from	ADP
aji-130	148	15	the	the	DET
aji-130	148	16	instituto	instituto	PROPN
aji-130	148	17	alergoimuno	alergoimuno	PROPN
aji-130	148	18	de	de	X
aji-130	148	19	americana	americana	PROPN
aji-130	148	20	(	(	PUNCT
aji-130	148	21	brazil	brazil	PROPN
aji-130	148	22	;	;	PUNCT
aji-130	148	23	03/2024	03/2024	NUM
aji-130	148	24	)	)	PUNCT
aji-130	148	25	,	,	PUNCT
aji-130	148	26	we	we	PRON
aji-130	148	27	proceeded	proceed	VERB
aji-130	148	28	with	with	ADP
aji-130	148	29	the	the	DET
aji-130	148	30	electronic	electronic	ADJ
aji-130	148	31	chart	chart	NOUN
aji-130	148	32	review	review	NOUN
aji-130	148	33	of	of	ADP
aji-130	148	34	8,500	8,500	NUM
aji-130	148	35	outpatients	outpatient	NOUN
aji-130	148	36	who	who	PRON
aji-130	148	37	attended	attend	VERB
aji-130	148	38	our	our	PRON
aji-130	148	39	facility	facility	NOUN
aji-130	148	40	from	from	ADP
aji-130	148	41	january	january	PROPN
aji-130	148	42	2018	2018	NUM
aji-130	148	43	to	to	ADP
aji-130	148	44	march	march	PROPN
aji-130	148	45	2024	2024	NUM
aji-130	148	46	.	.	PUNCT
aji-130	149	1	a	a	DET
aji-130	149	2	cohort	cohort	NOUN
aji-130	149	3	of	of	ADP
aji-130	149	4	100	100	NUM
aji-130	149	5	outside	outside	ADJ
aji-130	149	6	patients	patient	NOUN
aji-130	149	7	had	have	AUX
aji-130	149	8	been	be	AUX
aji-130	149	9	submitted	submit	VERB
aji-130	149	10	to	to	ADP
aji-130	149	11	an	an	DET
aji-130	149	12	ex	ex	X
aji-130	149	13	vivo	vivo	NOUN
aji-130	149	14	allergen	allergen	NOUN
aji-130	149	15	challenge	challenge	NOUN
aji-130	149	16	test	test	NOUN
aji-130	149	17	with	with	ADP
aji-130	149	18	benzoic	benzoic	ADJ
aji-130	149	19	acid	acid	NOUN
aji-130	149	20	1mg	1mg	PROPN
aji-130	149	21	/	/	SYM
aji-130	149	22	ml	ml	VERB
aji-130	149	23	monitored	monitor	VERB
aji-130	149	24	with	with	ADP
aji-130	149	25	lait	lait	NOUN
aji-130	149	26	for	for	ADP
aji-130	149	27	presenting	present	VERB
aji-130	149	28	non	non	ADJ
aji-130	149	29	–	–	PUNCT
aji-130	149	30	ige	ige	ADJ
aji-130	149	31	-	-	PUNCT
aji-130	149	32	mediated	mediate	VERB
aji-130	149	33	allergic	allergic	ADJ
aji-130	149	34	rhinitis	rhinitis	NOUN
aji-130	149	35	,	,	PUNCT
aji-130	149	36	allergic	allergic	ADJ
aji-130	149	37	bronchitis	bronchitis	NOUN
aji-130	149	38	,	,	PUNCT
aji-130	149	39	asthma	asthma	NOUN
aji-130	149	40	,	,	PUNCT
aji-130	149	41	sinus	sinus	NOUN
aji-130	149	42	headache	headache	NOUN
aji-130	149	43	,	,	PUNCT
aji-130	149	44	atopic	atopic	NOUN
aji-130	149	45	dermatitis	dermatitis	NOUN
aji-130	149	46	,	,	PUNCT
aji-130	149	47	and/or	and/or	CCONJ
aji-130	149	48	urticaria	urticaria	NOUN
aji-130	149	49	.	.	PUNCT
aji-130	150	1	this	this	DET
aji-130	150	2	study	study	NOUN
aji-130	150	3	did	do	AUX
aji-130	150	4	not	not	PART
aji-130	150	5	include	include	VERB
aji-130	150	6	pregnant	pregnant	ADJ
aji-130	150	7	women	woman	NOUN
aji-130	150	8	,	,	PUNCT
aji-130	150	9	breastfeeding	breastfeeding	NOUN
aji-130	150	10	,	,	PUNCT
aji-130	150	11	and	and	CCONJ
aji-130	150	12	patients	patient	NOUN
aji-130	150	13	under	under	ADP
aji-130	150	14	biological	biological	ADJ
aji-130	150	15	and/or	and/or	CCONJ
aji-130	150	16	systemic	systemic	ADJ
aji-130	150	17	anti	anti	ADJ
aji-130	150	18	-	-	ADJ
aji-130	150	19	inflammatory	inflammatory	ADJ
aji-130	150	20	therapy	therapy	NOUN
aji-130	150	21	(	(	PUNCT
aji-130	150	22	corticoids	corticoid	NOUN
aji-130	150	23	,	,	PUNCT
aji-130	150	24	cyclosporin	cyclosporin	NOUN
aji-130	150	25	)	)	PUNCT
aji-130	150	26	.	.	PUNCT
aji-130	151	1	“	"	PUNCT
aji-130	151	2	the	the	DET
aji-130	151	3	cohort	cohort	NOUN
aji-130	151	4	counted	count	VERB
aji-130	151	5	30	30	NUM
aji-130	151	6	males	male	NOUN
aji-130	151	7	;	;	PUNCT
aji-130	151	8	mean	mean	VERB
aji-130	151	9	age	age	NOUN
aji-130	151	10	41.9	41.9	NUM
aji-130	151	11	years	year	NOUN
aji-130	151	12	;	;	PUNCT
aji-130	151	13	sd	sd	ADP
aji-130	151	14	20.4	20.4	NUM
aji-130	151	15	years	year	NOUN
aji-130	151	16	;	;	PUNCT
aji-130	151	17	range	range	NOUN
aji-130	151	18	2	2	NUM
aji-130	151	19	to	to	PART
aji-130	151	20	90	90	NUM
aji-130	151	21	years	year	NOUN
aji-130	151	22	;	;	PUNCT
aji-130	151	23	median	median	NOUN
aji-130	151	24	43	43	NUM
aji-130	151	25	years	year	NOUN
aji-130	151	26	;	;	PUNCT
aji-130	151	27	modes	mode	NOUN
aji-130	151	28	=	=	SYM
aji-130	151	29	26	26	NUM
aji-130	151	30	;	;	PUNCT
aji-130	151	31	28	28	NUM
aji-130	151	32	;	;	PUNCT
aji-130	151	33	43	43	NUM
aji-130	151	34	;	;	PUNCT
aji-130	151	35	43	43	NUM
aji-130	151	36	and	and	CCONJ
aji-130	151	37	53	53	NUM
aji-130	151	38	(	(	PUNCT
aji-130	151	39	each	each	PRON
aji-130	151	40	appeared	appear	VERB
aji-130	151	41	four	four	NUM
aji-130	151	42	times	time	NOUN
aji-130	151	43	)	)	PUNCT
aji-130	151	44	;	;	PUNCT
aji-130	151	45	geometric	geometric	ADJ
aji-130	151	46	mean	mean	NOUN
aji-130	151	47	=	=	SYM
aji-130	151	48	34.4	34.4	NUM
aji-130	151	49	years	year	NOUN
aji-130	151	50	.	.	PUNCT
aji-130	152	1	this	this	DET
aji-130	152	2	procedure	procedure	NOUN
aji-130	152	3	was	be	AUX
aji-130	152	4	offered	offer	VERB
aji-130	152	5	to	to	ADP
aji-130	152	6	patients	patient	NOUN
aji-130	152	7	with	with	ADP
aji-130	152	8	clinical	clinical	ADJ
aji-130	152	9	suspicion	suspicion	NOUN
aji-130	152	10	of	of	ADP
aji-130	152	11	benzoate	benzoate	NOUN
aji-130	152	12	hypersensitivity	hypersensitivity	NOUN
aji-130	152	13	who	who	PRON
aji-130	152	14	demonstrated	demonstrate	VERB
aji-130	152	15	a	a	DET
aji-130	152	16	non	non	ADJ
aji-130	152	17	-	-	ADJ
aji-130	152	18	reactive	reactive	ADJ
aji-130	152	19	or	or	CCONJ
aji-130	152	20	inconclusive	inconclusive	ADJ
aji-130	152	21	skin	skin	NOUN
aji-130	152	22	test	test	NOUN
aji-130	152	23	against	against	ADP
aji-130	152	24	benzoic	benzoic	ADJ
aji-130	152	25	acid	acid	NOUN
aji-130	152	26	”	"	PUNCT
aji-130	153	1	[	[	X
aji-130	153	2	25	25	NUM
aji-130	153	3	]	]	PUNCT
aji-130	153	4	.	.	PUNCT
aji-130	154	1	2.2	2.2	NUM
aji-130	154	2	ex	ex	X
aji-130	154	3	vivo	vivo	ADJ
aji-130	154	4	investigation	investigation	NOUN
aji-130	154	5	:	:	PUNCT
aji-130	154	6	leukocyte	leukocyte	ADJ
aji-130	154	7	adherence	adherence	NOUN
aji-130	154	8	inhibition	inhibition	NOUN
aji-130	154	9	test	test	NOUN
aji-130	154	10	“	"	PUNCT
aji-130	154	11	we	we	PRON
aji-130	154	12	performed	perform	VERB
aji-130	154	13	the	the	DET
aji-130	154	14	lait	lait	NOUN
aji-130	154	15	as	as	SCONJ
aji-130	154	16	previously	previously	ADV
aji-130	154	17	described	describe	VERB
aji-130	154	18	”	"	PUNCT
aji-130	155	1	[	[	X
aji-130	155	2	26	26	NUM
aji-130	155	3	-	-	SYM
aji-130	155	4	34	34	NUM
aji-130	155	5	]	]	PUNCT
aji-130	155	6	.	.	PUNCT
aji-130	156	1	shortly	shortly	ADV
aji-130	156	2	,	,	PUNCT
aji-130	156	3	each	each	DET
aji-130	156	4	donor	donor	NOUN
aji-130	156	5	's	's	PART
aji-130	156	6	fresh	fresh	ADJ
aji-130	156	7	plasma	plasma	NOUN
aji-130	156	8	was	be	AUX
aji-130	156	9	divided	divide	VERB
aji-130	156	10	into	into	ADP
aji-130	156	11	two	two	NUM
aji-130	156	12	parts	part	NOUN
aji-130	156	13	and	and	CCONJ
aji-130	156	14	used	use	VERB
aji-130	156	15	in	in	ADP
aji-130	156	16	paralleled	parallel	VERB
aji-130	156	17	ex	ex	PRON
aji-130	156	18	vivo	vivo	ADJ
aji-130	156	19	challenging	challenge	VERB
aji-130	156	20	tests	test	NOUN
aji-130	156	21	with	with	ADP
aji-130	156	22	benzoic	benzoic	ADJ
aji-130	156	23	acid	acid	NOUN
aji-130	156	24	1	1	NUM
aji-130	156	25	mg	mg	NUM
aji-130	156	26	/	/	SYM
aji-130	156	27	ml	ml	NOUN
aji-130	156	28	and	and	CCONJ
aji-130	156	29	the	the	DET
aji-130	156	30	unchallenged	unchallenged	ADJ
aji-130	156	31	plasma	plasma	NOUN
aji-130	156	32	assay	assay	VERB
aji-130	156	33	.	.	PUNCT
aji-130	157	1	we	we	PRON
aji-130	157	2	collected	collect	VERB
aji-130	157	3	the	the	DET
aji-130	157	4	plasma	plasma	NOUN
aji-130	157	5	with	with	ADP
aji-130	157	6	high	high	ADJ
aji-130	157	7	leukocyte	leukocyte	NOUN
aji-130	157	8	content	content	NOUN
aji-130	157	9	(	(	PUNCT
aji-130	157	10	buffy	buffy	PROPN
aji-130	157	11	coat	coat	PROPN
aji-130	157	12	)	)	PUNCT
aji-130	157	13	from	from	ADP
aji-130	157	14	the	the	DET
aji-130	157	15	heparinized	heparinize	VERB
aji-130	157	16	tube	tube	NOUN
aji-130	157	17	after	after	ADP
aji-130	157	18	one	one	NUM
aji-130	157	19	hour	hour	NOUN
aji-130	157	20	of	of	ADP
aji-130	157	21	sedimentation	sedimentation	NOUN
aji-130	157	22	at	at	ADP
aji-130	157	23	37	37	NUM
aji-130	157	24	°	°	NOUN
aji-130	157	25	c	c	NOUN
aji-130	157	26	.	.	PUNCT
aji-130	158	1	then	then	ADV
aji-130	158	2	we	we	PRON
aji-130	158	3	distributed	distribute	VERB
aji-130	158	4	aliquots	aliquot	NOUN
aji-130	158	5	of	of	ADP
aji-130	158	6	100	100	NUM
aji-130	158	7	μl	μl	ADV
aji-130	158	8	into	into	ADP
aji-130	158	9	eppendorf	eppendorf	PROPN
aji-130	158	10	tubes	tube	NOUN
aji-130	158	11	kept	keep	VERB
aji-130	158	12	under	under	ADP
aji-130	158	13	agitation	agitation	NOUN
aji-130	158	14	for	for	ADP
aji-130	158	15	30	30	NUM
aji-130	158	16	minutes	minute	NOUN
aji-130	158	17	(	(	PUNCT
aji-130	158	18	200	200	NUM
aji-130	158	19	rpm	rpm	NOUN
aji-130	158	20	at	at	ADP
aji-130	158	21	37	37	NUM
aji-130	158	22	°	°	NOUN
aji-130	158	23	c	c	NOUN
aji-130	158	24	)	)	PUNCT
aji-130	158	25	with	with	ADP
aji-130	158	26	benzoic	benzoic	ADJ
aji-130	158	27	acid	acid	NOUN
aji-130	158	28	(	(	PUNCT
aji-130	158	29	10μl	10μl	ADV
aji-130	158	30	of	of	ADP
aji-130	158	31	a	a	DET
aji-130	158	32	solution	solution	NOUN
aji-130	158	33	with	with	ADP
aji-130	158	34	1mg	1mg	PROPN
aji-130	158	35	/	/	SYM
aji-130	158	36	ml	ml	PROPN
aji-130	158	37	and	and	CCONJ
aji-130	158	38	ph	ph	ADJ
aji-130	158	39	7.5	7.5	NUM
aji-130	158	40	)	)	PUNCT
aji-130	158	41	or	or	CCONJ
aji-130	158	42	without	without	ADP
aji-130	158	43	benzoic	benzoic	ADJ
aji-130	158	44	acid	acid	NOUN
aji-130	158	45	(	(	PUNCT
aji-130	158	46	when	when	SCONJ
aji-130	158	47	used	use	VERB
aji-130	158	48	as	as	ADP
aji-130	158	49	control	control	NOUN
aji-130	158	50	)	)	PUNCT
aji-130	158	51	.	.	PUNCT
aji-130	159	1	after	after	ADP
aji-130	159	2	incubation	incubation	NOUN
aji-130	159	3	,	,	PUNCT
aji-130	159	4	the	the	DET
aji-130	159	5	plasma	plasma	NOUN
aji-130	159	6	was	be	AUX
aji-130	159	7	allocated	allocate	VERB
aji-130	159	8	into	into	ADP
aji-130	159	9	a	a	DET
aji-130	159	10	standard	standard	ADJ
aji-130	159	11	neubauer	neubauer	PROPN
aji-130	159	12	hemocytometer	hemocytometer	PROPN
aji-130	159	13	counting	counting	PROPN
aji-130	159	14	chamber	chamber	NOUN
aji-130	159	15	with	with	ADP
aji-130	159	16	a	a	DET
aji-130	159	17	plain	plain	ADJ
aji-130	159	18	,	,	PUNCT
aji-130	159	19	non	non	ADJ
aji-130	159	20	-	-	ADJ
aji-130	159	21	metallic	metallic	ADJ
aji-130	159	22	glass	glass	NOUN
aji-130	159	23	surface	surface	NOUN
aji-130	159	24	and	and	CCONJ
aji-130	159	25	left	leave	VERB
aji-130	159	26	to	to	PART
aji-130	159	27	stand	stand	VERB
aji-130	159	28	for	for	ADP
aji-130	159	29	2	2	NUM
aji-130	159	30	hours	hour	NOUN
aji-130	159	31	at	at	ADP
aji-130	159	32	37	37	NUM
aji-130	159	33	°	°	SYM
aji-130	159	34	c	c	NOUN
aji-130	159	35	in	in	ADP
aji-130	159	36	the	the	DET
aji-130	159	37	humidified	humidified	ADJ
aji-130	159	38	atmosphere	atmosphere	NOUN
aji-130	159	39	of	of	ADP
aji-130	159	40	the	the	DET
aji-130	159	41	covered	cover	VERB
aji-130	159	42	water	water	NOUN
aji-130	159	43	bath	bath	NOUN
aji-130	159	44	to	to	PART
aji-130	159	45	allow	allow	VERB
aji-130	159	46	leukocytes	leukocyte	NOUN
aji-130	159	47	to	to	PART
aji-130	159	48	adhere	adhere	VERB
aji-130	159	49	to	to	ADP
aji-130	159	50	the	the	DET
aji-130	159	51	glass	glass	NOUN
aji-130	159	52	.	.	PUNCT
aji-130	160	1	next	next	ADV
aji-130	160	2	,	,	PUNCT
aji-130	160	3	we	we	PRON
aji-130	160	4	counted	count	VERB
aji-130	160	5	the	the	DET
aji-130	160	6	leukocytes	leukocyte	NOUN
aji-130	160	7	,	,	PUNCT
aji-130	160	8	removed	remove	VERB
aji-130	160	9	the	the	DET
aji-130	160	10	coverslip	coverslip	NOUN
aji-130	160	11	,	,	PUNCT
aji-130	160	12	and	and	CCONJ
aji-130	160	13	washed	wash	VERB
aji-130	160	14	the	the	DET
aji-130	160	15	chamber	chamber	NOUN
aji-130	160	16	by	by	ADP
aji-130	160	17	immersion	immersion	NOUN
aji-130	160	18	in	in	ADP
aji-130	160	19	a	a	DET
aji-130	160	20	beaker	beaker	NOUN
aji-130	160	21	with	with	ADP
aji-130	160	22	pbs	pbs	PROPN
aji-130	160	23	at	at	ADP
aji-130	160	24	37	37	NUM
aji-130	160	25	°	°	NOUN
aji-130	160	26	c	c	NOUN
aji-130	160	27	.	.	PUNCT
aji-130	161	1	then	then	ADV
aji-130	161	2	,	,	PUNCT
aji-130	161	3	we	we	PRON
aji-130	161	4	added	add	VERB
aji-130	161	5	a	a	DET
aji-130	161	6	drop	drop	NOUN
aji-130	161	7	of	of	ADP
aji-130	161	8	pbs	pbs	PROPN
aji-130	161	9	to	to	ADP
aji-130	161	10	the	the	DET
aji-130	161	11	hemocytometer	hemocytometer	NOUN
aji-130	161	12	's	's	PART
aji-130	161	13	chamber	chamber	NOUN
aji-130	161	14	and	and	CCONJ
aji-130	161	15	allocated	allocate	VERB
aji-130	161	16	a	a	DET
aji-130	161	17	clean	clean	ADJ
aji-130	161	18	coverslip	coverslip	NOUN
aji-130	161	19	over	over	ADP
aji-130	161	20	it	it	PRON
aji-130	161	21	.	.	PUNCT
aji-130	162	1	the	the	DET
aji-130	162	2	remaining	remain	VERB
aji-130	162	3	cells	cell	NOUN
aji-130	162	4	were	be	AUX
aji-130	162	5	counted	count	VERB
aji-130	162	6	in	in	ADP
aji-130	162	7	the	the	DET
aji-130	162	8	same	same	ADJ
aji-130	162	9	squares	square	NOUN
aji-130	162	10	as	as	SCONJ
aji-130	162	11	previously	previously	ADV
aji-130	162	12	examined	examine	VERB
aji-130	162	13	.	.	PUNCT
aji-130	163	1	the	the	DET
aji-130	163	2	percentage	percentage	NOUN
aji-130	163	3	of	of	ADP
aji-130	163	4	leukocyte	leukocyte	NOUN
aji-130	163	5	adherence	adherence	NOUN
aji-130	163	6	(	(	PUNCT
aji-130	163	7	la	la	NOUN
aji-130	163	8	)	)	PUNCT
aji-130	163	9	of	of	ADP
aji-130	163	10	each	each	DET
aji-130	163	11	assay	assay	NOUN
aji-130	163	12	was	be	AUX
aji-130	163	13	estimated	estimate	VERB
aji-130	163	14	as	as	ADP
aji-130	163	15	:	:	PUNCT
aji-130	163	16	(	(	PUNCT
aji-130	163	17	the	the	DET
aji-130	163	18	number	number	NOUN
aji-130	163	19	of	of	ADP
aji-130	163	20	leukocytes	leukocyte	NOUN
aji-130	163	21	observed	observe	VERB
aji-130	163	22	on	on	ADP
aji-130	163	23	the	the	DET
aji-130	163	24	hemocytometry	hemocytometry	PROPN
aji-130	163	25	chamber	chamber	PROPN
aji-130	163	26	after	after	ADP
aji-130	163	27	washing	wash	VERB
aji-130	163	28	divided	divide	VERB
aji-130	163	29	by	by	ADP
aji-130	163	30	the	the	DET
aji-130	163	31	number	number	NOUN
aji-130	163	32	of	of	ADP
aji-130	163	33	leukocytes	leukocyte	NOUN
aji-130	163	34	observed	observe	VERB
aji-130	163	35	on	on	ADP
aji-130	163	36	the	the	DET
aji-130	163	37	hemocytometry	hemocytometry	PROPN
aji-130	163	38	chamber	chamber	PROPN
aji-130	163	39	before	before	ADP
aji-130	163	40	washing	washing	NOUN
aji-130	163	41	)	)	PUNCT
aji-130	163	42	and	and	CCONJ
aji-130	163	43	multiplied	multiply	VERB
aji-130	163	44	by	by	ADP
aji-130	163	45	100	100	NUM
aji-130	163	46	(	(	PUNCT
aji-130	163	47	%	%	NOUN
aji-130	163	48	)	)	PUNCT
aji-130	163	49	.	.	PUNCT
aji-130	164	1	the	the	DET
aji-130	164	2	leukocyte	leukocyte	NOUN
aji-130	164	3	adherence	adherence	NOUN
aji-130	164	4	ratio	ratio	NOUN
aji-130	164	5	(	(	PUNCT
aji-130	164	6	lar	lar	ADJ
aji-130	164	7	)	)	PUNCT
aji-130	164	8	was	be	AUX
aji-130	164	9	estimated	estimate	VERB
aji-130	164	10	based	base	VERB
aji-130	164	11	on	on	ADP
aji-130	164	12	the	the	DET
aji-130	164	13	ratio	ratio	NOUN
aji-130	164	14	between	between	ADP
aji-130	164	15	the	the	DET
aji-130	164	16	la	la	NOUN
aji-130	164	17	from	from	ADP
aji-130	164	18	the	the	DET
aji-130	164	19	antigen	antigen	NOUN
aji-130	164	20	-	-	PUNCT
aji-130	164	21	specific	specific	ADJ
aji-130	164	22	challenged	challenge	VERB
aji-130	164	23	plasma	plasma	NOUN
aji-130	164	24	and	and	CCONJ
aji-130	164	25	the	the	DET
aji-130	164	26	la	la	PROPN
aji-130	164	27	from	from	ADP
aji-130	164	28	the	the	DET
aji-130	164	29	unchallenged	unchallenged	ADJ
aji-130	164	30	control	control	NOUN
aji-130	164	31	plasma	plasma	NOUN
aji-130	164	32	:	:	PUNCT
aji-130	164	33	lar	lar	PROPN
aji-130	164	34	=	=	PUNCT
aji-130	164	35	la	la	PROPN
aji-130	164	36	of	of	ADP
aji-130	164	37	the	the	DET
aji-130	164	38	challenged	challenge	VERB
aji-130	164	39	sample	sample	NOUN
aji-130	164	40	divided	divide	VERB
aji-130	164	41	by	by	ADP
aji-130	164	42	la	la	PROPN
aji-130	164	43	of	of	ADP
aji-130	164	44	unchallenged	unchallenged	ADJ
aji-130	164	45	control	control	NOUN
aji-130	164	46	plasma	plasma	NOUN
aji-130	164	47	multiplied	multiply	VERB
aji-130	164	48	by	by	ADP
aji-130	164	49	100	100	NUM
aji-130	164	50	(	(	PUNCT
aji-130	164	51	%	%	NOUN
aji-130	164	52	)	)	PUNCT
aji-130	164	53	.	.	PUNCT
aji-130	165	1	to	to	PART
aji-130	165	2	further	far	ADV
aji-130	165	3	calculate	calculate	VERB
aji-130	165	4	the	the	DET
aji-130	165	5	leukocyte	leukocyte	NOUN
aji-130	165	6	adherence	adherence	NOUN
aji-130	165	7	inhibition	inhibition	NOUN
aji-130	165	8	(	(	PUNCT
aji-130	165	9	lai	lai	PROPN
aji-130	165	10	)	)	PUNCT
aji-130	165	11	,	,	PUNCT
aji-130	165	12	we	we	PRON
aji-130	165	13	subtracted	subtract	VERB
aji-130	165	14	the	the	DET
aji-130	165	15	lar	lar	NOUN
aji-130	165	16	from	from	ADP
aji-130	165	17	100	100	NUM
aji-130	165	18	(	(	PUNCT
aji-130	165	19	%	%	NOUN
aji-130	165	20	)	)	PUNCT
aji-130	165	21	.	.	PUNCT
aji-130	166	1	we	we	PRON
aji-130	166	2	employed	employ	VERB
aji-130	166	3	the	the	DET
aji-130	166	4	lai	lai	PROPN
aji-130	166	5	results	result	NOUN
aji-130	166	6	for	for	ADP
aji-130	166	7	the	the	DET
aji-130	166	8	cascade	cascade	NOUN
aji-130	166	9	distribution	distribution	NOUN
aji-130	166	10	chart	chart	NOUN
aji-130	166	11	and	and	CCONJ
aji-130	166	12	the	the	DET
aji-130	166	13	statistics	statistic	NOUN
aji-130	166	14	calculations	calculation	NOUN
aji-130	166	15	,	,	PUNCT
aji-130	166	16	both	both	PRON
aji-130	166	17	performed	perform	VERB
aji-130	166	18	with	with	ADP
aji-130	166	19	the	the	DET
aji-130	166	20	help	help	NOUN
aji-130	166	21	of	of	ADP
aji-130	166	22	the	the	DET
aji-130	166	23	microsoft	microsoft	PROPN
aji-130	166	24	excel	excel	PROPN
aji-130	166	25	®	®	NOUN
aji-130	166	26	statistical	statistical	ADJ
aji-130	166	27	package	package	NOUN
aji-130	166	28	.	.	PUNCT
aji-130	167	1	3	3	X
aji-130	167	2	.	.	X
aji-130	167	3	results	result	NOUN
aji-130	167	4	as	as	ADP
aji-130	167	5	a	a	DET
aji-130	167	6	retrospective	retrospective	ADJ
aji-130	167	7	survey	survey	NOUN
aji-130	167	8	,	,	PUNCT
aji-130	167	9	there	there	PRON
aji-130	167	10	was	be	VERB
aji-130	167	11	no	no	DET
aji-130	167	12	research	research	NOUN
aji-130	167	13	protocol	protocol	NOUN
aji-130	167	14	;	;	PUNCT
aji-130	167	15	therefore	therefore	ADV
aji-130	167	16	,	,	PUNCT
aji-130	167	17	we	we	PRON
aji-130	167	18	report	report	VERB
aji-130	167	19	the	the	DET
aji-130	167	20	incidentally	incidentally	ADV
aji-130	167	21	immune	immune	ADJ
aji-130	167	22	investigation	investigation	NOUN
aji-130	167	23	as	as	SCONJ
aji-130	167	24	registered	register	VERB
aji-130	167	25	in	in	ADP
aji-130	167	26	the	the	DET
aji-130	167	27	digital	digital	ADJ
aji-130	167	28	medical	medical	ADJ
aji-130	167	29	charts	chart	NOUN
aji-130	167	30	.	.	PUNCT
aji-130	168	1	the	the	DET
aji-130	168	2	lai	lai	PROPN
aji-130	168	3	ranged	range	VERB
aji-130	168	4	from	from	ADP
aji-130	168	5	0	0	NUM
aji-130	168	6	%	%	NOUN
aji-130	168	7	to	to	PART
aji-130	168	8	97	97	NUM
aji-130	168	9	%	%	NOUN
aji-130	168	10	;	;	PUNCT
aji-130	168	11	the	the	DET
aji-130	168	12	mean	mean	NOUN
aji-130	168	13	was	be	AUX
aji-130	168	14	41.1	41.1	NUM
aji-130	168	15	%	%	NOUN
aji-130	168	16	;	;	PUNCT
aji-130	168	17	the	the	DET
aji-130	168	18	median	median	NOUN
aji-130	168	19	was	be	AUX
aji-130	168	20	40.5	40.5	NUM
aji-130	168	21	%	%	NOUN
aji-130	168	22	;	;	PUNCT
aji-130	168	23	the	the	DET
aji-130	168	24	standard	standard	ADJ
aji-130	168	25	deviation	deviation	NOUN
aji-130	168	26	was	be	AUX
aji-130	168	27	24.2	24.2	NUM
aji-130	168	28	%	%	NOUN
aji-130	168	29	;	;	PUNCT
aji-130	168	30	the	the	DET
aji-130	168	31	mode	mode	NOUN
aji-130	168	32	was	be	AUX
aji-130	168	33	0	0	NUM
aji-130	168	34	and	and	CCONJ
aji-130	168	35	59	59	NUM
aji-130	168	36	(	(	PUNCT
aji-130	168	37	each	each	PRON
aji-130	168	38	appeared	appear	VERB
aji-130	168	39	four	four	NUM
aji-130	168	40	times	time	NOUN
aji-130	168	41	)	)	PUNCT
aji-130	168	42	.	.	PUNCT
aji-130	169	1	olivier	olivier	PROPN
aji-130	169	2	et	et	PROPN
aji-130	169	3	al	al	PROPN
aji-130	169	4	.	.	PROPN
aji-130	169	5	;	;	PUNCT
aji-130	169	6	asian	asian	PROPN
aji-130	169	7	j.	j.	PROPN
aji-130	169	8	immunol	immunol	PROPN
aji-130	169	9	.	.	PROPN
aji-130	169	10	,	,	PUNCT
aji-130	169	11	vol	vol	NOUN
aji-130	169	12	.	.	PROPN
aji-130	170	1	7	7	NUM
aji-130	170	2	,	,	PUNCT
aji-130	170	3	no	no	INTJ
aji-130	170	4	.	.	NOUN
aji-130	170	5	1	1	NUM
aji-130	170	6	,	,	PUNCT
aji-130	170	7	pp	pp	ADJ
aji-130	170	8	.	.	PUNCT
aji-130	171	1	63	63	NUM
aji-130	171	2	-	-	SYM
aji-130	171	3	70	70	NUM
aji-130	171	4	,	,	PUNCT
aji-130	171	5	2024	2024	NUM
aji-130	171	6	;	;	PUNCT
aji-130	171	7	article	article	NOUN
aji-130	171	8	no.aji.115657	no.aji.115657	ADP
aji-130	171	9	66	66	NUM
aji-130	171	10	the	the	DET
aji-130	171	11	cascade	cascade	NOUN
aji-130	171	12	distribution	distribution	NOUN
aji-130	171	13	demonstrates	demonstrate	VERB
aji-130	171	14	a	a	DET
aji-130	171	15	wide	wide	ADJ
aji-130	171	16	range	range	NOUN
aji-130	171	17	of	of	ADP
aji-130	171	18	distribution	distribution	NOUN
aji-130	171	19	of	of	ADP
aji-130	171	20	lai	lai	PROPN
aji-130	171	21	results	result	NOUN
aji-130	171	22	(	(	PUNCT
aji-130	171	23	fig.1	fig.1	PROPN
aji-130	171	24	)	)	PUNCT
aji-130	171	25	.	.	PUNCT
aji-130	172	1	four	four	NUM
aji-130	172	2	patients	patient	NOUN
aji-130	172	3	ignored	ignore	VERB
aji-130	172	4	the	the	DET
aji-130	172	5	presence	presence	NOUN
aji-130	172	6	of	of	ADP
aji-130	172	7	the	the	DET
aji-130	172	8	allergen	allergen	NOUN
aji-130	172	9	on	on	ADP
aji-130	172	10	the	the	DET
aji-130	172	11	plasma	plasma	NOUN
aji-130	172	12	and	and	CCONJ
aji-130	172	13	presented	present	VERB
aji-130	172	14	no	no	DET
aji-130	172	15	inhibition	inhibition	NOUN
aji-130	172	16	of	of	ADP
aji-130	172	17	leukocyte	leukocyte	NOUN
aji-130	172	18	adherence	adherence	NOUN
aji-130	172	19	(	(	PUNCT
aji-130	172	20	lai	lai	NOUN
aji-130	172	21	=	=	PUNCT
aji-130	172	22	0	0	NUM
aji-130	172	23	%	%	NOUN
aji-130	172	24	)	)	PUNCT
aji-130	172	25	after	after	ADP
aji-130	172	26	contact	contact	NOUN
aji-130	172	27	with	with	ADP
aji-130	172	28	benzoic	benzoic	ADJ
aji-130	172	29	acid	acid	NOUN
aji-130	172	30	(	(	PUNCT
aji-130	172	31	4	4	NUM
aji-130	172	32	%	%	NOUN
aji-130	172	33	of	of	ADP
aji-130	172	34	the	the	DET
aji-130	172	35	tests	test	NOUN
aji-130	172	36	)	)	PUNCT
aji-130	172	37	.	.	PUNCT
aji-130	173	1	some	some	DET
aji-130	173	2	patients	patient	NOUN
aji-130	173	3	showed	show	VERB
aji-130	173	4	low	low	ADJ
aji-130	173	5	or	or	CCONJ
aji-130	173	6	moderate	moderate	ADJ
aji-130	173	7	immunoreactivity	immunoreactivity	NOUN
aji-130	173	8	during	during	ADP
aji-130	173	9	the	the	DET
aji-130	173	10	ex	ex	ADJ
aji-130	173	11	vivo	vivo	NOUN
aji-130	173	12	challenge	challenge	NOUN
aji-130	173	13	test	test	NOUN
aji-130	173	14	.	.	PUNCT
aji-130	174	1	in	in	ADP
aji-130	174	2	contrast	contrast	NOUN
aji-130	174	3	,	,	PUNCT
aji-130	174	4	others	other	NOUN
aji-130	174	5	displayed	display	VERB
aji-130	174	6	strong	strong	ADJ
aji-130	174	7	immunoreactivity	immunoreactivity	NOUN
aji-130	174	8	,	,	PUNCT
aji-130	174	9	which	which	PRON
aji-130	174	10	could	could	AUX
aji-130	174	11	possibly	possibly	ADV
aji-130	174	12	reflect	reflect	VERB
aji-130	174	13	the	the	DET
aji-130	174	14	participation	participation	NOUN
aji-130	174	15	of	of	ADP
aji-130	174	16	benzoic	benzoic	ADJ
aji-130	174	17	acid	acid	NOUN
aji-130	174	18	in	in	ADP
aji-130	174	19	a	a	DET
aji-130	174	20	theoretical	theoretical	ADJ
aji-130	174	21	non	non	ADJ
aji-130	174	22	–	–	PUNCT
aji-130	174	23	ige	ige	ADJ
aji-130	174	24	-	-	PUNCT
aji-130	174	25	mediated	mediate	VERB
aji-130	174	26	hypersensitivity	hypersensitivity	NOUN
aji-130	174	27	condition	condition	NOUN
aji-130	174	28	to	to	PART
aji-130	174	29	be	be	AUX
aji-130	174	30	further	far	ADV
aji-130	174	31	corroborated	corroborate	VERB
aji-130	174	32	by	by	ADP
aji-130	174	33	in	in	ADP
aji-130	174	34	vivo	vivo	ADJ
aji-130	174	35	provocation	provocation	NOUN
aji-130	174	36	tests	test	NOUN
aji-130	174	37	.	.	PUNCT
aji-130	175	1	4	4	X
aji-130	175	2	.	.	X
aji-130	175	3	discussion	discussion	NOUN
aji-130	175	4	the	the	DET
aji-130	175	5	non	non	ADJ
aji-130	175	6	-	-	ADJ
aji-130	175	7	ige	ige	ADJ
aji-130	175	8	-	-	PUNCT
aji-130	175	9	mediated	mediate	VERB
aji-130	175	10	hypersensitivities	hypersensitivity	NOUN
aji-130	175	11	are	be	AUX
aji-130	175	12	characterized	characterize	VERB
aji-130	175	13	by	by	ADP
aji-130	175	14	a	a	DET
aji-130	175	15	challenging	challenge	VERB
aji-130	175	16	technical	technical	ADJ
aji-130	175	17	diagnosis	diagnosis	NOUN
aji-130	175	18	due	due	ADP
aji-130	175	19	to	to	ADP
aji-130	175	20	the	the	DET
aji-130	175	21	lack	lack	NOUN
aji-130	175	22	of	of	ADP
aji-130	175	23	standardized	standardized	ADJ
aji-130	175	24	immunoassays	immunoassay	NOUN
aji-130	176	1	[	[	X
aji-130	176	2	35	35	NUM
aji-130	176	3	]	]	PUNCT
aji-130	176	4	.	.	PUNCT
aji-130	177	1	diagnosing	diagnose	VERB
aji-130	177	2	these	these	DET
aji-130	177	3	conditions	condition	NOUN
aji-130	177	4	among	among	ADP
aji-130	177	5	allergic	allergic	ADJ
aji-130	177	6	patients	patient	NOUN
aji-130	177	7	is	be	AUX
aji-130	177	8	based	base	VERB
aji-130	177	9	on	on	ADP
aji-130	177	10	individual	individual	ADJ
aji-130	177	11	laborious	laborious	ADJ
aji-130	177	12	medical	medical	ADJ
aji-130	177	13	work	work	NOUN
aji-130	177	14	accomplishing	accomplish	VERB
aji-130	177	15	anamnesis	anamnesis	NOUN
aji-130	177	16	,	,	PUNCT
aji-130	177	17	cutaneous	cutaneous	ADJ
aji-130	177	18	tests	test	NOUN
aji-130	177	19	,	,	PUNCT
aji-130	177	20	and	and	CCONJ
aji-130	177	21	challenge	challenge	VERB
aji-130	177	22	in	in	ADP
aji-130	177	23	vivo	vivo	ADJ
aji-130	177	24	provocation	provocation	NOUN
aji-130	177	25	tests	test	NOUN
aji-130	177	26	performed	perform	VERB
aji-130	177	27	after	after	ADP
aji-130	177	28	meticulous	meticulous	ADJ
aji-130	177	29	exclusion	exclusion	NOUN
aji-130	177	30	diets	diet	NOUN
aji-130	177	31	[	[	X
aji-130	177	32	36	36	NUM
aji-130	177	33	]	]	PUNCT
aji-130	177	34	.	.	PUNCT
aji-130	178	1	“	"	PUNCT
aji-130	178	2	as	as	SCONJ
aji-130	178	3	an	an	DET
aji-130	178	4	increaser	increaser	NOUN
aji-130	178	5	of	of	ADP
aji-130	178	6	the	the	DET
aji-130	178	7	sulfidoleukotriene	sulfidoleukotriene	NOUN
aji-130	178	8	production	production	NOUN
aji-130	178	9	,	,	PUNCT
aji-130	178	10	hypersensitivity	hypersensitivity	NOUN
aji-130	178	11	to	to	PART
aji-130	178	12	benzoic	benzoic	ADJ
aji-130	178	13	acid	acid	NOUN
aji-130	178	14	may	may	AUX
aji-130	178	15	be	be	AUX
aji-130	178	16	,	,	PUNCT
aji-130	178	17	in	in	ADP
aji-130	178	18	a	a	DET
aji-130	178	19	certain	certain	ADJ
aji-130	178	20	way	way	NOUN
aji-130	178	21	,	,	PUNCT
aji-130	178	22	similar	similar	ADJ
aji-130	178	23	(	(	PUNCT
aji-130	178	24	and	and	CCONJ
aji-130	178	25	potentially	potentially	ADV
aji-130	178	26	an	an	DET
aji-130	178	27	enhancer	enhancer	NOUN
aji-130	178	28	)	)	PUNCT
aji-130	178	29	of	of	ADP
aji-130	178	30	the	the	DET
aji-130	178	31	hypersensitivity	hypersensitivity	NOUN
aji-130	178	32	produced	produce	VERB
aji-130	178	33	by	by	ADP
aji-130	178	34	non	non	ADJ
aji-130	178	35	-	-	ADJ
aji-130	178	36	steroidal	steroidal	ADJ
aji-130	178	37	anti	anti	ADJ
aji-130	178	38	-	-	ADJ
aji-130	178	39	inflammatory	inflammatory	ADJ
aji-130	178	40	drugs	drug	NOUN
aji-130	178	41	(	(	PUNCT
aji-130	178	42	nsaids	nsaid	NOUN
aji-130	178	43	)	)	PUNCT
aji-130	178	44	.	.	PUNCT
aji-130	179	1	the	the	DET
aji-130	179	2	principal	principal	ADJ
aji-130	179	3	pharmacological	pharmacological	ADJ
aji-130	179	4	action	action	NOUN
aji-130	179	5	of	of	ADP
aji-130	179	6	nsaids	nsaid	NOUN
aji-130	179	7	is	be	AUX
aji-130	179	8	the	the	DET
aji-130	179	9	inhibition	inhibition	NOUN
aji-130	179	10	of	of	ADP
aji-130	179	11	the	the	DET
aji-130	179	12	cyclooxygenase	cyclooxygenase	NOUN
aji-130	179	13	enzymes	enzyme	NOUN
aji-130	179	14	,	,	PUNCT
aji-130	179	15	which	which	PRON
aji-130	179	16	catalyze	catalyze	VERB
aji-130	179	17	the	the	DET
aji-130	179	18	synthesis	synthesis	NOUN
aji-130	179	19	of	of	ADP
aji-130	179	20	prostaglandins	prostaglandin	NOUN
aji-130	179	21	and	and	CCONJ
aji-130	179	22	thromboxanes	thromboxane	NOUN
aji-130	179	23	”	"	PUNCT
aji-130	180	1	[	[	X
aji-130	180	2	37	37	NUM
aji-130	180	3	]	]	PUNCT
aji-130	180	4	.	.	PUNCT
aji-130	181	1	“	"	PUNCT
aji-130	181	2	cyclooxygenase	cyclooxygenase	VERB
aji-130	181	3	enzymes	enzyme	NOUN
aji-130	181	4	catalyze	catalyze	VERB
aji-130	181	5	the	the	DET
aji-130	181	6	conversion	conversion	NOUN
aji-130	181	7	of	of	ADP
aji-130	181	8	arachidonic	arachidonic	ADJ
aji-130	181	9	acid	acid	NOUN
aji-130	181	10	released	release	VERB
aji-130	181	11	from	from	ADP
aji-130	181	12	the	the	DET
aji-130	181	13	cellular	cellular	ADJ
aji-130	181	14	membrane	membrane	NOUN
aji-130	181	15	by	by	ADP
aji-130	181	16	cytosolic	cytosolic	ADJ
aji-130	181	17	phospholipases	phospholipase	NOUN
aji-130	181	18	activated	activate	VERB
aji-130	181	19	by	by	ADP
aji-130	181	20	nociceptive	nociceptive	ADJ
aji-130	181	21	mechanisms	mechanism	NOUN
aji-130	181	22	”	"	PUNCT
aji-130	182	1	[	[	X
aji-130	182	2	38	38	NUM
aji-130	182	3	]	]	PUNCT
aji-130	182	4	.	.	PUNCT
aji-130	183	1	“	"	PUNCT
aji-130	183	2	the	the	DET
aji-130	183	3	cyclooxygenases	cyclooxygenase	NOUN
aji-130	183	4	and	and	CCONJ
aji-130	183	5	the	the	DET
aji-130	183	6	lipoxygenases	lipoxygenase	NOUN
aji-130	183	7	oxidize	oxidize	VERB
aji-130	183	8	the	the	DET
aji-130	183	9	arachidonic	arachidonic	ADJ
aji-130	183	10	acid	acid	NOUN
aji-130	183	11	liberated	liberate	VERB
aji-130	183	12	into	into	ADP
aji-130	183	13	the	the	DET
aji-130	183	14	cytosol	cytosol	NOUN
aji-130	183	15	.	.	PUNCT
aji-130	184	1	the	the	DET
aji-130	184	2	cyclooxygenases	cyclooxygenase	NOUN
aji-130	184	3	pathway	pathway	NOUN
aji-130	184	4	generates	generate	VERB
aji-130	184	5	proinflammatory	proinflammatory	ADJ
aji-130	184	6	autacoids	autacoid	NOUN
aji-130	184	7	such	such	ADJ
aji-130	184	8	as	as	ADP
aji-130	184	9	prostaglandins	prostaglandin	NOUN
aji-130	184	10	and	and	CCONJ
aji-130	184	11	thromboxanes	thromboxane	NOUN
aji-130	184	12	.	.	PUNCT
aji-130	185	1	the	the	DET
aji-130	185	2	lipoxygenase	lipoxygenase	NOUN
aji-130	185	3	pathway	pathway	NOUN
aji-130	185	4	generates	generate	VERB
aji-130	185	5	leukotrienes	leukotriene	NOUN
aji-130	185	6	”	"	PUNCT
aji-130	186	1	[	[	X
aji-130	186	2	39	39	NUM
aji-130	186	3	]	]	PUNCT
aji-130	186	4	.	.	PUNCT
aji-130	187	1	the	the	DET
aji-130	187	2	pharmacologic	pharmacologic	ADJ
aji-130	187	3	inhibition	inhibition	NOUN
aji-130	187	4	of	of	ADP
aji-130	187	5	the	the	DET
aji-130	187	6	cyclooxygenases	cyclooxygenase	NOUN
aji-130	187	7	increases	increase	VERB
aji-130	187	8	the	the	DET
aji-130	187	9	lipoxygenases	lipoxygenase	NOUN
aji-130	187	10	'	'	PART
aji-130	187	11	activity	activity	NOUN
aji-130	187	12	,	,	PUNCT
aji-130	187	13	increasing	increase	VERB
aji-130	187	14	the	the	DET
aji-130	187	15	leukotrienes	leukotriene	NOUN
aji-130	187	16	'	'	PART
aji-130	187	17	production	production	NOUN
aji-130	187	18	.	.	PUNCT
aji-130	188	1	any	any	DET
aji-130	188	2	substance	substance	NOUN
aji-130	188	3	that	that	SCONJ
aji-130	188	4	(	(	PUNCT
aji-130	188	5	pharmacologically	pharmacologically	ADV
aji-130	188	6	or	or	CCONJ
aji-130	188	7	immunologically	immunologically	ADV
aji-130	188	8	)	)	PUNCT
aji-130	188	9	increases	increase	VERB
aji-130	188	10	the	the	DET
aji-130	188	11	production	production	NOUN
aji-130	188	12	of	of	ADP
aji-130	188	13	leukotrienes	leukotriene	NOUN
aji-130	188	14	affects	affect	VERB
aji-130	188	15	the	the	DET
aji-130	188	16	autacoid	autacoid	NOUN
aji-130	188	17	balance	balance	NOUN
aji-130	188	18	,	,	PUNCT
aji-130	188	19	adversely	adversely	ADV
aji-130	188	20	producing	produce	VERB
aji-130	188	21	allergic	allergic	ADJ
aji-130	188	22	symptoms	symptom	NOUN
aji-130	188	23	.	.	PUNCT
aji-130	189	1	the	the	DET
aji-130	189	2	lait	lait	PROPN
aji-130	189	3	theoretically	theoretically	ADV
aji-130	189	4	explores	explore	VERB
aji-130	189	5	every	every	DET
aji-130	189	6	immune	immune	ADJ
aji-130	189	7	pathway	pathway	NOUN
aji-130	189	8	as	as	ADP
aji-130	189	9	an	an	DET
aji-130	189	10	ex	ex	X
aji-130	189	11	vivo	vivo	NOUN
aji-130	189	12	challenge	challenge	NOUN
aji-130	189	13	test	test	NOUN
aji-130	189	14	with	with	ADP
aji-130	189	15	a	a	DET
aji-130	189	16	viable	viable	ADJ
aji-130	189	17	leukocyte	leukocyte	NOUN
aji-130	189	18	buffy	buffy	NOUN
aji-130	189	19	coat	coat	NOUN
aji-130	189	20	,	,	PUNCT
aji-130	189	21	allowing	allow	VERB
aji-130	189	22	the	the	DET
aji-130	189	23	interaction	interaction	NOUN
aji-130	189	24	of	of	ADP
aji-130	189	25	all	all	DET
aji-130	189	26	immune	immune	NOUN
aji-130	189	27	-	-	PUNCT
aji-130	189	28	circulating	circulate	VERB
aji-130	189	29	participants	participant	NOUN
aji-130	189	30	[	[	X
aji-130	189	31	40	40	NUM
aji-130	189	32	]	]	PUNCT
aji-130	189	33	.	.	PUNCT
aji-130	190	1	however	however	ADV
aji-130	190	2	,	,	PUNCT
aji-130	190	3	as	as	ADP
aji-130	190	4	an	an	DET
aji-130	190	5	observant	observant	NOUN
aji-130	190	6	of	of	ADP
aji-130	190	7	the	the	DET
aji-130	190	8	final	final	ADJ
aji-130	190	9	phenomenon	phenomenon	NOUN
aji-130	190	10	,	,	PUNCT
aji-130	190	11	the	the	DET
aji-130	190	12	lait	lait	NOUN
aji-130	190	13	did	do	AUX
aji-130	190	14	not	not	PART
aji-130	190	15	indicate	indicate	VERB
aji-130	190	16	which	which	DET
aji-130	190	17	pathways	pathway	NOUN
aji-130	190	18	were	be	AUX
aji-130	190	19	involved	involve	VERB
aji-130	190	20	in	in	ADP
aji-130	190	21	inhibiting	inhibit	VERB
aji-130	190	22	the	the	DET
aji-130	190	23	adherence	adherence	NOUN
aji-130	190	24	(	(	PUNCT
aji-130	190	25	or	or	CCONJ
aji-130	190	26	increasing	increase	VERB
aji-130	190	27	the	the	DET
aji-130	190	28	production	production	NOUN
aji-130	190	29	fig	fig	NOUN
aji-130	190	30	.	.	PUNCT
aji-130	191	1	1	1	NUM
aji-130	191	2	.	.	X
aji-130	191	3	cascade	cascade	NOUN
aji-130	191	4	distribution	distribution	NOUN
aji-130	191	5	chart	chart	NOUN
aji-130	191	6	of	of	ADP
aji-130	191	7	the	the	DET
aji-130	191	8	range	range	NOUN
aji-130	191	9	groups	group	NOUN
aji-130	191	10	of	of	ADP
aji-130	191	11	leukocyte	leukocyte	NOUN
aji-130	191	12	adherence	adherence	NOUN
aji-130	191	13	inhibition	inhibition	NOUN
aji-130	191	14	(	(	PUNCT
aji-130	191	15	lai	lai	NOUN
aji-130	191	16	)	)	PUNCT
aji-130	191	17	results	result	NOUN
aji-130	191	18	(	(	PUNCT
aji-130	191	19	x	x	NOUN
aji-130	191	20	-	-	ADJ
aji-130	191	21	axis	axis	ADJ
aji-130	191	22	%	%	NOUN
aji-130	191	23	)	)	PUNCT
aji-130	191	24	of	of	ADP
aji-130	191	25	ex	ex	PRON
aji-130	191	26	vivo	vivo	ADJ
aji-130	191	27	benzoic	benzoic	NOUN
aji-130	191	28	acid	acid	NOUN
aji-130	191	29	challenges	challenge	NOUN
aji-130	191	30	monitored	monitor	VERB
aji-130	191	31	by	by	ADP
aji-130	191	32	the	the	DET
aji-130	191	33	leukocyte	leukocyte	NOUN
aji-130	191	34	adherence	adherence	NOUN
aji-130	191	35	inhibition	inhibition	NOUN
aji-130	191	36	test	test	NOUN
aji-130	191	37	(	(	PUNCT
aji-130	191	38	lait	lait	NOUN
aji-130	191	39	)	)	PUNCT
aji-130	191	40	,	,	PUNCT
aji-130	191	41	according	accord	VERB
aji-130	191	42	to	to	ADP
aji-130	191	43	the	the	DET
aji-130	191	44	respective	respective	ADJ
aji-130	191	45	number	number	NOUN
aji-130	191	46	of	of	ADP
aji-130	191	47	outcomes	outcome	NOUN
aji-130	191	48	over	over	ADP
aji-130	191	49	100	100	NUM
aji-130	191	50	tests	test	NOUN
aji-130	191	51	/	/	SYM
aji-130	191	52	subjects	subject	NOUN
aji-130	191	53	(	(	PUNCT
aji-130	191	54	y	y	NOUN
aji-130	191	55	-	-	PUNCT
aji-130	191	56	axis	axis	NOUN
aji-130	191	57	)	)	PUNCT
aji-130	191	58	olivier	olivier	NOUN
aji-130	191	59	et	et	PROPN
aji-130	191	60	al	al	PROPN
aji-130	191	61	.	.	PROPN
aji-130	191	62	;	;	PUNCT
aji-130	191	63	asian	asian	PROPN
aji-130	191	64	j.	j.	PROPN
aji-130	191	65	immunol	immunol	PROPN
aji-130	191	66	.	.	PROPN
aji-130	191	67	,	,	PUNCT
aji-130	191	68	vol	vol	NOUN
aji-130	191	69	.	.	PROPN
aji-130	192	1	7	7	NUM
aji-130	192	2	,	,	PUNCT
aji-130	192	3	no	no	INTJ
aji-130	192	4	.	.	NOUN
aji-130	192	5	1	1	NUM
aji-130	192	6	,	,	PUNCT
aji-130	192	7	pp	pp	ADJ
aji-130	192	8	.	.	PUNCT
aji-130	193	1	63	63	NUM
aji-130	193	2	-	-	SYM
aji-130	193	3	70	70	NUM
aji-130	193	4	,	,	PUNCT
aji-130	193	5	2024	2024	NUM
aji-130	193	6	;	;	PUNCT
aji-130	193	7	article	article	NOUN
aji-130	193	8	no.aji.115657	no.aji.115657	PROPN
aji-130	193	9	67	67	NUM
aji-130	193	10	of	of	ADP
aji-130	193	11	leukotrienes	leukotriene	NOUN
aji-130	193	12	)	)	PUNCT
aji-130	193	13	,	,	PUNCT
aji-130	193	14	whether	whether	SCONJ
aji-130	193	15	pharmacological	pharmacological	ADJ
aji-130	193	16	or	or	CCONJ
aji-130	193	17	immunological	immunological	ADJ
aji-130	193	18	[	[	X
aji-130	193	19	41	41	NUM
aji-130	193	20	-	-	SYM
aji-130	193	21	44	44	NUM
aji-130	193	22	]	]	PUNCT
aji-130	193	23	.	.	PUNCT
aji-130	194	1	as	as	SCONJ
aji-130	194	2	proposed	propose	VERB
aji-130	194	3	by	by	ADP
aji-130	194	4	the	the	DET
aji-130	194	5	exposome	exposome	NOUN
aji-130	194	6	-	-	PUNCT
aji-130	194	7	wide	wide	ADJ
aji-130	194	8	association	association	NOUN
aji-130	194	9	study	study	NOUN
aji-130	194	10	,	,	PUNCT
aji-130	194	11	the	the	DET
aji-130	194	12	lait	lait	NOUN
aji-130	194	13	also	also	ADV
aji-130	194	14	configures	configure	VERB
aji-130	194	15	itself	itself	PRON
aji-130	194	16	as	as	ADP
aji-130	194	17	an	an	DET
aji-130	194	18	exposome	exposome	NOUN
aji-130	194	19	measurement	measurement	NOUN
aji-130	194	20	,	,	PUNCT
aji-130	194	21	qualifying	qualify	VERB
aji-130	194	22	itself	itself	PRON
aji-130	194	23	as	as	ADP
aji-130	194	24	an	an	DET
aji-130	194	25	immune	immune	ADJ
aji-130	194	26	marker	marker	NOUN
aji-130	194	27	of	of	ADP
aji-130	194	28	the	the	DET
aji-130	194	29	contact	contact	NOUN
aji-130	194	30	and	and	CCONJ
aji-130	194	31	the	the	DET
aji-130	194	32	response	response	NOUN
aji-130	194	33	to	to	ADP
aji-130	194	34	a	a	DET
aji-130	194	35	specific	specific	ADJ
aji-130	194	36	antigen	antigen	NOUN
aji-130	194	37	instead	instead	ADV
aji-130	194	38	of	of	ADP
aji-130	194	39	being	be	AUX
aji-130	194	40	associated	associate	VERB
aji-130	194	41	with	with	ADP
aji-130	194	42	a	a	DET
aji-130	194	43	specific	specific	ADJ
aji-130	194	44	phenotype	phenotype	NOUN
aji-130	194	45	[	[	X
aji-130	194	46	45	45	NUM
aji-130	194	47	]	]	PUNCT
aji-130	194	48	.	.	PUNCT
aji-130	195	1	this	this	DET
aji-130	195	2	preliminary	preliminary	ADJ
aji-130	195	3	retrospective	retrospective	ADJ
aji-130	195	4	survey	survey	NOUN
aji-130	195	5	demonstrated	demonstrate	VERB
aji-130	195	6	an	an	DET
aji-130	195	7	extensive	extensive	ADJ
aji-130	195	8	range	range	NOUN
aji-130	195	9	of	of	ADP
aji-130	195	10	results	result	NOUN
aji-130	195	11	from	from	ADP
aji-130	195	12	the	the	DET
aji-130	195	13	ex	ex	ADJ
aji-130	195	14	vivo	vivo	NOUN
aji-130	195	15	challenge	challenge	NOUN
aji-130	195	16	test	test	NOUN
aji-130	195	17	with	with	ADP
aji-130	195	18	benzoic	benzoic	ADJ
aji-130	195	19	acid	acid	NOUN
aji-130	195	20	monitored	monitor	VERB
aji-130	195	21	by	by	ADP
aji-130	195	22	lait	lait	NOUN
aji-130	195	23	in	in	ADP
aji-130	195	24	a	a	DET
aji-130	195	25	cohort	cohort	NOUN
aji-130	195	26	of	of	ADP
aji-130	195	27	patients	patient	NOUN
aji-130	195	28	with	with	ADP
aji-130	195	29	various	various	ADJ
aji-130	195	30	allergic	allergic	ADJ
aji-130	195	31	phenotypes	phenotype	NOUN
aji-130	195	32	.	.	PUNCT
aji-130	196	1	we	we	PRON
aji-130	196	2	routinely	routinely	ADV
aji-130	196	3	employ	employ	VERB
aji-130	196	4	the	the	DET
aji-130	196	5	lait	lait	NOUN
aji-130	196	6	as	as	ADP
aji-130	196	7	a	a	DET
aji-130	196	8	complementary	complementary	ADJ
aji-130	196	9	triage	triage	NOUN
aji-130	196	10	test	test	NOUN
aji-130	196	11	to	to	PART
aji-130	196	12	select	select	VERB
aji-130	196	13	worthwhile	worthwhile	ADJ
aji-130	196	14	antigens	antigen	NOUN
aji-130	196	15	to	to	PART
aji-130	196	16	proceed	proceed	VERB
aji-130	196	17	with	with	ADP
aji-130	196	18	more	more	ADV
aji-130	196	19	laborious	laborious	ADJ
aji-130	196	20	in	in	ADP
aji-130	196	21	vivo	vivo	ADJ
aji-130	196	22	provocation	provocation	NOUN
aji-130	196	23	tests	test	NOUN
aji-130	196	24	when	when	SCONJ
aji-130	196	25	the	the	DET
aji-130	196	26	specific	specific	ADJ
aji-130	196	27	ige	ige	NOUN
aji-130	196	28	is	be	AUX
aji-130	196	29	undetectable	undetectable	ADJ
aji-130	196	30	.	.	PUNCT
aji-130	197	1	none	none	NOUN
aji-130	197	2	of	of	ADP
aji-130	197	3	our	our	PRON
aji-130	197	4	patients	patient	NOUN
aji-130	197	5	presented	present	VERB
aji-130	197	6	an	an	DET
aji-130	197	7	exclusive	exclusive	ADJ
aji-130	197	8	reaction	reaction	NOUN
aji-130	197	9	to	to	ADP
aji-130	197	10	benzoic	benzoic	ADJ
aji-130	197	11	acid	acid	NOUN
aji-130	197	12	.	.	PUNCT
aji-130	198	1	every	every	DET
aji-130	198	2	patient	patient	NOUN
aji-130	198	3	was	be	AUX
aji-130	198	4	simultaneously	simultaneously	ADV
aji-130	198	5	tested	test	VERB
aji-130	198	6	with	with	ADP
aji-130	198	7	protein	protein	NOUN
aji-130	198	8	allergens	allergen	NOUN
aji-130	198	9	(	(	PUNCT
aji-130	198	10	mites	mite	NOUN
aji-130	198	11	,	,	PUNCT
aji-130	198	12	fungi	fungus	NOUN
aji-130	198	13	,	,	PUNCT
aji-130	198	14	food	food	NOUN
aji-130	198	15	allergens	allergen	NOUN
aji-130	198	16	)	)	PUNCT
aji-130	198	17	,	,	PUNCT
aji-130	198	18	demonstrating	demonstrate	VERB
aji-130	198	19	positive	positive	ADJ
aji-130	198	20	results	result	NOUN
aji-130	198	21	for	for	ADP
aji-130	198	22	some	some	PRON
aji-130	198	23	of	of	ADP
aji-130	198	24	them	they	PRON
aji-130	198	25	[	[	X
aji-130	198	26	46	46	NUM
aji-130	198	27	]	]	PUNCT
aji-130	198	28	.	.	PUNCT
aji-130	199	1	our	our	PRON
aji-130	199	2	results	result	NOUN
aji-130	199	3	may	may	AUX
aji-130	199	4	suggest	suggest	VERB
aji-130	199	5	that	that	SCONJ
aji-130	199	6	allergic	allergic	ADJ
aji-130	199	7	patients	patient	NOUN
aji-130	199	8	may	may	AUX
aji-130	199	9	impair	impair	VERB
aji-130	199	10	their	their	PRON
aji-130	199	11	symptoms	symptom	NOUN
aji-130	199	12	by	by	ADP
aji-130	199	13	a	a	DET
aji-130	199	14	pharmacological	pharmacological	NOUN
aji-130	199	15	or	or	CCONJ
aji-130	199	16	an	an	DET
aji-130	199	17	immune	immune	ADJ
aji-130	199	18	additional	additional	ADJ
aji-130	199	19	action	action	NOUN
aji-130	199	20	of	of	ADP
aji-130	199	21	benzoic	benzoic	ADJ
aji-130	199	22	acid	acid	NOUN
aji-130	199	23	over	over	ADP
aji-130	199	24	the	the	DET
aji-130	199	25	hypersensitivity	hypersensitivity	NOUN
aji-130	199	26	response	response	NOUN
aji-130	199	27	.	.	PUNCT
aji-130	200	1	5	5	X
aji-130	200	2	.	.	X
aji-130	200	3	conclusions	conclusion	NOUN
aji-130	200	4	our	our	PRON
aji-130	200	5	preliminary	preliminary	ADJ
aji-130	200	6	results	result	NOUN
aji-130	200	7	show	show	VERB
aji-130	200	8	that	that	SCONJ
aji-130	200	9	the	the	DET
aji-130	200	10	lait	lait	NOUN
aji-130	200	11	may	may	AUX
aji-130	200	12	differentiate	differentiate	VERB
aji-130	200	13	diverse	diverse	ADJ
aji-130	200	14	degrees	degree	NOUN
aji-130	200	15	of	of	ADP
aji-130	200	16	ex	ex	X
aji-130	200	17	vivo	vivo	NOUN
aji-130	200	18	immunoreactivity	immunoreactivity	NOUN
aji-130	200	19	against	against	ADP
aji-130	200	20	benzoic	benzoic	ADJ
aji-130	200	21	acid	acid	NOUN
aji-130	200	22	in	in	ADP
aji-130	200	23	patients	patient	NOUN
aji-130	200	24	clinically	clinically	ADV
aji-130	200	25	diagnosed	diagnose	VERB
aji-130	200	26	with	with	ADP
aji-130	200	27	non	non	ADJ
aji-130	200	28	–	–	PUNCT
aji-130	200	29	ige	ige	ADJ
aji-130	200	30	-	-	PUNCT
aji-130	200	31	mediated	mediate	VERB
aji-130	200	32	allergies	allergy	NOUN
aji-130	200	33	.	.	PUNCT
aji-130	201	1	the	the	DET
aji-130	201	2	propaedeutic	propaedeutic	ADJ
aji-130	201	3	meaning	meaning	NOUN
aji-130	201	4	of	of	ADP
aji-130	201	5	these	these	DET
aji-130	201	6	results	result	NOUN
aji-130	201	7	,	,	PUNCT
aji-130	201	8	however	however	ADV
aji-130	201	9	,	,	PUNCT
aji-130	201	10	must	must	AUX
aji-130	201	11	be	be	AUX
aji-130	201	12	established	establish	VERB
aji-130	201	13	.	.	PUNCT
aji-130	202	1	more	more	ADJ
aji-130	202	2	studies	study	NOUN
aji-130	202	3	with	with	ADP
aji-130	202	4	prospective	prospective	ADJ
aji-130	202	5	larger	large	ADJ
aji-130	202	6	double	double	ADJ
aji-130	202	7	-	-	PUNCT
aji-130	202	8	blind	blind	ADJ
aji-130	202	9	cohorts	cohort	NOUN
aji-130	202	10	need	need	VERB
aji-130	202	11	to	to	PART
aji-130	202	12	evaluate	evaluate	VERB
aji-130	202	13	the	the	DET
aji-130	202	14	potential	potential	ADJ
aji-130	202	15	contribution	contribution	NOUN
aji-130	202	16	of	of	ADP
aji-130	202	17	lait	lait	NOUN
aji-130	202	18	for	for	ADP
aji-130	202	19	the	the	DET
aji-130	202	20	etiologic	etiologic	ADJ
aji-130	202	21	diagnosis	diagnosis	NOUN
aji-130	202	22	of	of	ADP
aji-130	202	23	patients	patient	NOUN
aji-130	202	24	suspected	suspect	VERB
aji-130	202	25	of	of	ADP
aji-130	202	26	symptomatic	symptomatic	ADJ
aji-130	202	27	hypersensitivity	hypersensitivity	NOUN
aji-130	202	28	against	against	ADP
aji-130	202	29	benzoic	benzoic	ADJ
aji-130	202	30	acid	acid	NOUN
aji-130	202	31	and	and	CCONJ
aji-130	202	32	other	other	ADJ
aji-130	202	33	similar	similar	ADJ
aji-130	202	34	food	food	NOUN
aji-130	202	35	,	,	PUNCT
aji-130	202	36	cosmetic	cosmetic	NOUN
aji-130	202	37	,	,	PUNCT
aji-130	202	38	and	and	CCONJ
aji-130	202	39	pharmaceutical	pharmaceutical	NOUN
aji-130	202	40	additives	additive	NOUN
aji-130	202	41	.	.	PUNCT
aji-130	203	1	6	6	NUM
aji-130	203	2	.	.	X
aji-130	203	3	limitations	limitation	NOUN
aji-130	203	4	this	this	DET
aji-130	203	5	study	study	NOUN
aji-130	203	6	is	be	AUX
aji-130	203	7	a	a	DET
aji-130	203	8	retrospective	retrospective	ADJ
aji-130	203	9	analysis	analysis	NOUN
aji-130	203	10	of	of	ADP
aji-130	203	11	data	datum	NOUN
aji-130	203	12	collected	collect	VERB
aji-130	203	13	over	over	ADP
aji-130	203	14	six	six	NUM
aji-130	203	15	years	year	NOUN
aji-130	203	16	.	.	PUNCT
aji-130	204	1	there	there	PRON
aji-130	204	2	was	be	VERB
aji-130	204	3	no	no	DET
aji-130	204	4	protocol	protocol	NOUN
aji-130	204	5	research	research	NOUN
aji-130	204	6	,	,	PUNCT
aji-130	204	7	and	and	CCONJ
aji-130	204	8	the	the	DET
aji-130	204	9	subject	subject	NOUN
aji-130	204	10	's	's	PART
aji-130	204	11	data	datum	NOUN
aji-130	204	12	were	be	AUX
aji-130	204	13	limited	limit	VERB
aji-130	204	14	to	to	ADP
aji-130	204	15	the	the	DET
aji-130	204	16	essentials	essential	NOUN
aji-130	204	17	available	available	ADJ
aji-130	204	18	on	on	ADP
aji-130	204	19	our	our	PRON
aji-130	204	20	electronic	electronic	ADJ
aji-130	204	21	sheets	sheet	NOUN
aji-130	204	22	.	.	PUNCT
aji-130	205	1	the	the	DET
aji-130	205	2	number	number	NOUN
aji-130	205	3	of	of	ADP
aji-130	205	4	subjects	subject	NOUN
aji-130	205	5	is	be	AUX
aji-130	205	6	appropriate	appropriate	ADJ
aji-130	205	7	for	for	ADP
aji-130	205	8	a	a	DET
aji-130	205	9	preliminary	preliminary	ADJ
aji-130	205	10	study	study	NOUN
aji-130	205	11	;	;	PUNCT
aji-130	205	12	however	however	ADV
aji-130	205	13	,	,	PUNCT
aji-130	205	14	future	future	ADJ
aji-130	205	15	studies	study	NOUN
aji-130	205	16	must	must	AUX
aji-130	205	17	be	be	AUX
aji-130	205	18	more	more	ADV
aji-130	205	19	comprehensive	comprehensive	ADJ
aji-130	205	20	.	.	PUNCT
aji-130	206	1	the	the	DET
aji-130	206	2	lack	lack	NOUN
aji-130	206	3	of	of	ADP
aji-130	206	4	a	a	DET
aji-130	206	5	research	research	NOUN
aji-130	206	6	protocol	protocol	NOUN
aji-130	206	7	implies	imply	VERB
aji-130	206	8	the	the	DET
aji-130	206	9	possibility	possibility	NOUN
aji-130	206	10	of	of	ADP
aji-130	206	11	a	a	DET
aji-130	206	12	bias	bias	NOUN
aji-130	206	13	produced	produce	VERB
aji-130	206	14	by	by	ADP
aji-130	206	15	the	the	DET
aji-130	206	16	point	point	NOUN
aji-130	206	17	of	of	ADP
aji-130	206	18	view	view	NOUN
aji-130	206	19	of	of	ADP
aji-130	206	20	the	the	DET
aji-130	206	21	physician	physician	NOUN
aji-130	206	22	who	who	PRON
aji-130	206	23	indicated	indicate	VERB
aji-130	206	24	the	the	DET
aji-130	206	25	exam	exam	NOUN
aji-130	206	26	(	(	PUNCT
aji-130	206	27	ceo	ceo	NOUN
aji-130	206	28	)	)	PUNCT
aji-130	206	29	based	base	VERB
aji-130	206	30	on	on	ADP
aji-130	206	31	a	a	DET
aji-130	206	32	clinical	clinical	ADJ
aji-130	206	33	suspicion	suspicion	NOUN
aji-130	206	34	led	lead	VERB
aji-130	206	35	purely	purely	ADV
aji-130	206	36	by	by	ADP
aji-130	206	37	the	the	DET
aji-130	206	38	anamnesis	anamnesis	NOUN
aji-130	206	39	.	.	PUNCT
aji-130	207	1	the	the	DET
aji-130	207	2	study	study	NOUN
aji-130	207	3	lost	lose	VERB
aji-130	207	4	many	many	ADJ
aji-130	207	5	of	of	ADP
aji-130	207	6	these	these	DET
aji-130	207	7	patients	patient	NOUN
aji-130	207	8	to	to	PART
aji-130	207	9	follow	follow	VERB
aji-130	207	10	-	-	PUNCT
aji-130	207	11	up	up	NOUN
aji-130	207	12	,	,	PUNCT
aji-130	207	13	so	so	ADV
aji-130	207	14	assessing	assess	VERB
aji-130	207	15	the	the	DET
aji-130	207	16	relationship	relationship	NOUN
aji-130	207	17	between	between	ADP
aji-130	207	18	lait	lait	NOUN
aji-130	207	19	outcome	outcome	NOUN
aji-130	207	20	and	and	CCONJ
aji-130	207	21	the	the	DET
aji-130	207	22	patient	patient	NOUN
aji-130	207	23	's	's	PART
aji-130	207	24	subsequent	subsequent	ADJ
aji-130	207	25	clinical	clinical	ADJ
aji-130	207	26	outcome	outcome	NOUN
aji-130	207	27	was	be	AUX
aji-130	207	28	impossible	impossible	ADJ
aji-130	207	29	.	.	PUNCT
aji-130	208	1	consent	consent	NOUN
aji-130	208	2	as	as	ADP
aji-130	208	3	per	per	ADP
aji-130	208	4	international	international	ADJ
aji-130	208	5	standards	standard	NOUN
aji-130	208	6	or	or	CCONJ
aji-130	208	7	university	university	NOUN
aji-130	208	8	standards	standard	NOUN
aji-130	208	9	,	,	PUNCT
aji-130	208	10	patient(s	patient(s	PROPN
aji-130	208	11	)	)	PUNCT
aji-130	208	12	written	write	VERB
aji-130	208	13	consent	consent	NOUN
aji-130	208	14	has	have	AUX
aji-130	208	15	been	be	AUX
aji-130	208	16	collected	collect	VERB
aji-130	208	17	and	and	CCONJ
aji-130	208	18	preserved	preserve	VERB
aji-130	208	19	by	by	ADP
aji-130	208	20	the	the	DET
aji-130	208	21	author(s	author(s	NOUN
aji-130	208	22	)	)	PUNCT
aji-130	208	23	.	.	PUNCT
aji-130	209	1	ethical	ethical	ADJ
aji-130	209	2	approval	approval	NOUN
aji-130	209	3	as	as	ADP
aji-130	209	4	per	per	ADP
aji-130	209	5	international	international	ADJ
aji-130	209	6	standards	standard	NOUN
aji-130	209	7	or	or	CCONJ
aji-130	209	8	university	university	NOUN
aji-130	209	9	standards	standard	NOUN
aji-130	209	10	written	write	VERB
aji-130	209	11	ethical	ethical	ADJ
aji-130	209	12	approval	approval	NOUN
aji-130	209	13	has	have	AUX
aji-130	209	14	been	be	AUX
aji-130	209	15	collected	collect	VERB
aji-130	209	16	and	and	CCONJ
aji-130	209	17	preserved	preserve	VERB
aji-130	209	18	by	by	ADP
aji-130	209	19	the	the	DET
aji-130	209	20	author(s	author(s	NOUN
aji-130	209	21	)	)	PUNCT
aji-130	209	22	.	.	PUNCT
aji-130	210	1	competing	compete	VERB
aji-130	210	2	interests	interest	NOUN
aji-130	210	3	authors	author	NOUN
aji-130	210	4	have	have	AUX
aji-130	210	5	declared	declare	VERB
aji-130	210	6	that	that	SCONJ
aji-130	210	7	they	they	PRON
aji-130	210	8	have	have	VERB
aji-130	210	9	no	no	DET
aji-130	210	10	known	know	VERB
aji-130	210	11	competing	compete	VERB
aji-130	210	12	financial	financial	ADJ
aji-130	210	13	interests	interest	NOUN
aji-130	210	14	or	or	CCONJ
aji-130	210	15	non	non	ADJ
aji-130	210	16	-	-	ADJ
aji-130	210	17	financial	financial	ADJ
aji-130	210	18	interests	interest	NOUN
aji-130	210	19	or	or	CCONJ
aji-130	210	20	personal	personal	ADJ
aji-130	210	21	relationships	relationship	NOUN
aji-130	210	22	that	that	PRON
aji-130	210	23	could	could	AUX
aji-130	210	24	have	have	AUX
aji-130	210	25	appeared	appear	VERB
aji-130	210	26	to	to	PART
aji-130	210	27	influence	influence	VERB
aji-130	210	28	the	the	DET
aji-130	210	29	work	work	NOUN
aji-130	210	30	reported	report	VERB
aji-130	210	31	in	in	ADP
aji-130	210	32	this	this	DET
aji-130	210	33	paper	paper	NOUN
aji-130	210	34	.	.	PUNCT
aji-130	211	1	references	reference	NOUN
aji-130	211	2	1	1	NUM
aji-130	211	3	.	.	PUNCT
aji-130	211	4	nair	nair	PROPN
aji-130	211	5	b.	b.	PROPN
aji-130	211	6	final	final	PROPN
aji-130	211	7	report	report	NOUN
aji-130	211	8	on	on	ADP
aji-130	211	9	the	the	DET
aji-130	211	10	safety	safety	NOUN
aji-130	211	11	assessment	assessment	NOUN
aji-130	211	12	of	of	ADP
aji-130	211	13	benzyl	benzyl	NOUN
aji-130	211	14	alcohol	alcohol	NOUN
aji-130	211	15	,	,	PUNCT
aji-130	211	16	benzoic	benzoic	NOUN
aji-130	211	17	acid	acid	NOUN
aji-130	211	18	,	,	PUNCT
aji-130	211	19	and	and	CCONJ
aji-130	211	20	sodium	sodium	NOUN
aji-130	211	21	benzoate	benzoate	NOUN
aji-130	211	22	.	.	PUNCT
aji-130	212	1	int	int	PROPN
aji-130	212	2	j	j	PROPN
aji-130	212	3	toxicol	toxicol	NOUN
aji-130	212	4	.	.	PUNCT
aji-130	213	1	2001:20(suppl	2001:20(suppl	NUM
aji-130	213	2	3):23	3):23	NUM
aji-130	213	3	-	-	SYM
aji-130	213	4	50	50	NUM
aji-130	213	5	.	.	PUNCT
aji-130	214	1	2	2	X
aji-130	214	2	.	.	X
aji-130	214	3	adams	adams	PROPN
aji-130	214	4	tb	tb	PROPN
aji-130	214	5	,	,	PUNCT
aji-130	214	6	cohen	cohen	PROPN
aji-130	214	7	sm	sm	PROPN
aji-130	214	8	,	,	PUNCT
aji-130	214	9	doull	doull	PROPN
aji-130	214	10	j	j	PROPN
aji-130	214	11	,	,	PUNCT
aji-130	214	12	feron	feron	PROPN
aji-130	214	13	vj	vj	PROPN
aji-130	214	14	,	,	PUNCT
aji-130	214	15	goodman	goodman	PROPN
aji-130	214	16	ji	ji	PROPN
aji-130	214	17	,	,	PUNCT
aji-130	214	18	marnett	marnett	PROPN
aji-130	214	19	lj	lj	PROPN
aji-130	214	20	.	.	PUNCT
aji-130	214	21	et	et	PROPN
aji-130	215	1	al	al	PROPN
aji-130	215	2	.	.	PUNCT
aji-130	216	1	the	the	DET
aji-130	216	2	fema	fema	PROPN
aji-130	216	3	gras	gras	PROPN
aji-130	216	4	assessment	assessment	NOUN
aji-130	216	5	of	of	ADP
aji-130	216	6	benzyl	benzyl	NOUN
aji-130	216	7	derivatives	derivative	NOUN
aji-130	216	8	used	use	VERB
aji-130	216	9	as	as	ADP
aji-130	216	10	flavor	flavor	NOUN
aji-130	216	11	ingredients	ingredient	NOUN
aji-130	216	12	.	.	PUNCT
aji-130	217	1	food	food	NOUN
aji-130	217	2	chem	chem	NOUN
aji-130	217	3	toxicol	toxicol	NOUN
aji-130	217	4	.	.	PUNCT
aji-130	218	1	2005;43(8):1207	2005;43(8):1207	NOUN
aji-130	218	2	-	-	SYM
aji-130	218	3	40	40	NUM
aji-130	218	4	.	.	PUNCT
aji-130	219	1	3	3	X
aji-130	219	2	.	.	X
aji-130	219	3	fao	fao	NOUN
aji-130	219	4	-	-	PUNCT
aji-130	219	5	who	who	PRON
aji-130	219	6	expert	expert	NOUN
aji-130	219	7	committee	committee	NOUN
aji-130	219	8	.	.	PUNCT
aji-130	220	1	toxicological	toxicological	ADJ
aji-130	220	2	evaluation	evaluation	NOUN
aji-130	220	3	of	of	ADP
aji-130	220	4	certain	certain	ADJ
aji-130	220	5	food	food	NOUN
aji-130	220	6	additives	additive	NOUN
aji-130	220	7	with	with	ADP
aji-130	220	8	a	a	DET
aji-130	220	9	review	review	NOUN
aji-130	220	10	of	of	ADP
aji-130	220	11	general	general	ADJ
aji-130	220	12	principles	principle	NOUN
aji-130	220	13	and	and	CCONJ
aji-130	220	14	of	of	ADP
aji-130	220	15	specifications	specification	NOUN
aji-130	220	16	.	.	PUNCT
aji-130	221	1	seventeenth	seventeenth	ADJ
aji-130	221	2	report	report	NOUN
aji-130	221	3	of	of	ADP
aji-130	221	4	the	the	DET
aji-130	221	5	joint	joint	ADJ
aji-130	221	6	fao	fao	NOUN
aji-130	221	7	-	-	PUNCT
aji-130	221	8	who	who	PRON
aji-130	221	9	expert	expert	ADJ
aji-130	221	10	committee	committee	NOUN
aji-130	221	11	on	on	ADP
aji-130	221	12	food	food	NOUN
aji-130	221	13	additives	additive	NOUN
aji-130	221	14	.	.	PUNCT
aji-130	222	1	world	world	NOUN
aji-130	222	2	health	health	PROPN
aji-130	222	3	organization	organization	PROPN
aji-130	222	4	technical	technical	PROPN
aji-130	222	5	report	report	PROPN
aji-130	222	6	series	series	NOUN
aji-130	222	7	.	.	PUNCT
aji-130	223	1	1974;539:1	1974;539:1	X
aji-130	223	2	-	-	SYM
aji-130	223	3	40	40	NUM
aji-130	223	4	.	.	PUNCT
aji-130	224	1	4	4	X
aji-130	224	2	.	.	X
aji-130	224	3	fao	fao	NOUN
aji-130	224	4	-	-	PUNCT
aji-130	224	5	who	who	PRON
aji-130	224	6	expert	expert	NOUN
aji-130	224	7	committee	committee	NOUN
aji-130	224	8	.	.	PUNCT
aji-130	225	1	evaluation	evaluation	NOUN
aji-130	225	2	of	of	ADP
aji-130	225	3	certain	certain	ADJ
aji-130	225	4	food	food	NOUN
aji-130	225	5	additives	additive	NOUN
aji-130	225	6	.	.	PUNCT
aji-130	226	1	twenty	twenty	NUM
aji-130	226	2	-	-	PUNCT
aji-130	226	3	third	third	NOUN
aji-130	226	4	report	report	NOUN
aji-130	226	5	of	of	ADP
aji-130	226	6	the	the	DET
aji-130	226	7	joint	joint	ADJ
aji-130	226	8	fao	fao	NOUN
aji-130	226	9	/	/	SYM
aji-130	226	10	who	who	PRON
aji-130	226	11	expert	expert	ADJ
aji-130	226	12	committee	committee	NOUN
aji-130	226	13	on	on	ADP
aji-130	226	14	food	food	NOUN
aji-130	226	15	additives	additive	NOUN
aji-130	226	16	.	.	PUNCT
aji-130	227	1	world	world	NOUN
aji-130	227	2	health	health	PROPN
aji-130	227	3	organization	organization	PROPN
aji-130	227	4	technical	technical	PROPN
aji-130	227	5	report	report	PROPN
aji-130	227	6	series	series	NOUN
aji-130	227	7	.	.	PUNCT
aji-130	228	1	1980;648:1	1980;648:1	NUM
aji-130	228	2	-	-	SYM
aji-130	228	3	45	45	NUM
aji-130	228	4	.	.	NOUN
aji-130	228	5	5	5	NUM
aji-130	228	6	.	.	X
aji-130	228	7	jia	jia	PROPN
aji-130	228	8	w	w	PROPN
aji-130	228	9	,	,	PUNCT
aji-130	228	10	wang	wang	PROPN
aji-130	228	11	x	x	PROPN
aji-130	228	12	,	,	PUNCT
aji-130	228	13	shi	shi	PROPN
aji-130	228	14	l.	l.	PROPN
aji-130	228	15	endogenous	endogenous	ADJ
aji-130	228	16	benzoic	benzoic	NOUN
aji-130	228	17	acid	acid	NOUN
aji-130	228	18	interferes	interfere	VERB
aji-130	228	19	with	with	ADP
aji-130	228	20	the	the	DET
aji-130	228	21	signatures	signature	NOUN
aji-130	228	22	of	of	ADP
aji-130	228	23	amino	amino	ADJ
aji-130	228	24	acids	acid	NOUN
aji-130	228	25	and	and	CCONJ
aji-130	228	26	thiol	thiol	NOUN
aji-130	228	27	compounds	compound	VERB
aji-130	228	28	through	through	ADP
aji-130	228	29	perturbing	perturb	VERB
aji-130	228	30	n	n	CCONJ
aji-130	228	31	-	-	PUNCT
aji-130	228	32	methyltransferase	methyltransferase	NOUN
aji-130	228	33	,	,	PUNCT
aji-130	228	34	glutamate	glutamate	NOUN
aji-130	228	35	-	-	PUNCT
aji-130	228	36	cysteine	cysteine	NOUN
aji-130	228	37	ligase	ligase	NOUN
aji-130	228	38	,	,	PUNCT
aji-130	228	39	and	and	CCONJ
aji-130	228	40	glutathione	glutathione	NOUN
aji-130	228	41	s	s	NOUN
aji-130	228	42	-	-	PUNCT
aji-130	228	43	transferase	transferase	NOUN
aji-130	228	44	activity	activity	NOUN
aji-130	228	45	in	in	ADP
aji-130	228	46	dairy	dairy	NOUN
aji-130	228	47	products	product	NOUN
aji-130	228	48	.	.	PUNCT
aji-130	229	1	olivier	olivier	PROPN
aji-130	229	2	et	et	PROPN
aji-130	229	3	al	al	PROPN
aji-130	229	4	.	.	PROPN
aji-130	229	5	;	;	PUNCT
aji-130	229	6	asian	asian	PROPN
aji-130	229	7	j.	j.	PROPN
aji-130	229	8	immunol	immunol	PROPN
aji-130	229	9	.	.	PROPN
aji-130	229	10	,	,	PUNCT
aji-130	229	11	vol	vol	NOUN
aji-130	229	12	.	.	PROPN
aji-130	230	1	7	7	NUM
aji-130	230	2	,	,	PUNCT
aji-130	230	3	no	no	INTJ
aji-130	230	4	.	.	NOUN
aji-130	230	5	1	1	NUM
aji-130	230	6	,	,	PUNCT
aji-130	230	7	pp	pp	ADJ
aji-130	230	8	.	.	PUNCT
aji-130	231	1	63	63	NUM
aji-130	231	2	-	-	SYM
aji-130	231	3	70	70	NUM
aji-130	231	4	,	,	PUNCT
aji-130	231	5	2024	2024	NUM
aji-130	231	6	;	;	PUNCT
aji-130	232	1	article	article	NOUN
aji-130	232	2	no.aji.115657	no.aji.115657	X
aji-130	232	3	68	68	NUM
aji-130	232	4	food	food	NOUN
aji-130	232	5	res	re	NOUN
aji-130	232	6	int	int	NOUN
aji-130	232	7	(	(	PUNCT
aji-130	232	8	ottawa	ottawa	PROPN
aji-130	232	9	,	,	PUNCT
aji-130	232	10	ont	ont	PROPN
aji-130	232	11	.	.	PUNCT
aji-130	232	12	)	)	PUNCT
aji-130	232	13	2022	2022	NUM
aji-130	232	14	;	;	PUNCT
aji-130	232	15	161:111857	161:111857	NUM
aji-130	232	16	.	.	NOUN
aji-130	232	17	6	6	NUM
aji-130	232	18	.	.	X
aji-130	232	19	boelens	boelen	VERB
aji-130	232	20	mh	mh	PROPN
aji-130	232	21	,	,	PUNCT
aji-130	232	22	visscher	visscher	PROPN
aji-130	232	23	ca	ca	PROPN
aji-130	232	24	,	,	PUNCT
aji-130	232	25	willemsens	willemsens	PROPN
aji-130	232	26	lc	lc	PROPN
aji-130	232	27	,	,	PUNCT
aji-130	232	28	maarse	maarse	NOUN
aji-130	232	29	h.	h.	PROPN
aji-130	232	30	volatile	volatile	ADJ
aji-130	232	31	compounds	compound	NOUN
aji-130	232	32	in	in	ADP
aji-130	232	33	food	food	NOUN
aji-130	232	34	:	:	PUNCT
aji-130	232	35	qualitative	qualitative	ADJ
aji-130	232	36	and	and	CCONJ
aji-130	232	37	quantitative	quantitative	ADJ
aji-130	232	38	data	datum	NOUN
aji-130	232	39	.	.	PUNCT
aji-130	233	1	6	6	NUM
aji-130	233	2	.	.	X
aji-130	234	1	ed	ed	NOUN
aji-130	234	2	.	.	PUNCT
aji-130	235	1	zeist	zeist	PROPN
aji-130	235	2	food	food	PROPN
aji-130	235	3	analysis	analysis	PROPN
aji-130	235	4	institute	institute	NOUN
aji-130	235	5	.	.	PUNCT
aji-130	236	1	zeist	zeist	NOUN
aji-130	236	2	.	.	PUNCT
aji-130	237	1	1989	1989	NUM
aji-130	237	2	.	.	PUNCT
aji-130	238	1	7	7	X
aji-130	238	2	.	.	X
aji-130	238	3	simon	simon	PROPN
aji-130	238	4	ra	ra	PROPN
aji-130	238	5	.	.	PROPN
aji-130	239	1	adverse	adverse	ADJ
aji-130	239	2	reactions	reaction	NOUN
aji-130	239	3	to	to	ADP
aji-130	239	4	drug	drug	NOUN
aji-130	239	5	additives	additive	NOUN
aji-130	239	6	.	.	PUNCT
aji-130	240	1	j	j	PROPN
aji-130	240	2	allergy	allergy	PROPN
aji-130	240	3	clin	clin	PROPN
aji-130	240	4	immunol	immunol	PROPN
aji-130	240	5	.	.	PUNCT
aji-130	240	6	1984	1984	NUM
aji-130	240	7	;	;	PUNCT
aji-130	240	8	74(4	74(4	NUM
aji-130	240	9	pt	pt	NOUN
aji-130	240	10	2):623	2):623	NUM
aji-130	240	11	-	-	SYM
aji-130	240	12	30	30	NUM
aji-130	240	13	.	.	NOUN
aji-130	240	14	8	8	X
aji-130	240	15	.	.	X
aji-130	241	1	lahti	lahti	PROPN
aji-130	241	2	a	a	PRON
aji-130	241	3	,	,	PUNCT
aji-130	241	4	hannuksela	hannuksela	PROPN
aji-130	241	5	m.	m.	NOUN
aji-130	241	6	is	be	AUX
aji-130	241	7	benzoic	benzoic	ADJ
aji-130	241	8	acid	acid	NOUN
aji-130	241	9	really	really	ADV
aji-130	241	10	harmful	harmful	ADJ
aji-130	241	11	in	in	ADP
aji-130	241	12	cases	case	NOUN
aji-130	241	13	of	of	ADP
aji-130	241	14	atopy	atopy	NOUN
aji-130	241	15	and	and	CCONJ
aji-130	241	16	urticaria	urticaria	NOUN
aji-130	241	17	?	?	PUNCT
aji-130	242	1	lancet	lancet	NOUN
aji-130	242	2	.	.	PUNCT
aji-130	243	1	1981;2(8254):1055	1981;2(8254):1055	NOUN
aji-130	243	2	.	.	PUNCT
aji-130	244	1	9	9	NUM
aji-130	244	2	.	.	X
aji-130	244	3	jacob	jacob	PROPN
aji-130	244	4	se	se	PROPN
aji-130	244	5	,	,	PUNCT
aji-130	244	6	hill	hill	PROPN
aji-130	244	7	h	h	PROPN
aji-130	244	8	,	,	PUNCT
aji-130	244	9	lucero	lucero	PROPN
aji-130	244	10	h	h	NOUN
aji-130	244	11	,	,	PUNCT
aji-130	244	12	nedorost	nedorost	ADJ
aji-130	244	13	s.	s.	PROPN
aji-130	244	14	benzoate	benzoate	PROPN
aji-130	244	15	allergy	allergy	PROPN
aji-130	244	16	in	in	ADP
aji-130	244	17	children	child	NOUN
aji-130	244	18	from	from	ADP
aji-130	244	19	foods	food	NOUN
aji-130	244	20	to	to	ADP
aji-130	244	21	personal	personal	ADJ
aji-130	244	22	hygiene	hygiene	NOUN
aji-130	244	23	products	product	NOUN
aji-130	244	24	.	.	PUNCT
aji-130	245	1	pediatr	pediatr	ADJ
aji-130	245	2	dermatol	dermatol	NOUN
aji-130	245	3	.	.	PUNCT
aji-130	246	1	2016;33(2):213	2016;33(2):213	NUM
aji-130	246	2	-	-	SYM
aji-130	246	3	5	5	NUM
aji-130	246	4	.	.	NOUN
aji-130	246	5	10	10	NUM
aji-130	246	6	.	.	PUNCT
aji-130	247	1	balatsinou	balatsinou	PROPN
aji-130	247	2	l	l	PROPN
aji-130	247	3	,	,	PUNCT
aji-130	247	4	di	di	PROPN
aji-130	247	5	gioacchino	gioacchino	PROPN
aji-130	247	6	g	g	PROPN
aji-130	247	7	,	,	PUNCT
aji-130	247	8	sabatino	sabatino	PROPN
aji-130	247	9	g	g	PROPN
aji-130	247	10	,	,	PUNCT
aji-130	247	11	cavallucci	cavallucci	NOUN
aji-130	247	12	e	e	PROPN
aji-130	247	13	,	,	PUNCT
aji-130	247	14	caruso	caruso	PROPN
aji-130	247	15	r	r	PROPN
aji-130	247	16	,	,	PUNCT
aji-130	247	17	gabriele	gabriele	PROPN
aji-130	247	18	e.	e.	PROPN
aji-130	247	19	asthma	asthma	PROPN
aji-130	247	20	worsened	worsen	VERB
aji-130	247	21	by	by	ADP
aji-130	247	22	benzoate	benzoate	NOUN
aji-130	247	23	contained	contain	VERB
aji-130	247	24	in	in	ADP
aji-130	247	25	some	some	DET
aji-130	247	26	antiasthmatic	antiasthmatic	ADJ
aji-130	247	27	drugs	drug	NOUN
aji-130	247	28	.	.	PUNCT
aji-130	248	1	int	int	PROPN
aji-130	248	2	j	j	PROPN
aji-130	248	3	immunopathol	immunopathol	PROPN
aji-130	248	4	pharmacol	pharmacol	PROPN
aji-130	248	5	.	.	PUNCT
aji-130	249	1	2004;17(2):2256	2004;17(2):2256	NUM
aji-130	249	2	.	.	PUNCT
aji-130	250	1	11	11	NUM
aji-130	250	2	.	.	PUNCT
aji-130	251	1	ros	ros	PROPN
aji-130	251	2	am	am	PROPN
aji-130	251	3	,	,	PUNCT
aji-130	251	4	juhlin	juhlin	PROPN
aji-130	251	5	l	l	PROPN
aji-130	251	6	,	,	PUNCT
aji-130	251	7	michaëlsson	michaëlsson	PROPN
aji-130	251	8	g.	g.	PROPN
aji-130	251	9	a	a	DET
aji-130	251	10	follow	follow	VERB
aji-130	251	11	-	-	PUNCT
aji-130	251	12	up	up	ADP
aji-130	251	13	study	study	NOUN
aji-130	251	14	of	of	ADP
aji-130	251	15	patients	patient	NOUN
aji-130	251	16	with	with	ADP
aji-130	251	17	recurrent	recurrent	ADJ
aji-130	251	18	urticaria	urticaria	NOUN
aji-130	251	19	and	and	CCONJ
aji-130	251	20	hypersensitivity	hypersensitivity	NOUN
aji-130	251	21	to	to	ADP
aji-130	251	22	aspirin	aspirin	NOUN
aji-130	251	23	,	,	PUNCT
aji-130	251	24	benzoates	benzoate	NOUN
aji-130	251	25	and	and	CCONJ
aji-130	251	26	azo	azo	NOUN
aji-130	251	27	dyes	dye	NOUN
aji-130	251	28	.	.	PUNCT
aji-130	252	1	br	br	PROPN
aji-130	252	2	j	j	PROPN
aji-130	252	3	dermatol	dermatol	NOUN
aji-130	252	4	.	.	PUNCT
aji-130	253	1	1976;95	1976;95	NUM
aji-130	253	2	(	(	PUNCT
aji-130	253	3	1):19	1):19	NUM
aji-130	253	4	-	-	SYM
aji-130	253	5	24	24	NUM
aji-130	253	6	.	.	PUNCT
aji-130	254	1	12	12	NUM
aji-130	254	2	.	.	PUNCT
aji-130	254	3	michaëlsson	michaëlsson	PROPN
aji-130	254	4	,	,	PUNCT
aji-130	254	5	g.	g.	PROPN
aji-130	254	6	;	;	PUNCT
aji-130	255	1	juhlin	juhlin	PROPN
aji-130	255	2	,	,	PUNCT
aji-130	255	3	l.	l.	PROPN
aji-130	255	4	,	,	PUNCT
aji-130	255	5	urticaria	urticaria	NOUN
aji-130	255	6	induced	induce	VERB
aji-130	255	7	by	by	ADP
aji-130	255	8	preservatives	preservative	NOUN
aji-130	255	9	and	and	CCONJ
aji-130	255	10	dye	dye	NOUN
aji-130	255	11	additives	additive	NOUN
aji-130	255	12	in	in	ADP
aji-130	255	13	food	food	NOUN
aji-130	255	14	and	and	CCONJ
aji-130	255	15	drugs	drug	NOUN
aji-130	255	16	.	.	PUNCT
aji-130	256	1	br	br	PROPN
aji-130	256	2	j	j	PROPN
aji-130	256	3	dermatol	dermatol	PROPN
aji-130	256	4	.	.	PUNCT
aji-130	256	5	1973;88	1973;88	PROPN
aji-130	256	6	(	(	PUNCT
aji-130	256	7	6	6	NUM
aji-130	256	8	)	)	PUNCT
aji-130	256	9	,	,	PUNCT
aji-130	256	10	525	525	NUM
aji-130	256	11	-	-	SYM
aji-130	256	12	32	32	NUM
aji-130	256	13	.	.	PUNCT
aji-130	257	1	13	13	NUM
aji-130	257	2	.	.	PUNCT
aji-130	258	1	jutel	jutel	PROPN
aji-130	258	2	m	m	PRON
aji-130	258	3	,	,	PUNCT
aji-130	258	4	agache	agache	PROPN
aji-130	258	5	i	i	PRON
aji-130	258	6	,	,	PUNCT
aji-130	258	7	zemelka	zemelka	NOUN
aji-130	258	8	-	-	PUNCT
aji-130	258	9	wiacek	wiacek	PROPN
aji-130	258	10	m	m	PROPN
aji-130	258	11	,	,	PUNCT
aji-130	258	12	akdis	akdis	PROPN
aji-130	258	13	m	m	PROPN
aji-130	258	14	,	,	PUNCT
aji-130	258	15	chivato	chivato	PROPN
aji-130	258	16	,	,	PUNCT
aji-130	258	17	t	t	PROPN
aji-130	258	18	,	,	PUNCT
aji-130	258	19	del	del	PROPN
aji-130	258	20	giacco	giacco	PROPN
aji-130	258	21	s	s	PROPN
aji-130	258	22	,	,	PUNCT
aji-130	258	23	et	et	PROPN
aji-130	258	24	al	al	PROPN
aji-130	258	25	.	.	PUNCT
aji-130	259	1	nomenclature	nomenclature	NOUN
aji-130	259	2	of	of	ADP
aji-130	259	3	allergic	allergic	ADJ
aji-130	259	4	diseases	disease	NOUN
aji-130	259	5	and	and	CCONJ
aji-130	259	6	hypersensitivity	hypersensitivity	NOUN
aji-130	259	7	reactions	reaction	NOUN
aji-130	259	8	:	:	PUNCT
aji-130	259	9	adapted	adapt	VERB
aji-130	259	10	to	to	ADP
aji-130	259	11	modern	modern	ADJ
aji-130	259	12	needs	need	NOUN
aji-130	259	13	:	:	PUNCT
aji-130	259	14	an	an	DET
aji-130	259	15	eaaci	eaaci	NOUN
aji-130	259	16	position	position	NOUN
aji-130	259	17	paper	paper	NOUN
aji-130	259	18	.	.	PUNCT
aji-130	260	1	allergy	allergy	NOUN
aji-130	260	2	.	.	PUNCT
aji-130	261	1	2023;78(11):2851	2023;78(11):2851	NUM
aji-130	261	2	-	-	SYM
aji-130	261	3	2874	2874	NUM
aji-130	261	4	.	.	PUNCT
aji-130	262	1	14	14	NUM
aji-130	262	2	.	.	PUNCT
aji-130	263	1	worm	worm	PROPN
aji-130	263	2	m	m	PROPN
aji-130	263	3	,	,	PUNCT
aji-130	263	4	vieth	vieth	PROPN
aji-130	263	5	w	w	PROPN
aji-130	263	6	,	,	PUNCT
aji-130	263	7	ehlers	ehlers	PROPN
aji-130	263	8	i	i	PRON
aji-130	263	9	,	,	PUNCT
aji-130	263	10	sterry	sterry	PROPN
aji-130	263	11	w	w	PROPN
aji-130	263	12	,	,	PUNCT
aji-130	263	13	zuberbier	zuberbier	PROPN
aji-130	263	14	t.	t.	PROPN
aji-130	263	15	increased	increase	VERB
aji-130	263	16	leukotriene	leukotriene	NOUN
aji-130	263	17	production	production	NOUN
aji-130	263	18	by	by	ADP
aji-130	263	19	food	food	NOUN
aji-130	263	20	additives	additive	NOUN
aji-130	263	21	in	in	ADP
aji-130	263	22	patients	patient	NOUN
aji-130	263	23	with	with	ADP
aji-130	263	24	atopic	atopic	NOUN
aji-130	263	25	dermatitis	dermatitis	NOUN
aji-130	263	26	and	and	CCONJ
aji-130	263	27	proven	prove	VERB
aji-130	263	28	food	food	NOUN
aji-130	263	29	intolerance	intolerance	NOUN
aji-130	263	30	.	.	PUNCT
aji-130	264	1	clin	clin	PROPN
aji-130	264	2	exp	exp	PROPN
aji-130	264	3	allergy	allergy	PROPN
aji-130	264	4	.	.	PUNCT
aji-130	265	1	2001;31(2	2001;31(2	NUM
aji-130	265	2	):	):	PUNCT
aji-130	265	3	265	265	NUM
aji-130	265	4	-	-	SYM
aji-130	265	5	273	273	NUM
aji-130	265	6	.	.	NOUN
aji-130	265	7	15	15	NUM
aji-130	265	8	.	.	PUNCT
aji-130	265	9	fink	fink	VERB
aji-130	265	10	a	a	PRON
aji-130	265	11	,	,	PUNCT
aji-130	265	12	bibi	bibi	PROPN
aji-130	265	13	h	h	NOUN
aji-130	265	14	,	,	PUNCT
aji-130	265	15	eliraz	eliraz	VERB
aji-130	265	16	a	a	PRON
aji-130	265	17	,	,	PUNCT
aji-130	265	18	tabachnik	tabachnik	X
aji-130	265	19	e	e	NOUN
aji-130	265	20	,	,	PUNCT
aji-130	265	21	bentwich	bentwich	PROPN
aji-130	265	22	z.	z.	PROPN
aji-130	265	23	leukotrienes	leukotrienes	PROPN
aji-130	265	24	(	(	PUNCT
aji-130	265	25	ltc4	ltc4	PROPN
aji-130	265	26	,	,	PUNCT
aji-130	265	27	ltd4	ltd4	PROPN
aji-130	265	28	)	)	PUNCT
aji-130	265	29	confer	confer	NOUN
aji-130	265	30	glass	glass	NOUN
aji-130	265	31	non	non	NOUN
aji-130	265	32	-	-	NOUN
aji-130	265	33	adherence	adherence	NOUN
aji-130	265	34	on	on	ADP
aji-130	265	35	leukocytes	leukocyte	NOUN
aji-130	265	36	of	of	ADP
aji-130	265	37	asthmatic	asthmatic	ADJ
aji-130	265	38	individuals	individual	NOUN
aji-130	265	39	.	.	PUNCT
aji-130	266	1	dependency	dependency	NOUN
aji-130	266	2	on	on	ADP
aji-130	266	3	cyclooxygenase	cyclooxygenase	NOUN
aji-130	266	4	products	product	NOUN
aji-130	266	5	and	and	CCONJ
aji-130	266	6	calcium	calcium	NOUN
aji-130	266	7	ion	ion	NOUN
aji-130	266	8	.	.	PUNCT
aji-130	267	1	immunol	immunol	PROPN
aji-130	267	2	lett	lett	PROPN
aji-130	267	3	.	.	PUNCT
aji-130	268	1	1985;10(6):319	1985;10(6):319	PROPN
aji-130	268	2	-	-	PUNCT
aji-130	268	3	23	23	NUM
aji-130	268	4	.	.	PUNCT
aji-130	269	1	16	16	NUM
aji-130	269	2	.	.	PUNCT
aji-130	270	1	fink	fink	VERB
aji-130	270	2	a	a	PRON
aji-130	270	3	,	,	PUNCT
aji-130	270	4	bibi	bibi	PROPN
aji-130	270	5	h	h	NOUN
aji-130	270	6	,	,	PUNCT
aji-130	270	7	eliraz	eliraz	VERB
aji-130	270	8	a	a	PRON
aji-130	270	9	,	,	PUNCT
aji-130	270	10	schlesinger	schlesinger	PROPN
aji-130	270	11	m	m	PROPN
aji-130	270	12	,	,	PUNCT
aji-130	271	1	bentwich	bentwich	PROPN
aji-130	271	2	z.	z.	PROPN
aji-130	271	3	ketotifen	ketotifen	PROPN
aji-130	271	4	,	,	PUNCT
aji-130	271	5	disodium	disodium	NOUN
aji-130	271	6	cromoglycate	cromoglycate	NOUN
aji-130	271	7	,	,	PUNCT
aji-130	271	8	and	and	CCONJ
aji-130	271	9	verapamil	verapamil	NOUN
aji-130	271	10	inhibit	inhibit	VERB
aji-130	271	11	leukotriene	leukotriene	NOUN
aji-130	271	12	activity	activity	NOUN
aji-130	271	13	:	:	PUNCT
aji-130	271	14	determination	determination	NOUN
aji-130	271	15	by	by	ADP
aji-130	271	16	tube	tube	NOUN
aji-130	271	17	leukocyte	leukocyte	NOUN
aji-130	271	18	adherence	adherence	NOUN
aji-130	271	19	inhibition	inhibition	NOUN
aji-130	271	20	assay	assay	ADV
aji-130	271	21	.	.	PUNCT
aji-130	272	1	ann	ann	PROPN
aji-130	272	2	allergy	allergy	PROPN
aji-130	272	3	.	.	PUNCT
aji-130	273	1	1986;57(2):103	1986;57(2):103	PROPN
aji-130	273	2	-	-	SYM
aji-130	273	3	6	6	NUM
aji-130	273	4	.	.	NUM
aji-130	273	5	17	17	NUM
aji-130	273	6	.	.	PUNCT
aji-130	274	1	fink	fink	VERB
aji-130	274	2	a	a	PRON
aji-130	274	3	,	,	PUNCT
aji-130	274	4	shahin	shahin	PROPN
aji-130	274	5	r	r	PROPN
aji-130	274	6	,	,	PUNCT
aji-130	274	7	eliraz	eliraz	NOUN
aji-130	274	8	a	a	PRON
aji-130	274	9	,	,	PUNCT
aji-130	274	10	bibi	bibi	PROPN
aji-130	274	11	h	h	NOUN
aji-130	274	12	,	,	PUNCT
aji-130	274	13	berkenstadt	berkenstadt	ADJ
aji-130	274	14	h	h	NOUN
aji-130	274	15	,	,	PUNCT
aji-130	274	16	levin	levin	PROPN
aji-130	274	17	s	s	PROPN
aji-130	274	18	,	,	PUNCT
aji-130	274	19	et	et	PROPN
aji-130	274	20	al	al	PROPN
aji-130	274	21	.	.	PROPN
aji-130	275	1	interferon	interferon	PROPN
aji-130	275	2	modulates	modulate	VERB
aji-130	275	3	the	the	DET
aji-130	275	4	leukotriene	leukotriene	NOUN
aji-130	275	5	c4	c4	NOUN
aji-130	275	6	-	-	PUNCT
aji-130	275	7	induced	induce	VERB
aji-130	275	8	non	non	ADJ
aji-130	275	9	-	-	ADJ
aji-130	275	10	adherence	adherence	ADJ
aji-130	275	11	properties	property	NOUN
aji-130	275	12	of	of	ADP
aji-130	275	13	leukocytes	leukocyte	NOUN
aji-130	275	14	:	:	PUNCT
aji-130	275	15	acquisition	acquisition	NOUN
aji-130	275	16	of	of	ADP
aji-130	275	17	an	an	DET
aji-130	275	18	asthmatic	asthmatic	ADJ
aji-130	275	19	phenotype	phenotype	NOUN
aji-130	275	20	.	.	PUNCT
aji-130	276	1	immunol	immunol	PROPN
aji-130	276	2	lett	lett	PROPN
aji-130	276	3	.	.	PUNCT
aji-130	277	1	1985;10(3	1985;10(3	NUM
aji-130	277	2	-	-	PUNCT
aji-130	277	3	4):159	4):159	NUM
aji-130	277	4	-	-	SYM
aji-130	277	5	63	63	NUM
aji-130	277	6	.	.	PUNCT
aji-130	278	1	18	18	NUM
aji-130	278	2	.	.	PUNCT
aji-130	279	1	kuratsuji	kuratsuji	PROPN
aji-130	279	2	t.	t.	PROPN
aji-130	279	3	studies	study	NOUN
aji-130	279	4	on	on	ADP
aji-130	279	5	leukocyte	leukocyte	ADJ
aji-130	279	6	adherence	adherence	NOUN
aji-130	279	7	inhibition	inhibition	NOUN
aji-130	279	8	test	test	NOUN
aji-130	279	9	.	.	PUNCT
aji-130	280	1	part	part	PROPN
aji-130	280	2	ii	ii	PROPN
aji-130	280	3	.	.	PUNCT
aji-130	281	1	clinical	clinical	ADJ
aji-130	281	2	applications	application	NOUN
aji-130	281	3	of	of	ADP
aji-130	281	4	lai	lai	PROPN
aji-130	281	5	test	test	PROPN
aji-130	281	6	to	to	PART
aji-130	281	7	detect	detect	VERB
aji-130	281	8	delayed	delay	VERB
aji-130	281	9	type	type	NOUN
aji-130	281	10	hypersensitivity	hypersensitivity	NOUN
aji-130	281	11	in	in	ADP
aji-130	281	12	infants	infant	NOUN
aji-130	281	13	and	and	CCONJ
aji-130	281	14	children	child	NOUN
aji-130	281	15	.	.	PUNCT
aji-130	282	1	keio	keio	PROPN
aji-130	282	2	j	j	PROPN
aji-130	282	3	med	med	PROPN
aji-130	282	4	.	.	PUNCT
aji-130	283	1	1981;30(2):65	1981;30(2):65	NUM
aji-130	283	2	-	-	SYM
aji-130	283	3	9	9	NUM
aji-130	283	4	.	.	NOUN
aji-130	283	5	19	19	NUM
aji-130	283	6	.	.	PUNCT
aji-130	283	7	olivier	olivier	PROPN
aji-130	283	8	ce	ce	PROPN
aji-130	283	9	,	,	PUNCT
aji-130	283	10	pinto	pinto	NOUN
aji-130	283	11	dg	dg	PROPN
aji-130	283	12	,	,	PUNCT
aji-130	283	13	teixeira	teixeira	PROPN
aji-130	283	14	apm	apm	PROPN
aji-130	283	15	,	,	PUNCT
aji-130	283	16	santana	santana	PROPN
aji-130	283	17	jls	jls	PROPN
aji-130	283	18	,	,	PUNCT
aji-130	283	19	santos	santos	PROPN
aji-130	283	20	rapgs	rapgs	PROPN
aji-130	283	21	,	,	PUNCT
aji-130	283	22	lima	lima	PROPN
aji-130	283	23	rps	rps	PROPN
aji-130	283	24	,	,	PUNCT
aji-130	283	25	et	et	PROPN
aji-130	283	26	al	al	PROPN
aji-130	283	27	.	.	PUNCT
aji-130	284	1	evaluating	evaluate	VERB
aji-130	284	2	non	non	ADJ
aji-130	284	3	-	-	ADJ
aji-130	284	4	ige	ige	ADJ
aji-130	284	5	-	-	PUNCT
aji-130	284	6	mediated	mediate	VERB
aji-130	284	7	allergens	allergen	NOUN
aji-130	284	8	'	'	PART
aji-130	284	9	immunoreactivity	immunoreactivity	NOUN
aji-130	284	10	in	in	ADP
aji-130	284	11	patients	patient	NOUN
aji-130	284	12	with	with	ADP
aji-130	284	13	"	"	PUNCT
aji-130	284	14	intrinsic	intrinsic	ADJ
aji-130	284	15	"	"	PUNCT
aji-130	284	16	persistent	persistent	ADJ
aji-130	284	17	rhinitis	rhinitis	NOUN
aji-130	284	18	with	with	ADP
aji-130	284	19	help	help	NOUN
aji-130	284	20	of	of	ADP
aji-130	284	21	the	the	DET
aji-130	284	22	leukocyte	leukocyte	NOUN
aji-130	284	23	adherence	adherence	NOUN
aji-130	284	24	inhibition	inhibition	NOUN
aji-130	284	25	test	test	NOUN
aji-130	284	26	.	.	PUNCT
aji-130	285	1	eur	eur	PROPN
aji-130	285	2	j	j	PROPN
aji-130	285	3	med	med	PROPN
aji-130	285	4	health	health	PROPN
aji-130	285	5	sci	sci	PROPN
aji-130	285	6	.	.	PUNCT
aji-130	286	1	2023;5(1):1722	2023;5(1):1722	NUM
aji-130	286	2	.	.	NOUN
aji-130	286	3	20	20	NUM
aji-130	286	4	.	.	PUNCT
aji-130	286	5	olivier	olivier	PROPN
aji-130	286	6	ce	ce	PROPN
aji-130	286	7	,	,	PUNCT
aji-130	286	8	pinto	pinto	NOUN
aji-130	286	9	dg	dg	PROPN
aji-130	286	10	,	,	PUNCT
aji-130	286	11	teixeira	teixeira	PROPN
aji-130	286	12	apm	apm	PROPN
aji-130	286	13	,	,	PUNCT
aji-130	286	14	santana	santana	PROPN
aji-130	286	15	jls	jls	PROPN
aji-130	286	16	,	,	PUNCT
aji-130	286	17	santos	santos	PROPN
aji-130	286	18	rapgs	rapgs	PROPN
aji-130	286	19	,	,	PUNCT
aji-130	286	20	lima	lima	PROPN
aji-130	286	21	rps	rps	PROPN
aji-130	286	22	,	,	PUNCT
aji-130	286	23	et	et	PROPN
aji-130	286	24	al	al	PROPN
aji-130	286	25	.	.	PUNCT
aji-130	287	1	evaluating	evaluate	VERB
aji-130	287	2	non	non	ADJ
aji-130	287	3	-	-	ADJ
aji-130	287	4	ige	ige	ADJ
aji-130	287	5	-	-	PUNCT
aji-130	287	6	mediated	mediate	VERB
aji-130	287	7	allergens	allergen	NOUN
aji-130	287	8	'	'	PART
aji-130	287	9	immunoreactivity	immunoreactivity	NOUN
aji-130	287	10	in	in	ADP
aji-130	287	11	patients	patient	NOUN
aji-130	287	12	formerly	formerly	ADV
aji-130	287	13	classified	classify	VERB
aji-130	287	14	as	as	ADP
aji-130	287	15	"	"	PUNCT
aji-130	287	16	intrinsic	intrinsic	ADJ
aji-130	287	17	"	"	PUNCT
aji-130	287	18	asthmatics	asthmatic	NOUN
aji-130	287	19	with	with	ADP
aji-130	287	20	help	help	NOUN
aji-130	287	21	of	of	ADP
aji-130	287	22	the	the	DET
aji-130	287	23	leukocyte	leukocyte	NOUN
aji-130	287	24	adherence	adherence	NOUN
aji-130	287	25	inhibition	inhibition	NOUN
aji-130	287	26	test	test	NOUN
aji-130	287	27	.	.	PUNCT
aji-130	288	1	eur	eur	PROPN
aji-130	288	2	j	j	PROPN
aji-130	288	3	clin	clin	PROPN
aji-130	288	4	med	me	VERB
aji-130	288	5	.	.	PUNCT
aji-130	289	1	2023:4(2):1	2023:4(2):1	X
aji-130	289	2	-	-	SYM
aji-130	289	3	7	7	NUM
aji-130	289	4	.	.	NUM
aji-130	289	5	21	21	NUM
aji-130	289	6	.	.	PUNCT
aji-130	290	1	olivier	olivier	PROPN
aji-130	290	2	ce	ce	PROPN
aji-130	290	3	,	,	PUNCT
aji-130	290	4	pinto	pinto	NOUN
aji-130	290	5	dg	dg	PROPN
aji-130	290	6	,	,	PUNCT
aji-130	290	7	teixeira	teixeira	PROPN
aji-130	290	8	apm	apm	PROPN
aji-130	290	9	,	,	PUNCT
aji-130	290	10	santana	santana	PROPN
aji-130	290	11	jls	jls	PROPN
aji-130	290	12	,	,	PUNCT
aji-130	290	13	santos	santos	PROPN
aji-130	290	14	rapgs	rapgs	PROPN
aji-130	290	15	,	,	PUNCT
aji-130	290	16	lima	lima	PROPN
aji-130	290	17	rps	rps	PROPN
aji-130	290	18	,	,	PUNCT
aji-130	290	19	et	et	PROPN
aji-130	290	20	al	al	PROPN
aji-130	290	21	.	.	PROPN
aji-130	290	22	contribution	contribution	NOUN
aji-130	290	23	of	of	ADP
aji-130	290	24	the	the	DET
aji-130	290	25	leukocyte	leukocyte	NOUN
aji-130	290	26	adherence	adherence	NOUN
aji-130	290	27	inhibition	inhibition	NOUN
aji-130	290	28	test	test	NOUN
aji-130	290	29	to	to	ADP
aji-130	290	30	the	the	DET
aji-130	290	31	diagnosis	diagnosis	NOUN
aji-130	290	32	of	of	ADP
aji-130	290	33	innate	innate	ADJ
aji-130	290	34	non	non	ADJ
aji-130	290	35	–	–	PUNCT
aji-130	290	36	ige	ige	ADJ
aji-130	290	37	-	-	PUNCT
aji-130	290	38	mediated	mediate	VERB
aji-130	290	39	immunoreactivity	immunoreactivity	NOUN
aji-130	290	40	against	against	ADP
aji-130	290	41	alternaria	alternaria	PROPN
aji-130	290	42	alternata	alternata	PROPN
aji-130	290	43	.	.	PUNCT
aji-130	291	1	asian	asian	PROPN
aji-130	291	2	j	j	PROPN
aji-130	291	3	immunol	immunol	NOUN
aji-130	291	4	.	.	PUNCT
aji-130	292	1	2023;6(1):243251	2023;6(1):243251	NUM
aji-130	292	2	.	.	PUNCT
aji-130	293	1	22	22	NUM
aji-130	293	2	.	.	PUNCT
aji-130	294	1	olivier	olivier	PROPN
aji-130	294	2	ce	ce	PROPN
aji-130	294	3	,	,	PUNCT
aji-130	294	4	pinto	pinto	NOUN
aji-130	294	5	dg	dg	PROPN
aji-130	294	6	,	,	PUNCT
aji-130	294	7	teixeira	teixeira	PROPN
aji-130	294	8	apm	apm	PROPN
aji-130	294	9	,	,	PUNCT
aji-130	294	10	santana	santana	PROPN
aji-130	294	11	jls	jls	PROPN
aji-130	294	12	,	,	PUNCT
aji-130	294	13	santos	santos	PROPN
aji-130	294	14	rapgs	rapgs	PROPN
aji-130	294	15	,	,	PUNCT
aji-130	294	16	lima	lima	PROPN
aji-130	294	17	rps	rps	PROPN
aji-130	294	18	.	.	PUNCT
aji-130	295	1	contribution	contribution	NOUN
aji-130	295	2	of	of	ADP
aji-130	295	3	the	the	DET
aji-130	295	4	leukocyte	leukocyte	NOUN
aji-130	295	5	adherence	adherence	NOUN
aji-130	295	6	inhibition	inhibition	NOUN
aji-130	295	7	test	test	NOUN
aji-130	295	8	to	to	ADP
aji-130	295	9	the	the	DET
aji-130	295	10	diagnosis	diagnosis	NOUN
aji-130	295	11	of	of	ADP
aji-130	295	12	innate	innate	ADJ
aji-130	295	13	non	non	ADJ
aji-130	295	14	–	–	PUNCT
aji-130	295	15	ige	ige	ADJ
aji-130	295	16	-	-	PUNCT
aji-130	295	17	mediated	mediate	VERB
aji-130	295	18	immunoreactivity	immunoreactivity	NOUN
aji-130	295	19	against	against	ADP
aji-130	295	20	saccharomyces	saccharomyce	NOUN
aji-130	295	21	cerevisiae	cerevisiae	NOUN
aji-130	295	22	.	.	PUNCT
aji-130	296	1	asian	asian	PROPN
aji-130	296	2	j	j	PROPN
aji-130	296	3	immunol	immunol	NOUN
aji-130	296	4	.	.	PUNCT
aji-130	297	1	2023;6(1):185	2023;6(1):185	NUM
aji-130	297	2	195	195	NUM
aji-130	297	3	.	.	NOUN
aji-130	297	4	23	23	NUM
aji-130	297	5	.	.	PUNCT
aji-130	298	1	olivier	olivier	PROPN
aji-130	298	2	ce	ce	PROPN
aji-130	298	3	,	,	PUNCT
aji-130	298	4	pinto	pinto	NOUN
aji-130	298	5	dg	dg	PROPN
aji-130	298	6	,	,	PUNCT
aji-130	298	7	teixeira	teixeira	PROPN
aji-130	298	8	apm	apm	PROPN
aji-130	298	9	,	,	PUNCT
aji-130	298	10	santana	santana	PROPN
aji-130	298	11	jls	jls	PROPN
aji-130	298	12	,	,	PUNCT
aji-130	298	13	santos	santos	PROPN
aji-130	298	14	rapgs	rapgs	PROPN
aji-130	298	15	,	,	PUNCT
aji-130	298	16	lima	lima	PROPN
aji-130	298	17	rps	rps	PROPN
aji-130	298	18	,	,	PUNCT
aji-130	298	19	et	et	PROPN
aji-130	298	20	al	al	PROPN
aji-130	298	21	.	.	PROPN
aji-130	298	22	contribution	contribution	NOUN
aji-130	298	23	of	of	ADP
aji-130	298	24	the	the	DET
aji-130	298	25	leukocyte	leukocyte	NOUN
aji-130	298	26	adherence	adherence	NOUN
aji-130	298	27	inhibition	inhibition	NOUN
aji-130	298	28	test	test	NOUN
aji-130	298	29	to	to	ADP
aji-130	298	30	the	the	DET
aji-130	298	31	diagnosis	diagnosis	NOUN
aji-130	298	32	of	of	ADP
aji-130	298	33	non	non	ADJ
aji-130	298	34	–	–	PUNCT
aji-130	298	35	ige	ige	ADJ
aji-130	298	36	-	-	PUNCT
aji-130	298	37	mediated	mediate	VERB
aji-130	298	38	immunoreactivity	immunoreactivity	NOUN
aji-130	298	39	against	against	ADP
aji-130	298	40	candida	candida	NOUN
aji-130	298	41	albicans	albican	NOUN
aji-130	298	42	in	in	ADP
aji-130	298	43	patients	patient	NOUN
aji-130	298	44	with	with	ADP
aji-130	298	45	atopic	atopic	NOUN
aji-130	298	46	dermatitis	dermatitis	NOUN
aji-130	298	47	.	.	PUNCT
aji-130	299	1	asian	asian	PROPN
aji-130	299	2	j	j	PROPN
aji-130	299	3	immunol	immunol	NOUN
aji-130	299	4	.	.	PUNCT
aji-130	300	1	2023;6(1):268	2023;6(1):268	NUM
aji-130	300	2	-	-	SYM
aji-130	300	3	276	276	NUM
aji-130	300	4	.	.	PUNCT
aji-130	301	1	24	24	NUM
aji-130	301	2	.	.	PUNCT
aji-130	302	1	olivier	olivier	PROPN
aji-130	302	2	ce	ce	PROPN
aji-130	302	3	,	,	PUNCT
aji-130	302	4	pinto	pinto	NOUN
aji-130	302	5	dg	dg	PROPN
aji-130	302	6	,	,	PUNCT
aji-130	302	7	teixeira	teixeira	PROPN
aji-130	302	8	apm	apm	PROPN
aji-130	302	9	,	,	PUNCT
aji-130	302	10	santana	santana	PROPN
aji-130	302	11	jls	jls	PROPN
aji-130	302	12	,	,	PUNCT
aji-130	302	13	santos	santos	PROPN
aji-130	302	14	rapgs	rapgs	PROPN
aji-130	302	15	,	,	PUNCT
aji-130	302	16	lima	lima	PROPN
aji-130	302	17	rps	rps	PROPN
aji-130	302	18	,	,	PUNCT
aji-130	302	19	et	et	PROPN
aji-130	302	20	al	al	PROPN
aji-130	302	21	.	.	PROPN
aji-130	302	22	contribution	contribution	NOUN
aji-130	302	23	of	of	ADP
aji-130	302	24	the	the	DET
aji-130	302	25	leukocyte	leukocyte	NOUN
aji-130	302	26	adherence	adherence	NOUN
aji-130	302	27	inhibition	inhibition	NOUN
aji-130	302	28	test	test	NOUN
aji-130	302	29	in	in	ADP
aji-130	302	30	diagnosing	diagnose	VERB
aji-130	302	31	non	non	ADJ
aji-130	302	32	–	–	PUNCT
aji-130	302	33	ige	ige	ADJ
aji-130	302	34	-	-	PUNCT
aji-130	302	35	mediated	mediate	VERB
aji-130	302	36	immunoreactivity	immunoreactivity	NOUN
aji-130	302	37	against	against	ADP
aji-130	302	38	aspergillus	aspergillus	NOUN
aji-130	302	39	fumigatus	fumigatus	NOUN
aji-130	302	40	in	in	ADP
aji-130	302	41	patients	patient	NOUN
aji-130	302	42	with	with	ADP
aji-130	302	43	allergic	allergic	ADJ
aji-130	302	44	rhinitis	rhinitis	NOUN
aji-130	302	45	and	and	CCONJ
aji-130	302	46	asthma	asthma	NOUN
aji-130	302	47	.	.	PUNCT
aji-130	303	1	asian	asian	PROPN
aji-130	303	2	j	j	PROPN
aji-130	303	3	immunol	immunol	NOUN
aji-130	303	4	.	.	PUNCT
aji-130	304	1	2024;7(1):12	2024;7(1):12	NUM
aji-130	304	2	-	-	SYM
aji-130	304	3	20	20	NUM
aji-130	304	4	.	.	PUNCT
aji-130	305	1	olivier	olivier	PROPN
aji-130	305	2	et	et	PROPN
aji-130	305	3	al	al	PROPN
aji-130	305	4	.	.	PROPN
aji-130	305	5	;	;	PUNCT
aji-130	305	6	asian	asian	PROPN
aji-130	305	7	j.	j.	PROPN
aji-130	305	8	immunol	immunol	PROPN
aji-130	305	9	.	.	PROPN
aji-130	305	10	,	,	PUNCT
aji-130	305	11	vol	vol	NOUN
aji-130	305	12	.	.	PROPN
aji-130	306	1	7	7	NUM
aji-130	306	2	,	,	PUNCT
aji-130	306	3	no	no	INTJ
aji-130	306	4	.	.	NOUN
aji-130	306	5	1	1	NUM
aji-130	306	6	,	,	PUNCT
aji-130	306	7	pp	pp	ADJ
aji-130	306	8	.	.	PUNCT
aji-130	307	1	63	63	NUM
aji-130	307	2	-	-	SYM
aji-130	307	3	70	70	NUM
aji-130	307	4	,	,	PUNCT
aji-130	307	5	2024	2024	NUM
aji-130	307	6	;	;	PUNCT
aji-130	308	1	article	article	NOUN
aji-130	308	2	no.aji.115657	no.aji.115657	ADV
aji-130	308	3	69	69	NUM
aji-130	308	4	25	25	NUM
aji-130	308	5	.	.	PUNCT
aji-130	309	1	olivier	olivier	PROPN
aji-130	309	2	ce	ce	PROPN
aji-130	309	3	,	,	PUNCT
aji-130	309	4	argentão	argentão	PROPN
aji-130	309	5	dgp	dgp	NOUN
aji-130	309	6	,	,	PUNCT
aji-130	309	7	santos	santos	PROPN
aji-130	309	8	rapg	rapg	PROPN
aji-130	309	9	,	,	PUNCT
aji-130	309	10	silva	silva	PROPN
aji-130	309	11	md	md	PROPN
aji-130	309	12	,	,	PUNCT
aji-130	309	13	lima	lima	PROPN
aji-130	309	14	rps	rps	PROPN
aji-130	309	15	,	,	PUNCT
aji-130	309	16	zollner	zollner	NOUN
aji-130	309	17	rl	rl	PROPN
aji-130	309	18	.	.	PROPN
aji-130	309	19	skin	skin	PROPN
aji-130	309	20	scrape	scrape	PROPN
aji-130	309	21	test	test	NOUN
aji-130	309	22	:	:	PUNCT
aji-130	309	23	an	an	DET
aji-130	309	24	inexpensive	inexpensive	ADJ
aji-130	309	25	and	and	CCONJ
aji-130	309	26	painless	painless	ADJ
aji-130	309	27	skin	skin	NOUN
aji-130	309	28	test	test	NOUN
aji-130	309	29	for	for	ADP
aji-130	309	30	recognition	recognition	NOUN
aji-130	309	31	of	of	ADP
aji-130	309	32	immediate	immediate	ADJ
aji-130	309	33	hypersensitivity	hypersensitivity	NOUN
aji-130	309	34	in	in	ADP
aji-130	309	35	children	child	NOUN
aji-130	309	36	and	and	CCONJ
aji-130	309	37	adults	adult	NOUN
aji-130	309	38	.	.	PUNCT
aji-130	310	1	open	open	ADJ
aji-130	310	2	allergy	allergy	NOUN
aji-130	310	3	j.	j.	PROPN
aji-130	310	4	2013;6:9	2013;6:9	PROPN
aji-130	310	5	-	-	SYM
aji-130	310	6	17	17	NUM
aji-130	310	7	.	.	PUNCT
aji-130	310	8	26	26	NUM
aji-130	310	9	.	.	PUNCT
aji-130	311	1	olivier	olivier	PROPN
aji-130	311	2	ce	ce	PROPN
aji-130	311	3	,	,	PUNCT
aji-130	311	4	lima	lima	PROPN
aji-130	311	5	rps	rps	PROPN
aji-130	311	6	,	,	PUNCT
aji-130	311	7	pinto	pinto	NOUN
aji-130	311	8	dg	dg	NOUN
aji-130	311	9	,	,	PUNCT
aji-130	311	10	santos	santos	PROPN
aji-130	311	11	rapg	rapg	PROPN
aji-130	311	12	,	,	PUNCT
aji-130	311	13	silva	silva	PROPN
aji-130	311	14	gkm	gkm	PROPN
aji-130	311	15	,	,	PUNCT
aji-130	311	16	lorena	lorena	PROPN
aji-130	311	17	sls	sls	PROPN
aji-130	311	18	,	,	PUNCT
aji-130	311	19	et	et	PROPN
aji-130	311	20	al	al	PROPN
aji-130	311	21	.	.	PROPN
aji-130	312	1	in	in	ADP
aji-130	312	2	search	search	NOUN
aji-130	312	3	of	of	ADP
aji-130	312	4	a	a	DET
aji-130	312	5	tolerance	tolerance	NOUN
aji-130	312	6	-	-	PUNCT
aji-130	312	7	induction	induction	NOUN
aji-130	312	8	strategy	strategy	NOUN
aji-130	312	9	for	for	ADP
aji-130	312	10	cow	cow	NOUN
aji-130	312	11	's	's	PART
aji-130	312	12	milk	milk	NOUN
aji-130	312	13	allergies	allergy	NOUN
aji-130	312	14	:	:	PUNCT
aji-130	312	15	significant	significant	ADJ
aji-130	312	16	reduction	reduction	NOUN
aji-130	312	17	of	of	ADP
aji-130	312	18	beta	beta	NOUN
aji-130	312	19	-	-	PUNCT
aji-130	312	20	lactoglobulin	lactoglobulin	NOUN
aji-130	312	21	allergenicity	allergenicity	NOUN
aji-130	312	22	via	via	ADP
aji-130	312	23	transglutaminase	transglutaminase	NOUN
aji-130	312	24	/	/	SYM
aji-130	312	25	cysteine	cysteine	NOUN
aji-130	312	26	polymerization	polymerization	NOUN
aji-130	312	27	.	.	PUNCT
aji-130	313	1	clinics	clinic	NOUN
aji-130	313	2	.	.	PUNCT
aji-130	314	1	2012;67(10):1171	2012;67(10):1171	NUM
aji-130	314	2	-	-	SYM
aji-130	314	3	1179	1179	NUM
aji-130	314	4	.	.	PUNCT
aji-130	315	1	27	27	NUM
aji-130	315	2	.	.	PUNCT
aji-130	316	1	olivier	olivier	PROPN
aji-130	316	2	ce	ce	PROPN
aji-130	316	3	,	,	PUNCT
aji-130	316	4	santos	santos	PROPN
aji-130	316	5	rapg	rapg	PROPN
aji-130	316	6	,	,	PUNCT
aji-130	316	7	lima	lima	PROPN
aji-130	316	8	rps	rps	PROPN
aji-130	316	9	,	,	PUNCT
aji-130	316	10	argentão	argentão	ADJ
aji-130	316	11	dgp	dgp	NOUN
aji-130	316	12	,	,	PUNCT
aji-130	316	13	silva	silva	NOUN
aji-130	316	14	gkm	gkm	PROPN
aji-130	316	15	,	,	PUNCT
aji-130	316	16	silva	silva	PROPN
aji-130	316	17	md	md	PROPN
aji-130	316	18	.	.	PUNCT
aji-130	317	1	a	a	DET
aji-130	317	2	novel	novel	ADJ
aji-130	317	3	utility	utility	NOUN
aji-130	317	4	for	for	ADP
aji-130	317	5	an	an	DET
aji-130	317	6	old	old	ADJ
aji-130	317	7	method	method	NOUN
aji-130	317	8	:	:	PUNCT
aji-130	317	9	the	the	DET
aji-130	317	10	leukocyte	leukocyte	NOUN
aji-130	317	11	adherence	adherence	NOUN
aji-130	317	12	inhibition	inhibition	NOUN
aji-130	317	13	test	test	NOUN
aji-130	317	14	is	be	AUX
aji-130	317	15	an	an	DET
aji-130	317	16	easy	easy	ADJ
aji-130	317	17	way	way	NOUN
aji-130	317	18	to	to	PART
aji-130	317	19	detect	detect	VERB
aji-130	317	20	the	the	DET
aji-130	317	21	immunoreactive	immunoreactive	ADJ
aji-130	317	22	interference	interference	NOUN
aji-130	317	23	of	of	ADP
aji-130	317	24	the	the	DET
aji-130	317	25	collection	collection	NOUN
aji-130	317	26	tube	tube	NOUN
aji-130	317	27	anticoagulant	anticoagulant	NOUN
aji-130	317	28	on	on	ADP
aji-130	317	29	cellular	cellular	ADJ
aji-130	317	30	immunoassays	immunoassay	NOUN
aji-130	317	31	.	.	PUNCT
aji-130	318	1	j	j	NOUN
aji-130	318	2	cell	cell	NOUN
aji-130	318	3	adhesion	adhesion	NOUN
aji-130	318	4	.	.	PUNCT
aji-130	319	1	2014:1	2014:1	NUM
aji-130	319	2	-	-	SYM
aji-130	319	3	6	6	NUM
aji-130	319	4	article	article	NOUN
aji-130	319	5	i	i	PROPN
aji-130	319	6	d	d	PROPN
aji-130	319	7	860427	860427	NUM
aji-130	319	8	available	available	ADJ
aji-130	319	9	:	:	PUNCT
aji-130	319	10	http://dx.doi.org/10.1155/2014/86	http://dx.doi.org/10.1155/2014/86	NOUN
aji-130	319	11	0427	0427	NUM
aji-130	319	12	28	28	NUM
aji-130	319	13	.	.	PUNCT
aji-130	320	1	olivier	olivier	PROPN
aji-130	320	2	ce	ce	PROPN
aji-130	320	3	,	,	PUNCT
aji-130	320	4	pinto	pinto	NOUN
aji-130	320	5	dg	dg	PROPN
aji-130	320	6	,	,	PUNCT
aji-130	320	7	lima	lima	PROPN
aji-130	320	8	rps	rps	PROPN
aji-130	320	9	,	,	PUNCT
aji-130	320	10	silva	silva	PROPN
aji-130	320	11	md	md	PROPN
aji-130	320	12	,	,	PUNCT
aji-130	320	13	santos	santos	PROPN
aji-130	320	14	rapg	rapg	PROPN
aji-130	320	15	,	,	PUNCT
aji-130	320	16	teixeira	teixeira	PROPN
aji-130	320	17	,	,	PUNCT
aji-130	320	18	et	et	PROPN
aji-130	320	19	al	al	PROPN
aji-130	320	20	.	.	PROPN
aji-130	320	21	assessment	assessment	NOUN
aji-130	320	22	of	of	ADP
aji-130	320	23	immunoreactivity	immunoreactivity	NOUN
aji-130	320	24	against	against	ADP
aji-130	320	25	therapeutic	therapeutic	ADJ
aji-130	320	26	options	option	NOUN
aji-130	320	27	employing	employ	VERB
aji-130	320	28	the	the	DET
aji-130	320	29	leukocyte	leukocyte	NOUN
aji-130	320	30	adherence	adherence	NOUN
aji-130	320	31	inhibition	inhibition	NOUN
aji-130	320	32	test	test	NOUN
aji-130	320	33	as	as	ADP
aji-130	320	34	a	a	DET
aji-130	320	35	tool	tool	NOUN
aji-130	320	36	for	for	ADP
aji-130	320	37	precision	precision	NOUN
aji-130	320	38	medicine	medicine	NOUN
aji-130	320	39	.	.	PUNCT
aji-130	321	1	eur	eur	PROPN
aji-130	321	2	j	j	PROPN
aji-130	321	3	clin	clin	PROPN
aji-130	321	4	med	med	PROPN
aji-130	321	5	.	.	PUNCT
aji-130	322	1	2021;2(3):40	2021;2(3):40	NUM
aji-130	322	2	-	-	SYM
aji-130	322	3	45	45	NUM
aji-130	322	4	.	.	NOUN
aji-130	322	5	29	29	NUM
aji-130	322	6	.	.	PUNCT
aji-130	323	1	olivier	olivier	PROPN
aji-130	323	2	ce	ce	PROPN
aji-130	323	3	,	,	PUNCT
aji-130	323	4	pinto	pinto	NOUN
aji-130	323	5	dg	dg	PROPN
aji-130	323	6	,	,	PUNCT
aji-130	323	7	santos	santos	PROPN
aji-130	323	8	rapg	rapg	PROPN
aji-130	323	9	,	,	PUNCT
aji-130	323	10	lima	lima	PROPN
aji-130	323	11	rps	rps	PROPN
aji-130	323	12	.	.	PUNCT
aji-130	323	13	dextran	dextran	PROPN
aji-130	323	14	's	's	PART
aji-130	323	15	interference	interference	NOUN
aji-130	323	16	over	over	ADP
aji-130	323	17	the	the	DET
aji-130	323	18	leukocyte	leukocyte	NOUN
aji-130	323	19	adherence	adherence	NOUN
aji-130	323	20	inhibition	inhibition	NOUN
aji-130	323	21	test	test	NOUN
aji-130	323	22	.	.	PUNCT
aji-130	324	1	academia	academia	PROPN
aji-130	324	2	letter	letter	PROPN
aji-130	324	3	2021	2021	NUM
aji-130	324	4	,	,	PUNCT
aji-130	324	5	article	article	NOUN
aji-130	324	6	(	(	PUNCT
aji-130	324	7	number	number	NOUN
aji-130	324	8	)	)	PUNCT
aji-130	324	9	,	,	PUNCT
aji-130	324	10	3792	3792	NUM
aji-130	324	11	.	.	PUNCT
aji-130	325	1	30	30	NUM
aji-130	325	2	.	.	PUNCT
aji-130	326	1	olivier	olivier	PROPN
aji-130	326	2	ce	ce	PROPN
aji-130	326	3	,	,	PUNCT
aji-130	326	4	pinto	pinto	NOUN
aji-130	326	5	dg	dg	PROPN
aji-130	326	6	,	,	PUNCT
aji-130	326	7	teixeira	teixeira	PROPN
aji-130	326	8	apm	apm	PROPN
aji-130	326	9	,	,	PUNCT
aji-130	326	10	santana	santana	PROPN
aji-130	326	11	jls	jls	PROPN
aji-130	326	12	,	,	PUNCT
aji-130	326	13	santos	santos	PROPN
aji-130	326	14	rapgs	rapgs	PROPN
aji-130	326	15	,	,	PUNCT
aji-130	326	16	lima	lima	PROPN
aji-130	326	17	rps	rps	PROPN
aji-130	326	18	.	.	PUNCT
aji-130	327	1	immunoreactivity	immunoreactivity	NOUN
aji-130	327	2	against	against	ADP
aji-130	327	3	dermatophagoides	dermatophagoide	NOUN
aji-130	327	4	pteronyssinus	pteronyssinus	NOUN
aji-130	327	5	assessed	assess	VERB
aji-130	327	6	by	by	ADP
aji-130	327	7	the	the	DET
aji-130	327	8	leukocyte	leukocyte	NOUN
aji-130	327	9	adherence	adherence	NOUN
aji-130	327	10	inhibition	inhibition	NOUN
aji-130	327	11	test	test	NOUN
aji-130	327	12	in	in	ADP
aji-130	327	13	patients	patient	NOUN
aji-130	327	14	with	with	ADP
aji-130	327	15	intrinsic	intrinsic	ADJ
aji-130	327	16	atopic	atopic	NOUN
aji-130	327	17	dermatitis	dermatitis	NOUN
aji-130	327	18	and	and	CCONJ
aji-130	327	19	correlated	correlate	VERB
aji-130	327	20	"	"	PUNCT
aji-130	327	21	intrinsic	intrinsic	ADJ
aji-130	327	22	"	"	PUNCT
aji-130	327	23	non	non	ADJ
aji-130	327	24	–	–	PUNCT
aji-130	327	25	ige	ige	ADJ
aji-130	327	26	-	-	PUNCT
aji-130	327	27	mediated	mediate	VERB
aji-130	327	28	allergic	allergic	ADJ
aji-130	327	29	conditions	condition	NOUN
aji-130	327	30	.	.	PUNCT
aji-130	328	1	eur	eur	PROPN
aji-130	328	2	j	j	PROPN
aji-130	328	3	clin	clin	PROPN
aji-130	328	4	med	me	VERB
aji-130	328	5	.	.	PUNCT
aji-130	329	1	2021;2(6):45	2021;2(6):45	NUM
aji-130	329	2	-	-	SYM
aji-130	329	3	50	50	NUM
aji-130	329	4	.	.	PUNCT
aji-130	330	1	31	31	NUM
aji-130	330	2	.	.	PUNCT
aji-130	331	1	olivier	olivier	PROPN
aji-130	331	2	ce	ce	PROPN
aji-130	331	3	,	,	PUNCT
aji-130	331	4	pinto	pinto	NOUN
aji-130	331	5	dg	dg	PROPN
aji-130	331	6	,	,	PUNCT
aji-130	331	7	teixeira	teixeira	PROPN
aji-130	331	8	apm	apm	PROPN
aji-130	331	9	,	,	PUNCT
aji-130	331	10	santana	santana	PROPN
aji-130	331	11	jls	jls	PROPN
aji-130	331	12	,	,	PUNCT
aji-130	331	13	santos	santos	PROPN
aji-130	331	14	rapgs	rapgs	PROPN
aji-130	331	15	,	,	PUNCT
aji-130	331	16	lima	lima	PROPN
aji-130	331	17	rps	rps	PROPN
aji-130	331	18	,	,	PUNCT
aji-130	331	19	et	et	PROPN
aji-130	331	20	al	al	PROPN
aji-130	331	21	.	.	PROPN
aji-130	331	22	contribution	contribution	NOUN
aji-130	331	23	of	of	ADP
aji-130	331	24	the	the	DET
aji-130	331	25	leukocyte	leukocyte	NOUN
aji-130	331	26	adherence	adherence	NOUN
aji-130	331	27	inhibition	inhibition	NOUN
aji-130	331	28	test	test	NOUN
aji-130	331	29	to	to	ADP
aji-130	331	30	the	the	DET
aji-130	331	31	evaluation	evaluation	NOUN
aji-130	331	32	of	of	ADP
aji-130	331	33	cellular	cellular	ADJ
aji-130	331	34	immunoreactivity	immunoreactivity	NOUN
aji-130	331	35	against	against	ADP
aji-130	331	36	latex	latex	NOUN
aji-130	331	37	extracts	extract	NOUN
aji-130	331	38	for	for	ADP
aji-130	331	39	non	non	ADJ
aji-130	331	40	—	—	PUNCT
aji-130	331	41	ige	ige	ADJ
aji-130	331	42	-	-	PUNCT
aji-130	331	43	mediated	mediate	VERB
aji-130	331	44	latexfruit	latexfruit	NOUN
aji-130	331	45	-	-	PUNCT
aji-130	331	46	pollen	pollen	NOUN
aji-130	331	47	syndrome	syndrome	NOUN
aji-130	331	48	in	in	ADP
aji-130	331	49	allergic	allergic	ADJ
aji-130	331	50	candidates	candidate	NOUN
aji-130	331	51	to	to	PART
aji-130	331	52	exclusion	exclusion	VERB
aji-130	331	53	diets	diet	NOUN
aji-130	331	54	and	and	CCONJ
aji-130	331	55	allergic	allergic	ADJ
aji-130	331	56	desensitization	desensitization	NOUN
aji-130	331	57	.	.	PUNCT
aji-130	332	1	eur	eur	PROPN
aji-130	332	2	j	j	PROPN
aji-130	332	3	clin	clin	PROPN
aji-130	332	4	med	me	VERB
aji-130	332	5	.	.	PUNCT
aji-130	333	1	2022;3(1):11	2022;3(1):11	NUM
aji-130	333	2	-	-	SYM
aji-130	333	3	17	17	NUM
aji-130	333	4	.	.	PUNCT
aji-130	334	1	32	32	NUM
aji-130	334	2	.	.	PUNCT
aji-130	335	1	olivier	olivier	PROPN
aji-130	335	2	ce	ce	PROPN
aji-130	335	3	,	,	PUNCT
aji-130	335	4	pinto	pinto	NOUN
aji-130	335	5	dg	dg	PROPN
aji-130	335	6	,	,	PUNCT
aji-130	335	7	teixeira	teixeira	PROPN
aji-130	335	8	apm	apm	PROPN
aji-130	335	9	,	,	PUNCT
aji-130	335	10	santana	santana	PROPN
aji-130	335	11	jls	jls	PROPN
aji-130	335	12	,	,	PUNCT
aji-130	335	13	santos	santos	PROPN
aji-130	335	14	rapgs	rapgs	PROPN
aji-130	335	15	,	,	PUNCT
aji-130	335	16	lima	lima	PROPN
aji-130	335	17	rps	rps	PROPN
aji-130	335	18	,	,	PUNCT
aji-130	335	19	et	et	PROPN
aji-130	335	20	al	al	PROPN
aji-130	335	21	.	.	PROPN
aji-130	335	22	contribution	contribution	NOUN
aji-130	335	23	of	of	ADP
aji-130	335	24	the	the	DET
aji-130	335	25	leukocyte	leukocyte	NOUN
aji-130	335	26	adherence	adherence	NOUN
aji-130	335	27	inhibition	inhibition	NOUN
aji-130	335	28	test	test	NOUN
aji-130	335	29	for	for	ADP
aji-130	335	30	the	the	DET
aji-130	335	31	evaluation	evaluation	NOUN
aji-130	335	32	of	of	ADP
aji-130	335	33	immunoreactivity	immunoreactivity	NOUN
aji-130	335	34	against	against	ADP
aji-130	335	35	gluten	gluten	ADJ
aji-130	335	36	extracts	extract	NOUN
aji-130	335	37	in	in	ADP
aji-130	335	38	non	non	ADJ
aji-130	335	39	—	—	PUNCT
aji-130	335	40	ige	ige	ADJ
aji-130	335	41	-	-	PUNCT
aji-130	335	42	mediated	mediate	VERB
aji-130	335	43	/	/	SYM
aji-130	335	44	non	non	ADJ
aji-130	335	45	-	-	ADJ
aji-130	335	46	autoimmune	autoimmune	ADJ
aji-130	335	47	gluten	gluten	NOUN
aji-130	335	48	-	-	PUNCT
aji-130	335	49	related	relate	VERB
aji-130	335	50	disorders	disorder	NOUN
aji-130	335	51	.	.	PUNCT
aji-130	336	1	eur	eur	PROPN
aji-130	336	2	j	j	PROPN
aji-130	336	3	clin	clin	PROPN
aji-130	336	4	med	med	PROPN
aji-130	336	5	.	.	PUNCT
aji-130	337	1	2022;3(2):1	2022;3(2):1	PROPN
aji-130	337	2	-	-	PUNCT
aji-130	337	3	7	7	NUM
aji-130	337	4	.	.	NOUN
aji-130	337	5	33	33	NUM
aji-130	337	6	.	.	PUNCT
aji-130	338	1	olivier	olivier	PROPN
aji-130	338	2	ce	ce	PROPN
aji-130	338	3	,	,	PUNCT
aji-130	338	4	pinto	pinto	NOUN
aji-130	338	5	dg	dg	PROPN
aji-130	338	6	,	,	PUNCT
aji-130	338	7	teixeira	teixeira	PROPN
aji-130	338	8	apm	apm	PROPN
aji-130	338	9	,	,	PUNCT
aji-130	338	10	santana	santana	PROPN
aji-130	338	11	jls	jls	PROPN
aji-130	338	12	,	,	PUNCT
aji-130	338	13	santos	santos	PROPN
aji-130	338	14	rapgs	rapgs	PROPN
aji-130	338	15	,	,	PUNCT
aji-130	338	16	lima	lima	PROPN
aji-130	338	17	rps	rps	PROPN
aji-130	338	18	,	,	PUNCT
aji-130	338	19	et	et	PROPN
aji-130	338	20	al	al	PROPN
aji-130	338	21	.	.	PUNCT
aji-130	339	1	leukocyte	leukocyte	ADJ
aji-130	339	2	adherence	adherence	NOUN
aji-130	339	3	inhibition	inhibition	NOUN
aji-130	339	4	test	test	NOUN
aji-130	339	5	to	to	ADP
aji-130	339	6	the	the	DET
aji-130	339	7	assessment	assessment	NOUN
aji-130	339	8	of	of	ADP
aji-130	339	9	immunoreactivity	immunoreactivity	NOUN
aji-130	339	10	against	against	ADP
aji-130	339	11	cow	cow	NOUN
aji-130	339	12	's	's	PART
aji-130	339	13	milk	milk	NOUN
aji-130	339	14	proteins	protein	NOUN
aji-130	339	15	in	in	ADP
aji-130	339	16	non	non	ADJ
aji-130	339	17	—	—	PUNCT
aji-130	339	18	igemediated	igemediate	VERB
aji-130	339	19	gastrointestinal	gastrointestinal	ADJ
aji-130	339	20	food	food	NOUN
aji-130	339	21	allergy	allergy	NOUN
aji-130	339	22	.	.	PUNCT
aji-130	340	1	eur	eur	PROPN
aji-130	340	2	j	j	PROPN
aji-130	340	3	clin	clin	PROPN
aji-130	340	4	med	me	VERB
aji-130	340	5	.	.	PUNCT
aji-130	341	1	2022;3(2):38	2022;3(2):38	NUM
aji-130	341	2	-	-	SYM
aji-130	341	3	43	43	NUM
aji-130	341	4	.	.	PUNCT
aji-130	342	1	34	34	NUM
aji-130	342	2	.	.	PUNCT
aji-130	343	1	olivier	olivier	PROPN
aji-130	343	2	ce	ce	PROPN
aji-130	343	3	,	,	PUNCT
aji-130	343	4	pinto	pinto	NOUN
aji-130	343	5	dg	dg	PROPN
aji-130	343	6	,	,	PUNCT
aji-130	343	7	teixeira	teixeira	PROPN
aji-130	343	8	apm	apm	PROPN
aji-130	343	9	,	,	PUNCT
aji-130	343	10	santana	santana	PROPN
aji-130	343	11	jls	jls	PROPN
aji-130	343	12	,	,	PUNCT
aji-130	343	13	santos	santos	PROPN
aji-130	343	14	rapgs	rapgs	PROPN
aji-130	343	15	,	,	PUNCT
aji-130	343	16	lima	lima	PROPN
aji-130	343	17	rps	rps	PROPN
aji-130	343	18	,	,	PUNCT
aji-130	343	19	et	et	PROPN
aji-130	343	20	al	al	PROPN
aji-130	343	21	.	.	PROPN
aji-130	343	22	contribution	contribution	NOUN
aji-130	343	23	of	of	ADP
aji-130	343	24	the	the	DET
aji-130	343	25	leukocyte	leukocyte	NOUN
aji-130	343	26	adherence	adherence	NOUN
aji-130	343	27	inhibition	inhibition	NOUN
aji-130	343	28	test	test	NOUN
aji-130	343	29	to	to	ADP
aji-130	343	30	the	the	DET
aji-130	343	31	diagnosis	diagnosis	NOUN
aji-130	343	32	of	of	ADP
aji-130	343	33	immunoreactivity	immunoreactivity	NOUN
aji-130	343	34	against	against	ADP
aji-130	343	35	cobalt	cobalt	NOUN
aji-130	343	36	.	.	PUNCT
aji-130	344	1	asian	asian	PROPN
aji-130	344	2	j	j	PROPN
aji-130	344	3	immunol	immunol	NOUN
aji-130	344	4	.	.	PUNCT
aji-130	345	1	2023;6(1):174	2023;6(1):174	X
aji-130	345	2	-	-	PUNCT
aji-130	345	3	184	184	NUM
aji-130	345	4	.	.	NOUN
aji-130	345	5	35	35	NUM
aji-130	345	6	.	.	PUNCT
aji-130	346	1	venter	venter	PROPN
aji-130	346	2	c	c	PROPN
aji-130	346	3	,	,	PUNCT
aji-130	346	4	vieira	vieira	PROPN
aji-130	346	5	mc	mc	PROPN
aji-130	346	6	,	,	PUNCT
aji-130	346	7	fleischer	fleischer	PROPN
aji-130	346	8	d.	d.	PROPN
aji-130	346	9	tolerance	tolerance	PROPN
aji-130	346	10	development	development	NOUN
aji-130	346	11	in	in	ADP
aji-130	346	12	non	non	ADJ
aji-130	346	13	-	-	ADJ
aji-130	346	14	ige	ige	ADJ
aji-130	346	15	mediated	mediate	VERB
aji-130	346	16	food	food	NOUN
aji-130	346	17	allergies	allergy	NOUN
aji-130	346	18	:	:	PUNCT
aji-130	346	19	lessons	lesson	NOUN
aji-130	346	20	from	from	ADP
aji-130	346	21	brazil	brazil	PROPN
aji-130	346	22	.	.	PUNCT
aji-130	347	1	jornal	jornal	PROPN
aji-130	347	2	de	de	X
aji-130	347	3	pediatria	pediatria	NOUN
aji-130	347	4	.	.	PUNCT
aji-130	348	1	2023;2(30):1	2023;2(30):1	NUM
aji-130	348	2	-	-	SYM
aji-130	348	3	4	4	NUM
aji-130	348	4	.	.	NUM
aji-130	348	5	36	36	NUM
aji-130	348	6	.	.	PUNCT
aji-130	348	7	asero	asero	PROPN
aji-130	348	8	r.	r.	PROPN
aji-130	348	9	sodium	sodium	PROPN
aji-130	348	10	benzoate	benzoate	NOUN
aji-130	348	11	-	-	PUNCT
aji-130	348	12	induced	induce	VERB
aji-130	348	13	pruritus	pruritus	NOUN
aji-130	348	14	.	.	PUNCT
aji-130	349	1	allergy	allergy	NOUN
aji-130	349	2	.	.	PUNCT
aji-130	350	1	2006;61(10):1240	2006;61(10):1240	NUM
aji-130	350	2	-	-	SYM
aji-130	350	3	1	1	NUM
aji-130	350	4	.	.	PUNCT
aji-130	351	1	37	37	NUM
aji-130	351	2	.	.	PUNCT
aji-130	352	1	smith	smith	PROPN
aji-130	352	2	wl	wl	PROPN
aji-130	352	3	,	,	PUNCT
aji-130	352	4	garavito	garavito	PROPN
aji-130	352	5	rm	rm	PROPN
aji-130	352	6	,	,	PUNCT
aji-130	352	7	dewitt	dewitt	PROPN
aji-130	352	8	dl	dl	PROPN
aji-130	352	9	.	.	PROPN
aji-130	352	10	prostaglandin	prostaglandin	VERB
aji-130	352	11	endoperoxide	endoperoxide	ADJ
aji-130	352	12	h	h	NOUN
aji-130	352	13	synthases	synthase	NOUN
aji-130	352	14	(	(	PUNCT
aji-130	352	15	cyclooxygenases	cyclooxygenase	NOUN
aji-130	352	16	)	)	PUNCT
aji-130	352	17	1	1	NUM
aji-130	352	18	and	and	CCONJ
aji-130	352	19	2	2	NUM
aji-130	352	20	.	.	X
aji-130	352	21	j	j	PROPN
aji-130	352	22	biol	biol	PROPN
aji-130	352	23	chem	chem	NOUN
aji-130	352	24	.	.	PUNCT
aji-130	353	1	1996;271(52):33157	1996;271(52):33157	NUM
aji-130	353	2	-	-	SYM
aji-130	353	3	33160	33160	NUM
aji-130	353	4	.	.	PUNCT
aji-130	354	1	38	38	NUM
aji-130	354	2	.	.	PUNCT
aji-130	355	1	shimizu	shimizu	PROPN
aji-130	355	2	t.	t.	PROPN
aji-130	355	3	lipid	lipid	PROPN
aji-130	355	4	mediators	mediator	NOUN
aji-130	355	5	in	in	ADP
aji-130	355	6	health	health	NOUN
aji-130	355	7	and	and	CCONJ
aji-130	355	8	disease	disease	NOUN
aji-130	355	9	:	:	PUNCT
aji-130	355	10	enzymes	enzyme	NOUN
aji-130	355	11	and	and	CCONJ
aji-130	355	12	receptors	receptor	NOUN
aji-130	355	13	as	as	ADP
aji-130	355	14	therapeutic	therapeutic	ADJ
aji-130	355	15	targets	target	NOUN
aji-130	355	16	for	for	ADP
aji-130	355	17	the	the	DET
aji-130	355	18	regulation	regulation	NOUN
aji-130	355	19	of	of	ADP
aji-130	355	20	immunity	immunity	NOUN
aji-130	355	21	and	and	CCONJ
aji-130	355	22	inflammation	inflammation	NOUN
aji-130	355	23	.	.	PUNCT
aji-130	356	1	annual	annual	ADJ
aji-130	356	2	rev	rev	PROPN
aji-130	356	3	pharmacol	pharmacol	PROPN
aji-130	356	4	toxicol	toxicol	PROPN
aji-130	356	5	.	.	PUNCT
aji-130	357	1	2009;49(1):123	2009;49(1):123	NOUN
aji-130	357	2	-	-	SYM
aji-130	357	3	150	150	NUM
aji-130	357	4	.	.	NOUN
aji-130	357	5	39	39	NUM
aji-130	357	6	.	.	PUNCT
aji-130	358	1	liu	liu	PROPN
aji-130	358	2	m	m	PROPN
aji-130	358	3	,	,	PUNCT
aji-130	358	4	yokomizo	yokomizo	PROPN
aji-130	358	5	t.	t.	PROPN
aji-130	358	6	the	the	DET
aji-130	358	7	role	role	NOUN
aji-130	358	8	of	of	ADP
aji-130	358	9	leukotrienes	leukotriene	NOUN
aji-130	358	10	in	in	ADP
aji-130	358	11	allergic	allergic	ADJ
aji-130	358	12	diseases	disease	NOUN
aji-130	358	13	.	.	PUNCT
aji-130	359	1	allergol	allergol	PROPN
aji-130	359	2	int	int	PROPN
aji-130	359	3	.	.	PUNCT
aji-130	360	1	2015;64(1):17	2015;64(1):17	VERB
aji-130	360	2	-	-	SYM
aji-130	360	3	26	26	NUM
aji-130	360	4	.	.	PUNCT
aji-130	361	1	40	40	NUM
aji-130	361	2	.	.	PUNCT
aji-130	362	1	olivier	olivier	PROPN
aji-130	362	2	ce	ce	PROPN
aji-130	362	3	,	,	PUNCT
aji-130	362	4	lima	lima	PROPN
aji-130	362	5	rps	rps	PROPN
aji-130	362	6	,	,	PUNCT
aji-130	362	7	pinto	pinto	NOUN
aji-130	362	8	dg	dg	NOUN
aji-130	362	9	,	,	PUNCT
aji-130	362	10	santos	santos	PROPN
aji-130	362	11	rapg	rapg	VERB
aji-130	362	12	.	.	PUNCT
aji-130	363	1	the	the	DET
aji-130	363	2	plasma	plasma	NOUN
aji-130	363	3	preincubation	preincubation	NOUN
aji-130	363	4	with	with	ADP
aji-130	363	5	papain	papain	NOUN
aji-130	363	6	before	before	SCONJ
aji-130	363	7	the	the	DET
aji-130	363	8	assay	assay	NOUN
aji-130	363	9	suggests	suggest	VERB
aji-130	363	10	that	that	SCONJ
aji-130	363	11	a	a	DET
aji-130	363	12	gell	gell	NOUN
aji-130	363	13	and	and	CCONJ
aji-130	363	14	coombs	coombs	PROPN
aji-130	363	15	type	type	PROPN
aji-130	363	16	ii	ii	PROPN
aji-130	363	17	reaction	reaction	NOUN
aji-130	363	18	is	be	AUX
aji-130	363	19	been	be	AUX
aji-130	363	20	demonstrated	demonstrate	VERB
aji-130	363	21	by	by	ADP
aji-130	363	22	the	the	DET
aji-130	363	23	leukocyte	leukocyte	NOUN
aji-130	363	24	adherence	adherence	NOUN
aji-130	363	25	inhibition	inhibition	NOUN
aji-130	363	26	test	test	NOUN
aji-130	363	27	.	.	PUNCT
aji-130	364	1	biom	biom	PROPN
aji-130	364	2	j	j	PROPN
aji-130	364	3	sci	sci	PROPN
aji-130	364	4	tech	tech	NOUN
aji-130	364	5	res	re	NOUN
aji-130	364	6	.	.	PUNCT
aji-130	365	1	2021;36(3):28647	2021;36(3):28647	NUM
aji-130	365	2	-	-	SYM
aji-130	365	3	28655	28655	NUM
aji-130	365	4	.	.	PUNCT
aji-130	366	1	41	41	NUM
aji-130	366	2	.	.	PUNCT
aji-130	367	1	thomson	thomson	PROPN
aji-130	367	2	dmp	dmp	PROPN
aji-130	367	3	.	.	PROPN
aji-130	367	4	assessment	assessment	NOUN
aji-130	367	5	of	of	ADP
aji-130	367	6	immune	immune	ADJ
aji-130	367	7	status	status	NOUN
aji-130	367	8	by	by	ADP
aji-130	367	9	the	the	DET
aji-130	367	10	leukocyte	leukocyte	NOUN
aji-130	367	11	adherence	adherence	NOUN
aji-130	367	12	inhibition	inhibition	NOUN
aji-130	367	13	test	test	NOUN
aji-130	367	14	.	.	PUNCT
aji-130	368	1	academic	academic	ADJ
aji-130	368	2	press	press	NOUN
aji-130	368	3	:	:	PUNCT
aji-130	368	4	new	new	PROPN
aji-130	368	5	york	york	PROPN
aji-130	368	6	.	.	PUNCT
aji-130	369	1	1982:380p	1982:380p	NUM
aji-130	369	2	.	.	PUNCT
aji-130	370	1	42	42	NUM
aji-130	370	2	.	.	PUNCT
aji-130	371	1	tong	tong	PROPN
aji-130	371	2	aw	aw	INTJ
aji-130	371	3	,	,	PUNCT
aji-130	371	4	burger	burger	PROPN
aji-130	371	5	dr	dr	PROPN
aji-130	371	6	,	,	PUNCT
aji-130	371	7	finke	finke	PROPN
aji-130	371	8	p	p	PROPN
aji-130	371	9	,	,	PUNCT
aji-130	371	10	barney	barney	PROPN
aji-130	371	11	c	c	PROPN
aji-130	371	12	,	,	PUNCT
aji-130	371	13	vandenbark	vandenbark	PROPN
aji-130	371	14	aa	aa	PROPN
aji-130	371	15	,	,	PUNCT
aji-130	371	16	vetto	vetto	PROPN
aji-130	371	17	rm	rm	PROPN
aji-130	371	18	.	.	PROPN
aji-130	371	19	assessment	assessment	NOUN
aji-130	371	20	of	of	ADP
aji-130	371	21	the	the	DET
aji-130	371	22	mechanism	mechanism	NOUN
aji-130	371	23	of	of	ADP
aji-130	371	24	the	the	DET
aji-130	371	25	leukocyte	leukocyte	NOUN
aji-130	371	26	adherence	adherence	NOUN
aji-130	371	27	inhibition	inhibition	NOUN
aji-130	371	28	test	test	NOUN
aji-130	371	29	.	.	PUNCT
aji-130	372	1	cancer	cancer	NOUN
aji-130	372	2	res	re	NOUN
aji-130	372	3	.	.	PUNCT
aji-130	373	1	1979;39(2pt2):597	1979;39(2pt2):597	PROPN
aji-130	373	2	-	-	PUNCT
aji-130	373	3	603	603	NUM
aji-130	373	4	.	.	PUNCT
aji-130	374	1	43	43	NUM
aji-130	374	2	.	.	PUNCT
aji-130	375	1	fink	fink	VERB
aji-130	375	2	a	a	PRON
aji-130	375	3	,	,	PUNCT
aji-130	375	4	heller	heller	NOUN
aji-130	375	5	l	l	PROPN
aji-130	375	6	,	,	PUNCT
aji-130	375	7	eliraz	eliraz	VERB
aji-130	375	8	a	a	PRON
aji-130	375	9	,	,	PUNCT
aji-130	375	10	weisman	weisman	PROPN
aji-130	375	11	z	z	PROPN
aji-130	375	12	,	,	PUNCT
aji-130	375	13	miskin	miskin	PROPN
aji-130	375	14	a	a	DET
aji-130	375	15	,	,	PUNCT
aji-130	375	16	schlezinger	schlezinger	NOUN
aji-130	375	17	m	m	PROPN
aji-130	375	18	,	,	PUNCT
aji-130	375	19	et	et	PROPN
aji-130	375	20	al	al	PROPN
aji-130	375	21	.	.	PROPN
aji-130	375	22	allergenspecific	allergenspecific	PROPN
aji-130	375	23	leukocyte	leukocyte	NOUN
aji-130	375	24	adherence	adherence	NOUN
aji-130	375	25	inhibition	inhibition	NOUN
aji-130	375	26	(	(	PUNCT
aji-130	375	27	lai	lai	NOUN
aji-130	375	28	)	)	PUNCT
aji-130	375	29	assay	assay	VERB
aji-130	375	30	:	:	PUNCT
aji-130	375	31	sensitivity	sensitivity	NOUN
aji-130	375	32	,	,	PUNCT
aji-130	375	33	specificity	specificity	NOUN
aji-130	375	34	and	and	CCONJ
aji-130	375	35	olivier	olivier	NOUN
aji-130	375	36	et	et	PROPN
aji-130	375	37	al	al	PROPN
aji-130	375	38	.	.	PROPN
aji-130	375	39	;	;	PUNCT
aji-130	375	40	asian	asian	PROPN
aji-130	375	41	j.	j.	PROPN
aji-130	375	42	immunol	immunol	PROPN
aji-130	375	43	.	.	PROPN
aji-130	375	44	,	,	PUNCT
aji-130	375	45	vol	vol	NOUN
aji-130	375	46	.	.	PROPN
aji-130	376	1	7	7	NUM
aji-130	376	2	,	,	PUNCT
aji-130	376	3	no	no	INTJ
aji-130	376	4	.	.	NOUN
aji-130	376	5	1	1	NUM
aji-130	376	6	,	,	PUNCT
aji-130	376	7	pp	pp	ADJ
aji-130	376	8	.	.	PUNCT
aji-130	377	1	63	63	NUM
aji-130	377	2	-	-	SYM
aji-130	377	3	70	70	NUM
aji-130	377	4	,	,	PUNCT
aji-130	377	5	2024	2024	NUM
aji-130	377	6	;	;	PUNCT
aji-130	378	1	article	article	NOUN
aji-130	378	2	no.aji.115657	no.aji.115657	ADP
aji-130	378	3	70	70	NUM
aji-130	378	4	mechanism	mechanism	NOUN
aji-130	378	5	.	.	PUNCT
aji-130	379	1	immunol	immunol	PROPN
aji-130	379	2	lett	lett	PROPN
aji-130	379	3	.	.	PUNCT
aji-130	380	1	1987;16(1):6570	1987;16(1):6570	NOUN
aji-130	380	2	.	.	PUNCT
aji-130	381	1	44	44	NUM
aji-130	381	2	.	.	PUNCT
aji-130	382	1	halliday	halliday	PROPN
aji-130	382	2	wj	wj	PROPN
aji-130	382	3	,	,	PUNCT
aji-130	382	4	maluish	maluish	NOUN
aji-130	382	5	a	a	PRON
aji-130	382	6	,	,	PUNCT
aji-130	382	7	miller	miller	PROPN
aji-130	382	8	s.	s.	PROPN
aji-130	382	9	blocking	block	VERB
aji-130	382	10	and	and	CCONJ
aji-130	382	11	unblocking	unblocking	NOUN
aji-130	382	12	of	of	ADP
aji-130	382	13	cell	cell	NOUN
aji-130	382	14	-	-	PUNCT
aji-130	382	15	mediated	mediate	VERB
aji-130	382	16	anti	anti	ADJ
aji-130	382	17	-	-	ADJ
aji-130	382	18	tumor	tumor	ADJ
aji-130	382	19	immunity	immunity	NOUN
aji-130	382	20	in	in	ADP
aji-130	382	21	mice	mouse	NOUN
aji-130	382	22	,	,	PUNCT
aji-130	382	23	as	as	SCONJ
aji-130	382	24	detected	detect	VERB
aji-130	382	25	by	by	ADP
aji-130	382	26	the	the	DET
aji-130	382	27	leucocyte	leucocyte	PROPN
aji-130	382	28	adherence	adherence	NOUN
aji-130	382	29	inhibition	inhibition	NOUN
aji-130	382	30	test	test	NOUN
aji-130	382	31	.	.	PUNCT
aji-130	383	1	cell	cell	NOUN
aji-130	383	2	immunol	immunol	NOUN
aji-130	383	3	.	.	PUNCT
aji-130	384	1	1974;10(3):467	1974;10(3):467	NUM
aji-130	384	2	-	-	SYM
aji-130	384	3	475	475	NUM
aji-130	384	4	.	.	PUNCT
aji-130	385	1	45	45	NUM
aji-130	385	2	.	.	PUNCT
aji-130	386	1	chung	chung	PROPN
aji-130	386	2	mk	mk	PROPN
aji-130	386	3	,	,	PUNCT
aji-130	386	4	house	house	PROPN
aji-130	386	5	js	js	PROPN
aji-130	386	6	,	,	PUNCT
aji-130	386	7	akhtari	akhtari	NOUN
aji-130	386	8	fs	fs	PROPN
aji-130	386	9	,	,	PUNCT
aji-130	386	10	makris	makris	PROPN
aji-130	386	11	kc	kc	PROPN
aji-130	386	12	,	,	PUNCT
aji-130	386	13	langston	langston	PROPN
aji-130	386	14	ma	ma	PROPN
aji-130	386	15	islam	islam	PROPN
aji-130	386	16	,	,	PUNCT
aji-130	386	17	et	et	PROPN
aji-130	386	18	al	al	PROPN
aji-130	386	19	.	.	PUNCT
aji-130	386	20	decoding	decode	VERB
aji-130	386	21	the	the	DET
aji-130	386	22	exposome	exposome	NOUN
aji-130	386	23	:	:	PUNCT
aji-130	386	24	data	datum	NOUN
aji-130	386	25	science	science	NOUN
aji-130	386	26	methodologies	methodology	NOUN
aji-130	386	27	and	and	CCONJ
aji-130	386	28	implications	implication	NOUN
aji-130	386	29	in	in	ADP
aji-130	386	30	exposome	exposome	NOUN
aji-130	386	31	-	-	PUNCT
aji-130	386	32	wide	wide	ADJ
aji-130	386	33	association	association	NOUN
aji-130	386	34	studies	study	NOUN
aji-130	386	35	(	(	PUNCT
aji-130	386	36	exwass	exwass	PROPN
aji-130	386	37	)	)	PUNCT
aji-130	386	38	.	.	PUNCT
aji-130	387	1	exposome	exposome	NOUN
aji-130	387	2	.	.	PUNCT
aji-130	388	1	2024;4(1):osae0	2024;4(1):osae0	NUM
aji-130	388	2	01	01	NUM
aji-130	388	3	.	.	PROPN
aji-130	389	1	46	46	NUM
aji-130	389	2	.	.	PUNCT
aji-130	390	1	world	world	PROPN
aji-130	390	2	medical	medical	PROPN
aji-130	390	3	association	association	PROPN
aji-130	390	4	declaration	declaration	PROPN
aji-130	390	5	of	of	ADP
aji-130	390	6	helsinki	helsinki	PROPN
aji-130	390	7	:	:	PUNCT
aji-130	390	8	ethical	ethical	ADJ
aji-130	390	9	principles	principle	NOUN
aji-130	390	10	for	for	ADP
aji-130	390	11	medical	medical	ADJ
aji-130	390	12	research	research	NOUN
aji-130	390	13	involving	involve	VERB
aji-130	390	14	human	human	ADJ
aji-130	390	15	subjects	subject	NOUN
aji-130	390	16	.	.	PUNCT
aji-130	391	1	jama	jama	NOUN
aji-130	391	2	.	.	PUNCT
aji-130	392	1	2013;310(20):2191	2013;310(20):2191	X
aji-130	392	2	-	-	SYM
aji-130	392	3	4	4	NUM
aji-130	392	4	.	.	PUNCT
aji-130	393	1	_	_	PUNCT
aji-130	394	1	_	_	PUNCT
aji-130	395	1	_	_	PUNCT
aji-130	396	1	_	_	PUNCT
aji-130	397	1	_	_	PUNCT
aji-130	398	1	_	_	PUNCT
aji-130	399	1	_	_	PUNCT
aji-130	400	1	_	_	PUNCT
aji-130	401	1	_	_	PUNCT
aji-130	402	1	_	_	PUNCT
aji-130	403	1	_	_	PUNCT
aji-130	404	1	_	_	PUNCT
aji-130	405	1	_	_	PUNCT
aji-130	406	1	_	_	PUNCT
aji-130	407	1	_	_	PUNCT
aji-130	408	1	_	_	PUNCT
aji-130	409	1	_	_	PUNCT
aji-130	410	1	_	_	PUNCT
aji-130	411	1	_	_	PUNCT
aji-130	412	1	_	_	PUNCT
aji-130	413	1	_	_	PUNCT
aji-130	414	1	_	_	PUNCT
aji-130	415	1	_	_	PUNCT
aji-130	416	1	_	_	PUNCT
aji-130	417	1	_	_	PUNCT
aji-130	418	1	_	_	PUNCT
aji-130	419	1	_	_	PUNCT
aji-130	420	1	_	_	PUNCT
aji-130	421	1	_	_	PUNCT
aji-130	422	1	_	_	PUNCT
aji-130	423	1	_	_	PUNCT
aji-130	424	1	_	_	PUNCT
aji-130	425	1	_	_	PUNCT
aji-130	426	1	_	_	PUNCT
aji-130	427	1	_	_	PUNCT
aji-130	428	1	_	_	PUNCT
aji-130	429	1	_	_	PUNCT
aji-130	430	1	_	_	PUNCT
aji-130	431	1	_	_	PUNCT
aji-130	432	1	_	_	PUNCT
aji-130	433	1	_	_	PUNCT
aji-130	434	1	_	_	PUNCT
aji-130	435	1	_	_	PUNCT
aji-130	436	1	_	_	PUNCT
aji-130	437	1	_	_	PUNCT
aji-130	438	1	_	_	PUNCT
aji-130	439	1	_	_	PUNCT
aji-130	440	1	_	_	PUNCT
aji-130	441	1	_	_	PUNCT
aji-130	442	1	_	_	PUNCT
aji-130	443	1	_	_	PUNCT
aji-130	444	1	_	_	PUNCT
aji-130	445	1	_	_	PUNCT
aji-130	446	1	_	_	PUNCT
aji-130	447	1	_	_	PUNCT
aji-130	448	1	_	_	PUNCT
aji-130	449	1	_	_	PUNCT
aji-130	450	1	_	_	PUNCT
aji-130	451	1	_	_	PUNCT
aji-130	452	1	_	_	PUNCT
aji-130	453	1	_	_	PUNCT
aji-130	454	1	_	_	PUNCT
aji-130	455	1	_	_	PUNCT
aji-130	456	1	_	_	PUNCT
aji-130	457	1	_	_	PUNCT
aji-130	458	1	_	_	PUNCT
aji-130	459	1	_	_	PUNCT
aji-130	460	1	_	_	PUNCT
aji-130	461	1	_	_	PUNCT
aji-130	462	1	_	_	PUNCT
aji-130	463	1	_	_	PUNCT
aji-130	464	1	_	_	PUNCT
aji-130	465	1	_	_	PUNCT
aji-130	466	1	_	_	PUNCT
aji-130	467	1	_	_	PUNCT
aji-130	468	1	_	_	PUNCT
aji-130	469	1	_	_	PUNCT
aji-130	470	1	_	_	PUNCT
aji-130	471	1	_	_	PUNCT
aji-130	472	1	_	_	PUNCT
aji-130	473	1	_	_	PUNCT
aji-130	474	1	©	©	PRON
aji-130	474	2	copyright	copyright	NOUN
aji-130	474	3	(	(	PUNCT
aji-130	474	4	2024	2024	NUM
aji-130	474	5	):	):	PUNCT
aji-130	474	6	author(s	author(s	NOUN
aji-130	474	7	)	)	PUNCT
aji-130	474	8	.	.	PUNCT
aji-130	475	1	the	the	DET
aji-130	475	2	licensee	licensee	NOUN
aji-130	475	3	is	be	AUX
aji-130	475	4	the	the	DET
aji-130	475	5	journal	journal	PROPN
aji-130	475	6	publisher	publisher	NOUN
aji-130	475	7	.	.	PUNCT
aji-130	476	1	this	this	PRON
aji-130	476	2	is	be	AUX
aji-130	476	3	an	an	DET
aji-130	476	4	open	open	ADJ
aji-130	476	5	access	access	NOUN
aji-130	476	6	article	article	NOUN
aji-130	476	7	distributed	distribute	VERB
aji-130	476	8	under	under	ADP
aji-130	476	9	the	the	DET
aji-130	476	10	terms	term	NOUN
aji-130	476	11	of	of	ADP
aji-130	476	12	the	the	DET
aji-130	476	13	creative	creative	ADJ
aji-130	476	14	commons	common	NOUN
aji-130	476	15	attribution	attribution	NOUN
aji-130	476	16	license	license	NOUN
aji-130	476	17	(	(	PUNCT
aji-130	476	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-130	476	19	)	)	PUNCT
aji-130	476	20	,	,	PUNCT
aji-130	476	21	which	which	PRON
aji-130	476	22	permits	permit	VERB
aji-130	476	23	unrestricted	unrestricted	ADJ
aji-130	476	24	use	use	NOUN
aji-130	476	25	,	,	PUNCT
aji-130	476	26	distribution	distribution	NOUN
aji-130	476	27	,	,	PUNCT
aji-130	476	28	and	and	CCONJ
aji-130	476	29	reproduction	reproduction	NOUN
aji-130	476	30	in	in	ADP
aji-130	476	31	any	any	DET
aji-130	476	32	medium	medium	NOUN
aji-130	476	33	,	,	PUNCT
aji-130	476	34	provided	provide	VERB
aji-130	476	35	the	the	DET
aji-130	476	36	original	original	ADJ
aji-130	476	37	work	work	NOUN
aji-130	476	38	is	be	AUX
aji-130	476	39	properly	properly	ADV
aji-130	476	40	cited	cite	VERB
aji-130	476	41	.	.	PUNCT
aji-130	477	1	peer	peer	NOUN
aji-130	477	2	-	-	PUNCT
aji-130	477	3	review	review	NOUN
aji-130	477	4	history	history	NOUN
aji-130	477	5	:	:	PUNCT
aji-130	477	6	the	the	DET
aji-130	477	7	peer	peer	NOUN
aji-130	477	8	review	review	NOUN
aji-130	477	9	history	history	NOUN
aji-130	477	10	for	for	ADP
aji-130	477	11	this	this	DET
aji-130	477	12	paper	paper	NOUN
aji-130	477	13	can	can	AUX
aji-130	477	14	be	be	AUX
aji-130	477	15	accessed	access	VERB
aji-130	477	16	here	here	ADV
aji-130	477	17	:	:	PUNCT
aji-130	477	18	https://www.sdiarticle5.com/review-history/115657	https://www.sdiarticle5.com/review-history/115657	X